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Abstract  
Chikungunya virus (CHIKV) is a pathogenic, single-stranded, positive-sense RNA virus 
transmitted to humans by Aedes spp. mosquitoes. After decades of low-level endemic circulation, 
CHIKV has re-emerged to establish local transmission on five continents, infecting upwards of 
3,000,000 people (1). There are no currently available vaccines or direct-acting anti-viral 
therapeutic agents. A greater understanding of the CHIKV replication cycle is essential, as much 
of what is known about the replication cycle is assumed from studies of related but divergent 
viruses, which have provided conflicting reports. Preliminary work carried out by A. Tuplin 
(University of Leeds) suggested a highly ordered structured region at the 5′ end of the CHIKV 
genome, spanning ~300 nt including the 5′ untranslated region (UTR) and the 5′ coding sequence 
of nsp1. The aim of this project was to determine the phenotypic importance of secondary structure 
in this region for the CHIKV lifecycle in human and mosquito cells at multiple stages of viral 
replication and to investigate the sequence and structure requirements for functional interactions. 
This study represents the first investigation of functional elements within the 5′ UTR and adjacent 
nsP1-coding region in CHIKV. 
 
Taking a structure-led reverse genetic approach, in both infectious virus and sub-genomic replicon 
systems, the wild-type secondary structure of the 5′ 300 nt of the CHIKV genome was found to be 
essential for genome replication in human- and Ae. albopictus-derived cells. Six RNA stem-loops 
were determined to individually enhance CHIKV genome replication - including novel structures 
analysed for the first time in this study. Comparative analysis in human and mosquito-derived cell 
lines revealed that the novel stem-loop SL47 in the 5′ UTR functions in a host-independent manner 
while stem-loops in nsp1 function in a host-dependent manner. Stem-loops were demonstrated to 
function within the positive-strand genomic RNA, via predominantly structure-dependent 
mechanisms. Furthermore, single-host passaging studies suggested strong selection pressure to 
regenerate secondary structures and highlighted potential differences in translational recoding 
between host species. Finally, the potential for tertiary structure formation was explored. In 
addition to furthering knowledge of fundamental aspects of the molecular virology of this 
important human pathogen, this study will inform rational design of a genetically stable attenuated 
vaccine. 
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Chapter 1. Introduction 
 
1.1 General introduction 
Chikungunya virus (CHIKV) is an arthropod-borne (arbo-) virus which poses a significant threat 
to public health. After ~60 years of endemic circulation in Africa and Asia, CHIKV has entered 
naïve populations in Europe and the Americas, resulting in nearly 3,000,000 cases of Chikungunya 
fever (1). At present there are no licensed vaccines or direct-acting therapeutic agents against 
CHIKV. Very little is known about the mechanism of CHIKV replication and the requirements for 
productive infection of both the human and mosquito host. Therefore, a better mechanistic 
understanding of CHIKV replication could identify potential attenuation sites for vaccine design 
or novel drug targets for prophylactic use or post-exposure treatment. Conserved RNA structures 
within the CHIKV genome represent a potential target. 
 
In this chapter, CHIKV is described within virus phylogeny, followed by a discussion of its 
emergence, clinical features, vector specificity and control. The molecular virology of the virus is 
then described in detail including the viral genome, encoded proteins and replication cycle. 
Additionally, RNA structure is introduced, primarily in the context of mammalian virus 
replication. Finally, known and predicted RNA structures in the CHIKV genome are described and 
are summarised in Fig 1.21.  
 
1.1.1 The Togaviridae family 
The Togaviridae are a family of positive-sense, single-stranded, enveloped RNA viruses. The 
togavirus genome consists of a single RNA molecule with 5′ and 3′ untranslated regions (UTRs), 
terminating in a 5′ m7G (N7-methylguanosine) cap and 3′ polyadenylate tail. The genome contains 
two open reading frames (ORF) separated by an intergenic region. The Rubivirus genus was 
previously included in the Togaviridae, but has since been recategorised as Matonaviridae (2). 
The Togaviridae family currently comprises a single genus, the Alphavirus genus consisting of 31 
recognised species in distinct antigenic complexes based on antibody cross-reactivity (Fig 1.1). 
Alphaviruses are transmitted by mosquitoes with the exception of two aquatic alphaviruses: 
Salmon pancreatic disease virus and Southern elephant seal virus (3,4). Whole-genome 
phylogenetic analysis of the entire Alphavirus genus places marine alphaviruses  
 20 
 
 
 
Figure 1.1: The Alphavirus genus (5). Phylogeny of the Alphavirus genus based on whole-
genome analysis, excluding the hypervariable domain of nsP3. Bootstrap values are denoted for 
major branchpoints, indicating the number of times per hundred that the same branch was observed 
during re-sampling of the dataset. Viruses are grouped as sero-complexes (coloured ovals, 
labelled), where cross-reactivity is observed during haemagglutination assays. The aquatic 
alphaviruses are basal (peach). The WEE complex contains New World (WEEV) and Old World 
(SINV) viruses due to the recombination event that gave rise to WEEV. 
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at a basal position, suggesting that the ancestral alphavirus was aquatic (6). While marine 
alphaviruses are thought to be transmitted by lice, the majority of recognised alphavirus species 
are transmitted by haematophagous mosquitoes to vertebrates during bloodmeals (3,7).  
 
1.1.1.1 New World and Old World alphaviruses 
Alphaviruses have historically been classified into Old World and New World alphaviruses based 
on endemic regions, although geographical classification is becoming less useful given recent 
translocation events. New World alphaviruses are endemic to the USA, the Caribbean and South 
America, where they infect mosquitoes, horses, humans, and birds. Examples include Venezuelan 
equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV) and western equine 
encephalitis virus (WEEV). New World alphaviruses are associated with neurotropic disease, 
characterised by acute onset fever and headache progressing to altered mental state, paralysis, 
seizures and coma. The severity of disease in humans varies greatly within the New World 
alphaviruses: ~70% mortality for EEEV and ~4% for WEEV (8). In contrast, infection with Old 
World alphaviruses is rarely fatal and is typically associated with arthritogenic disease, 
characterised by maculopapular rash, severe fever and chronic musculoskeletal pain. Prior to 
recent epidemics, Old World alphaviruses such as CHIKV, Semliki Forest virus (SFV) and Sindbis 
virus (SINV) were restricted to Africa, Asia and Australia. Reservoirs of the Old World 
alphaviruses are much more diverse, including non-human primates, rodents, horses, wallabies 
and kangaroos (9,10).  
The serological cross-reactivity of SINV (an Old World virus) and WEEV (a New World virus) 
groups them into the WEE complex (Fig 1.1). This is due to a recombination event, whereby an 
EEEV-like ancestral virus acquired SINV-like envelope proteins (11). Aside from this 
recombination event, New World and Old World alphaviruses are fairly divergent, sharing ~40% 
sequence identity in structural proteins and 60-80% identity in non-structural proteins (12). 
However, conservation of RNA structures has been demonstrated by selective 2′-hydroxyl 
acylation analysed by primer extension (SHAPE) mapping in viruses as divergent as VEEV and 
SINV (13). SHAPE mapping determines the likelihood of base-pairing at single nucleotide 
resolution via reactivity of each nucleotide with N-methylisatoic anhydride (NMIA) and is 
described in more detail in 1.3.2. 
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1.1.1.2 Insect-specific alphaviruses 
The first and only recognised insect-specific alphavirus, Eilat virus (EILV), was discovered in 
2012 in Anopheles mosquitoes (14). During the last two years, four additional insect-specific 
alphaviruses have been discovered: Taï forest and Mwinilunga alphaviruses in Africa, and Agua 
Salud and Caainguá alphaviruses in South America (15–18). Almost every recognised alphavirus 
species is pathogenic to humans, livestock or wildlife. Bias in virus discovery has resulted in an 
underrepresentation of non-pathogenic, insect-specific and marine alphaviruses within the genus. 
Further expansion of the Alphavirus genus will provide insight into virulence factors of currently 
recognised members.  
 
1.1.1.3 CHIKV phylogeny 
CHIKV comprises three genotypes based on nucleic acid sequence and geographical origin: Asian, 
West African (WA) and East, Central and South African (ECSA) (19) (Fig 1.2). CHIKV is well 
conserved across the genotypes. Intra-lineage comparisons demonstrate up to 99.8% nucleotide 
sequence identity within envelope protein genes, while inter-lineage comparisons indicate genetic 
divergence of up to 15% (20). However, even the most divergent CHIKV strains share a minimum 
of 95% amino acid (aa) identity in the envelope proteins (21). Despite genetic similarity between 
genotypes, relatively few amino acid substitutions are necessary to alter key processes of 
pathogenesis and virulence. For example, Asian CHIKV exhibited increased neurovirulence 
compared to ECSA CHIKV following intracerebral inoculation of mice as a result of a 7 aa 
deletion in nsP3 (22). Comparison of pathology in vertebrates and altered vector specificity 
suggests the emergence of a distinct lineage within the ECSA genotype, the Indian Ocean lineage 
(IOL) (23) (Fig 1.2).  
 
Comparative studies of virulence in the three genotypes, including the ECSA-derived IOL lineage, 
demonstrated higher virulence for WA genotypes and lower virulence associated with Asian 
CHIKV infection of mice (24). Vaccination of cynomolgus macaques with an experimental 
CHIKV/IRESv1 vaccine based on the IOL lineage (discussed in 1.1.5.1) provided cross-protection 
against lethal challenge with CHIKV of all genotypes and similar cross-protection was observed 
in mice. Cross-protection against all CHIKV lineages following vaccination agrees with 
observations that induction of humoral immunity following natural CHIKV infection is associated  
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Figure 1.2: Phylogenetic tree of CHIKV strains based on amino acid identity of the complete 
coding region (adapted from (23)).  Three genotypes are shown: Asian, West African, East, 
Central and South African (ECSA). The Indian Ocean lineage arose from the ECSA, thus is shown 
within the genotype, but exhibits more severe pathogenicity. The scale bar (bottom) represents 
time in years, with CHIKV strains isolated between 1953 and 2015. 
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with lifelong immunity (25,26). In spite of high genetic similarity between genotypes, lineage-
specific differences in the length and identity of the 3′ untranslated region (UTR) have been 
determined in the number of repeated cis-acting structures and sequences (27,28) (discussed in 
1.3.3). In contrast, the identity and length of the 5′ UTR is highly conserved across the lineages.  
 
1.1.2 CHIKV epidemiology 
 
1.1.2.1 Emergence of CHIKV 
CHIKV was first isolated in 1952 in the Newala district of modern-day Tanzania (29,30). 
Following the Newala epidemic, frequent epidemics occurred between 1952 and 1980 in fifteen 
African states (23,31) (Fig 1.3). CHIKV presumably emerged as a zoonotic infection from non-
human primates, transmitted by arboreal Aedes spp. mosquitoes. CHIKV has been isolated from 
Ae. furcifer and Ae. africanus in sylvatic cycle with non-human primates: African green monkeys, 
mandrills, red-tail monkeys, Guinea baboons and a bushbaby (32–37). In contrast, CHIKV in Asia 
is primarily transmitted by the peridomestic Ae. aegypti and Ae. albopictus in an urban 
transmission cycle with no identified reservoir host. The first Asian epidemic of CHIKV was 
reported in Thailand in 1958, although recent whole-genome phylogenetic analysis of CHIKV 
strains estimates introduction as early as 1920 (38,39). Subsequent endemic spread was described 
in Southeast Asia and India (40,41) (Fig 1.3). In endemic regions of Africa and Asia, major 
outbreaks ceased from ~1980-2000.  
 
1.1.2.2 Re-emergence of CHIKV 
A resurgence in CHIKV infections began with an epidemic in the Democratic Republic of Congo 
in 2000 (42). In 2004, a large epidemic began in Kenya and spread rapidly to islands in the Indian 
Ocean including La Réunion in 2005 (Fig 1.4A). The La Réunion CHIKV strain diverged from 
the ECSA sufficiently to be termed the Indian Ocean lineage (IOL). The IOL was associated with 
more severe disease: neurological symptoms, fulminant hepatitis and higher mortality (43,44).  
The IOL also developed adaptive mutations enabling higher rates of replication in Ae. albopictus 
(45). Naïve populations, where Ae. albopictus was the only competent vector, exhibited high attack 
rates, between 35-70% (44,46). Subsequently, the IOL circulated in India, China and Southeast 
Asia as well as infecting urban populations of African Ae. albopictus (20,47–49). 
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Figure 1.3: Map of CHIKV endemic areas prior to 2004. Countries which had reported local 
transmission of CHIKV prior to 2004 are coloured according to the first reports in Africa and Asia 
(red) and subsequent reports of clinical disease (orange). Grey colouring indicates no local 
transmission. Imported cases are not shown. Map produced using mapchart.net using data collated 
from: (19,23,31). 
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A second CHIKV re-emergence took place in 2013 when an epidemic strain of Asian genotype 
CHIKV circulating in China and the Philippines was introduced to the Caribbean island of Saint 
Martin (50). Within 3 years, autochthonous transmission of CHIKV was reported in 45 countries 
in the Caribbean, North, South and Central America (1) (Fig 1.4B). A third translocation event 
occurred in 2014 when an ECSA strain from Cameroon was introduced to Brazil and Haiti (28,51–
53) (Fig 1.4C). Concurrent epidemics resulting from distinct CHIKV lineages highlight the need 
for pan-lineage CHIKV treatments and vaccines with targets such as the RNA-dependent RNA 
polymerase and conserved RNA structures (described in 1.2.5.4 and 1.3.2). 
 
As of 2019, only two European countries have reported autochthonous transmission of CHIKV, 
by Ae. albopictus in both instances (54,55) (Fig 1.5). A CHIKV outbreak in northern Italy in the 
summer of 2007 resulted in 217 symptomatic cases (54). The A226V ECSA CHIKV strain was 
isolated from local Ae. albopictus populations, confirming autochthonous transmission (56). 
Vector control measures limited the outbreak, halting local transmission. A second outbreak 
occurred in central Italy a decade later in the summer of 2017, leading to a secondary outbreak in 
southern Italy with a total number of symptomatic cases exceeding 400 (57).  
 
Autochthonous transmission of CHIKV in Europe was also demonstrated during three small 
epidemics of Chikungunya fever in southern France in 2011, 2014 and 2017 (55,58,59). Temperate 
Ae. albopictus captured in France were found to transmit CHIKV with high efficiency, comparable 
to that of Ae. aegypti (60). Local transmission was prevented in France by the same aggressive 
vector control as in Italy (61). The CHIKV-competent vector Ae. albopictus is present in almost 
20 European countries, rendering Europe vulnerable to CHIKV epidemics. Furthermore, global 
warming has enabled survival of vector species in previously inhospitable regions, as demonstrated 
by the recent discovery of Ae. albopictus eggs and adults in southern England (62,63). European 
epidemics would involve immunologically naïve populations, which are associated with increased 
morbidity and mortality (64–66). Although arboviral research often utilises Ae. aegypti-derived 
cells, Ae. albopictus represents the most likely vector of CHIKV epidemics in Europe. 
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Figure 1.4: Map of CHIKV re-emergence from 2004-2019 during three separate pandemics. 
The lineage responsible for each pandemic is displayed in the top right (black box). Major 
translocation events (grey arrows) and significant locations (red dots) are displayed for each 
pandemic. (A) The 2005-2006 La Réunion (red dot) epidemic of the Indian Ocean lineage began 
in Kenya (light purple) and was reported in many countries throughout Asia (dark purple). (B) The 
2012 Asian genotype epidemic began in China (light blue) and spread throughout the Americas, 
beginning in Saint Martin (red dot). Countries reporting local transmission are coloured (dark 
blue). Alaska remains grey due to geographical separation and lack of cases. (C) The 2014 ECSA 
epidemic in Brazil (red dot) began in Cameroon (light pink) and was transmitted by travelers 
returning from Angola, spreading to several countries (dark pink). Map produced using 
mapchart.net using data collated from: (1,19,23,28,31,52,53). 
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Figure 1.5: Worldwide distribution of CHIKV in 2019. Countries which have reported 
autochthonous, local transmission of CHIKV as of September 2019 are coloured (green). Grey 
colouring indicates no local transmission. Imported cases are not shown. Map produced using 
mapchart.net using data from the centre for disease control (CDC), 2019 (67,68). 
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1.1.3  The pathogenesis of CHIKV infection in humans 
The name ‘Chikungunya’ derives from the Kimakonde dialect of southern Tanzania, meaning “to 
walk bent over” due to the distinctive bent posture of sufferers. Following transmission by a 
mosquito bite, CHIKV replicates in fibroblasts and macrophages at the site of inoculation, 
producing viraemia up to 108 virions/mL of blood (69) (Fig 1.6). The virus then disseminates to 
the muscle, joints, brain, liver and lymphoid tissue (70,71).  
 
After an incubation period of 2-4 days, a sudden onset of clinical disease is observed in the majority 
of infections;  around 25% remain asymptomatic (72–74). Increasing viraemia coincides with the 
acute phase of infection, characterised by high fever (39-40°C), maculopapular rash and 
debilitating, symmetric polyarthralgia in the wrists, ankles, hands and feet (75) (Fig 1.7). The 
painful symptoms of CHIKV are a result of tissue injury induced by cytopathic infection and the 
inflammatory immune response (69). Additional symptoms include arthritis, headache, myalgia, 
back pain, conjunctivitis and gastrointestinal distress. Fatal CHIKV infections and severe 
complications such as hepatitis, haemorrhage, encephalopathy and myocarditis were recorded for 
the first time during the La Réunion epidemic of 2005-6 (254 deaths) and the Indian epidemic of 
2006 (76–78). Pregnant women, neonates, the elderly and patients with pre-existing chronic 
illnesses were particularly at risk for complications (78,79).  
 
CHIKV infection is typically self-limiting. Rising viral titre induces a strong type I interferon 
response leading to clearance of viraemia within one week and resolution of acute symptoms 
within two weeks (80). CHIKV-specific adaptive immunity (immunoglobulins IgM and IgG) is 
detectable at the time of viral clearance, associated with life-long immunity against all CHIKV 
lineages (26). Following the acute phase, ~60% patients experience chronic arthralgia for an 
average of 9 months (81–83). Post-Chikungunya chronic inflammatory rheumatism is more 
common in people over 35 and those with previous injury, where arthritis may result in deformity 
(84,85) (Fig 1.8). Ongoing chronic inflammation in the joints is thought to be an induced 
autoimmune response; CHIKV was not detectable in the synovial fluid of 38 patients with chronic 
arthralgia 22 months post-infection (86) However, macrophages have been identified as a cellular 
reservoir of persistent CHIKV infection in the muscle, joints and liver of chronically infected 
cynomolgus macaques (70) and one La Réunion patient (82). 
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Figure 1.6: Dissemination of CHIKV in vertebrates (87). CHIKV is transmitted by mosquito 
bite, followed by replication in fibroblasts in the skin (dashed box). CHIKV then disseminates into 
cells of the liver, muscle, joints, lymphoid tissue and brain, as labelled.  
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Figure 1.7: Clinical presentation of Chikungunya fever (adapted from (88)). (A) Percentage 
of symptomatic patients displaying a range of symptoms, in decreasing order of frequency: 
(89,90). A schematic representation of a symptomatic patient is shown, coloured circles represent 
the typical location of symptoms. Symptoms of Chikungunya fever include (B) a stooped posture 
adopted to relieve arthralgia, (C) swollen, painful joints, especially wrists and phalanges, and (D) 
maculopapular rash. 
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Figure 1.8: Model of post-infection chronic inflammation and arthritis. (A) Schematic 
representation of acute inflammation and post-Chikungunya chronic inflammation. The synovial 
fluid of the chronically inflamed joint retains a subset of leukocytes and increased levels of pro-
inflammatory mediators such as IL-6 which contribute to prolonged inflammation, swelling and 
pain. The pathology of the joint mirrors that of rheumatoid arthritis (adapted from (91)) (B) Hand 
X-Ray of patient with chronic, debilitating post-infection arthritis (85). 
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1.1.4  Replication of CHIKV within Aedes spp. mosquitoes 
In addition to replication in humans and non-human primates, CHIKV replicates within Aedes spp. 
mosquitoes; they are biological vectors and do not mechanically transfer CHIKV by passive means 
(Fig 1.9). After a female mosquito ingests an infectious bloodmeal, CHIKV penetrates the midgut 
by infection of epithelial cells or, more rarely, by extravasation directly into the haemocoel (92). 
Dissemination of the virus through the haemocoel leads to rapid infection of secondary tissues 
including the fat body, muscle, haemocytes and salivary glands (93). Infectious CHIKV in the 
salivary glands is detectable 48 hours post-ingestion by immunostaining and plaque assay (7,94). 
In contrast to the acute pathogenic infection seen in vertebrates, CHIKV infection of Aedes spp. 
mosquitoes is typically lifelong and asymptomatic despite extensive, disseminated viremia (95). 
One exception to apathogenic CHIKV infection in mosquitoes was observed during experimental 
infection with the IOL epidemic strain. Ae. albopictus populations from La Réunion infected with 
A226V-IOL CHIKV died 7-9 days sooner than uninfected counterparts, representing loss of a 
quarter of the typical lifespan. Interestingly, no pathogenesis was observed during infection of Ae. 
albopictus or Ae. aegypti from nearby Mayotte island, suggesting intra-species differences in 
vector competence and pathogenesis. Mayotte island, located a similar distance from Madagascar, 
experienced an epidemic during the same period. Ae. albopictus from La Réunion exhibited a 
higher concentration of CHIKV in the salivary glands than those from Mayotte, in addition to 
higher concentrations of CHIKV disseminated through the organism (96).  
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Figure 1.9: Schematic representation of CHIKV replication within Aedes spp. mosquitoes 
(adapted from (97)). A longitudinal cross section of an Aedes spp. mosquito is shown, with 
labelled midgut (MG) and salivary glands (SG). The passage of virions is denoted by black arrows 
and described in 5 stages (circled numbers). Within the midgut, the peritrophic membrane formed 
after a bloodmeal is shown (dashed circle). Escape of CHIKV from the midgut lumen (bottom 
right): (1) CHIKV infects midgut epithelial cells, (2) replicates and (3) buds into the haemocoel 
through the basal lamina. Alternatively, (4) ‘leaky’ midgut may allow direct extravasation or (5) 
CHIKV may infect the trachea before (6) entering the haemocoel. Entry into the salivary gland 
lumen (bottom left): (1) CHIKV crosses the basal lamina and infects salivary gland epithelium, 
(2) replicates and (3) buds into the lumen or (4) is released during apoptosis of infected cells. 
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Vector competence refers to the suitability of a species to transmit a pathogen. This property 
depends on appropriate cellular biology, anatomy and behaviour of the vector species. A 
competent vector must display intracellular permissivity to infection, high levels of replication 
within the organism and efficient, frequent transmission to susceptible hosts (98). Aedes spp. 
mosquitoes facilitate high, continuous levels of CHIKV replication and dissemination to the 
salivary glands (34). Within the Aedes genus, the behaviour of Ae. aeygpti confers the greatest 
vector competence, especially compared to arboreal and rural mosquitoes (99). Ae. aegypti is 
exclusively anthropophilic and takes multiple bloodmeals per gonotrophic cycle, enabling frequent 
transmission between humans (100). Ae. aegypti also demonstrates a preference for artificial larval 
habitats in urban environments, such as water containers, increasing levels of contact with humans. 
In comparison, Ae. albopictus is more ecologically flexible; it is found in urban and rural 
environments, tropical and temperate climates and uses a range of natural and artificial larval 
habitats (101). Ae. albopictus is not exclusively anthropophilic and typically ingests a single blood 
meal per gonotrophic cycle, reducing the likelihood of human-to-human transmission. However, 
Ae. albopictus is more susceptible to CHIKV infection than Ae. aegypti, resulting in a greater 
proportion of infected mosquitoes and higher titres in the salivary glands. Experimental infection 
of Ae. aegypti and Ae. albopictus from a range of North and South American countries determined 
transmission efficiency of 83% and 97% respectively (102). In addition, Ae. albopictus is invasive 
and widespread, particularly in more temperate regions where Ae. aegypti is not established (103). 
Despite species-specific differences, Ae. aegypti and Ae. albopictus share several important 
characteristics; they are both aggressive, diurnal species with desiccation-resistant eggs, enabling 
survival in urban environments (104) (Fig 1.10). One particularly devastating similarity is the 
ability of Ae. aegypti and Ae. albopictus to support productive co-infection with CHIKV and 
DENV. Oral inoculation of each species resulted in infectious CHIKV and DENV particles in the 
saliva which could be transmitted by a single bite, with no significant increase in mortality for the 
mosquito (105,106). Triple experimental infection with CHIKV, DENV and ZIKV was supported 
by Ae. aegypti and serological studies indicated the presence of triple infections in patients in South 
America (106,107).  
Prior to recent epidemics, Ae. aegypti was considered the primary vector of CHIKV and Ae. 
albopictus a secondary vector. During the La Réunion epidemic, adaptive mutations in the CHIKV 
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envelope proteins E1 and E2 significantly increased infectivity for Ae. albopictus. A single E1-
A226V mutation increased CHIKV vector infectivity, dissemination, and transmissibility to mice 
(45). Epistatic mutations E2-G60D, E2-L210Q and E2-I211T increased infectivity for midgut 
epithelium in the context of the E1-A226V mutation (108,109). The emergence of more severe 
CHIKV pathogenesis, including the first reports of fatal infections, coincided with CHIKV 
adaptation to Ae. albopictus (45,75). However, transmission by Ae. albopictus during this epidemic 
involved a naïve population. Thus, it is difficult to disentangle the relative importance of the novel 
vector of ECSA CHIKV and the immunologically vulnerable human population.  
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Figure 1.10: CHIKV vectors (redrawn from (19)). Typical behaviour and ecological features of 
the two CHIKV vectors Ae. aegypti (left) and Ae. albopictus (right). Scales below indicate the 
relative contribution of behavior and susceptibility in determining level of vector competence for 
each species. Photographs by James Gathany, CDC Public Health Image Library. 
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1.1.5  Treatments, vaccines and control 
 
1.1.5.1 Vaccines  
Currently, there are no licensed vaccines or anti-viral therapeutic agents for prevention or 
treatment of CHIKV infection (110). The first live vaccine candidate, developed by 18 plaque-to-
plaque passages in human embryonic lung cells, was attenuated during Phase 1 trials (111,112). 
Unfortunately, transient arthralgia was reported by 8.5% of recipients during Phase 2, resulting in 
abandonment over safety concerns despite 98% seroconversion (113). Later studies determined 
that attenuation of the passaged strain was due to two point mutations in the E2 envelope protein, 
which reverted to the wild-type sequence during infection of mice (114).  
 
Several vaccine strategies have been evaluated including live-attenuated vaccines generated by 
deletions (115), virus-like particles (116), DNA (117) and subunit vaccines (118). Two approaches 
in particular have utilised host alternation of CHIKV. Firstly, an Eilat virus/CHIKV chimeric 
alphavirus (EILV-CHIKV) was designed, composed of the non-structural genes of the insect-
specific EILV and the structural genes of CHIKV. EILV-CHIKV can be generated easily in 
mosquito cells but is attenuated in mice, inducing protective levels of neutralising antibodies 
within 4 days post-infection (119). Secondly, a CHIKV strain with a picornavirus internal 
ribosome entry site (IRES) in place of the sub-genomic promoter cannot replicate in mosquitoes 
(120) (sub-genomic promoter described in 1.3.2.2.1). Furthermore, in mice and cynomolgus 
macaques, CHIKV-IRESv1 structural protein expression is reduced, attenuating viral replication 
and protecting against challenge with all CHIKV lineages (121,122). One particularly promising 
live-attenuated vaccine candidate is in preparation for Phase 3 trials, combining the Schwartz 
measles virus (MV) vaccine strain with the structural genes of CHIKV to form the recombinant 
MV-CHIKV. During Phase 2 trials of the MV-CHIKV vaccine in 263 recipients, a single 
immunisation induced seroconversion in 50-93% of recipients, while a second immunisation 
within six months produced high titres of neutralising antibodies in 86-100% with minor adverse 
effects (123).  
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1.1.5.2 Anti-viral therapeutics  
In the absence of specific anti-viral compounds, non-specific antipyretics, anti-inflammatory drugs 
and analgesics are the only available treatments for symptomatic patients. Screens of existing food 
and drug administration (FDA)-approved compounds in cell culture has revealed several 
compounds which prevent productive CHIKV infection due to inhibited entry or replication, 
including flavonoids (124), flavaglines (125), suramin (126) and natural products such as curcumin 
(127). In particular, known anti-virals have been investigated for activity against CHIKV, 
including ribavirin (128). A small clinical study in 10 patients suffering with chronic post-CHIKV 
arthritis confirmed the efficacy of ribavirin treatment; 200mg ribavirin twice per day significantly 
reduced joint swelling and arthralgia in 80% subjects (129). Combination therapy with interferon 
(IFN)-α and ribavirin synergistically suppressed CHIKV replication in cell culture compared to 
monotherapy (130). Another promising approach is the use of monoclonal antibodies (mAbs). 
Derivatives of the extremely potent human mAb 4N12 were protective against a lethal CHIKV 
dose when administered up to 3 days post-infection in mice and rhesus macaques (131,132).  
 
1.1.5.3 Vector control 
At present, control of CHIKV epidemics relies on personal preventative measures and reduction 
of mosquito populations. During CHIKV outbreaks, individuals are encouraged to apply topical 
repellents such as DEET (N,N-diethyl-3-methylbenzamide) and minimise skin exposure (133). 
20% concentrated DEET repels Aedes spp. for up to 10 hours and insecticide-treated nets have 
been shown to reduce the incidence of vector-borne diseases (134,135).  
 
As described above, Ae. aegypti and Ae. albopictus deposit eggs in refuse and water containers. 
Community-based involvement in reducing the number of accessible breeding sites has proven 
effective in reducing Ae. aeypti populations (136). Potential breeding sites which cannot be 
removed can be treated with larvicides such as organophosphates and growth regulators (137,138). 
During emergencies, adult mosquito populations are reduced by space and residual insecticide 
spraying, along with mass trapping in autocidal gravid ovitraps (AGO) (139,140). One study of 
integrated vector control in Puerto Rico combined source reduction, larvaciding and mass trapping, 
demonstrating ~85-95% reduction in Ae. aegypti around target houses (140). A recent study in 
Puerto Rico demonstrated that AGO traps reduced rates of CHIKV infection from 70% to 20%, as 
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determined by seroconversion, suggesting that vector control can reduce incidence of CHIKV-
related disease (141). Despite their efficacy, current control methods are expensive, labour-
intensive and require high levels of compliance from individuals, communities and governmental 
agencies. Additionally, resistance to insecticides has been documented in Ae. aegypti (142).  
 
Controlled testing of a unique approach to vector control is underway, involving the release of 
male mosquitoes which are sterile or cannot produce viable offspring with wild-type field females. 
Release of irradiated Ae. aeypti males has been shown to reduce vector populations, but irradiation 
lowers their mating competitiveness (143). Infection of male mosquitoes with the maternally 
inherited endosymbiont Wolbachia does not reduce competitiveness and results in sterile matings 
with females carrying an incompatible strain of Wolbachia, due to cytoplasmic incompatibility 
(144). However, any anomaly during rearing which led to the release of lab-infected females would 
overcome the engineered cytoplasmic incompatibility. A combination of triple-strain Wolbachia 
infection and low-level irradiation of males, to prevent fertility in any accidentally released 
females, has proven effective in eliminating Ae. albopictus populations in a field trial in China 
(145). An alternative approach was taken by Oxitec Ltd, whereby transgenic males with a lethal 
tetracycline-repressed gene were reared in the presence of tetracycline prior to release. Male 
OX513A mosquitos successfully reduced Ae. aegypti populations by 95% in field trials in 
Jacobina, Brazil (146). However, portions of the transgenic OX513A genome were detected in the 
Ae. aegypti population 12-24 months later, indicating that lethality of offspring was not complete 
(147).  
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1.2 CHIKV 
 
1.2.1  Virion structure 
CHIKV is a small, enveloped virus of ~70 nm in diameter (148). The icosahedral nucleocapsid is 
formed from 240 capsomeres with T=4 symmetry, encapsidating a single-stranded, positive-sense 
RNA genome (Fig 1.11A). The virion surface consists of a host-derived lipid bilayer studded with 
80 trimeric glycoprotein spikes (Fig 1.11B). The structure of the spikes, each a trimer of E1-E2 
heterodimers, was determined by X-ray crystallography (149). The nucleocapsid, formed from 
pentameric and hexameric capsomeres, tightly associates with the lipid bilayer via direct 
interactions of capsomeres with the trans-membrane helix of the viral envelope protein E2 (Fig 
1.11C). Cryo-electron microscopy studies of mature and immature CHIKV virus-like particles 
confirm that E3 is cleaved from released virions during maturation (150–152). The structural 
proteins are discussed in more detail in 1.2.4. 
 
1.2.2  Genome organisation 
The CHIKV genome is a single-stranded, positive-sense RNA molecule roughly 11.8 kb in length 
(153). The genome comprises two open reading frames (ORFs) flanked by 5′ and 3′ untranslated 
regions (UTRs) and separated by a non-coding intergenic region (IGR) (Fig 1.12A). The 5′ UTR 
is 76 nt in length and contains a 5′ type-0 N7-methylguanosine cap for initiation of cap-dependent 
translation. The 3′ UTR varies in length between ∼500 and ∼900 nt and includes a 3′ polyadenylate 
tail. ORF-1 encodes the non-structural proteins nsP1–4, which form distinct modules of the viral 
replicase complex that is responsible for CHIKV RNA synthesis. ORF1 is translated directly from 
the genomic 49S RNA as a polyprotein. An opal stop codon between nsp3 and nsp4 regulates 
expression of nsP4, the RNA-dependent RNA polymerase (RdRp) (43,154). ORF2 encodes six 
proteins including three major structural proteins (C, E1 and E2). In contrast to ORF1, ORF2 is 
translated from a sub-genomic 26S RNA transcribed from a sub-genomic promoter in the negative 
strand. Expression of the 26S RNA depends on successful genome replication, allowing temporal 
control of structural gene expression (12,155) (Fig 1.12B). In addition to protein-coding 
sequences, the CHIKV genome harbours important RNA elements within coding and non-coding 
regions (described in detail in 1.3.3). 
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Figure 1.11: Cryo-electron microscopy (cryo-EM) structure of the mature CHIKV virion at ∼5.3 Å (adapted from (151)). Surface-shaded figure of (A) nucleocapsid and (B) ectodomain. 
White triangles indicate one icosahedral asymmetric unit. (C) Cross-section of a virion showing 
density above 1.5 σ. Each figure is coloured according to the radial distance from the centre of the 
virus, as shown by the key (far right). The RNA genome is shown in blue, the capsid and membrane 
in turquoise and green, and the envelope (E) proteins in yellow and red. The trans-membrane (TM) 
helix of E2 can be seen associating with the nucleocapsid. 
 
 
 
 
Figure 1.12: CHIKV genome organisation (redrawn from (156)). (A) Schematic representation 
of the CHIKV genome (49S) displaying two open reading frames (ORFs) encoding the non-
structural and structural proteins. The methylguanosine cap is denoted by a black circle and the 
polyadenosine tail by AAA…. The position of an opal termination codon between nsp3 and nsp4 
in ORF1 is denoted (*). (B) Schematic representation of the sub-genomic 26S RNA encoding the 
structural proteins. The AUG start codon of genomic 49S RNA and 26S sub-genomic RNA are 
denoted by black arrows. 
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1.2.3  Replication cycle 
The CHIKV envelope protein E2 binds to the cell adhesion molecule matrix remodeling-associated 
8 (Mxra8) at the plasma membrane, in addition to attachment factors such as glycosaminoglycans 
(157–160) (Fig 1.13). After E2-mediated binding to surface receptors, the CHIKV virion is 
internalised via an Eps15-dependent, clathrin-independent mechanism and delivered to early 
endosomes (161). In mosquito cells, early (Rab5+) and late (Rab7+) endosomes are both required 
for CHIKV entry (162). Endosomal acidification protonates histidine residues on E2, loosening 
interactions between E1/E2 and exposing the E1 fusogenic peptide (149,163). Intercalation of the 
fusogenic peptide with the endosomal membrane causes formation of E1 homotrimers. Multiple 
E1 homotrimers associate to form a fusion pore, releasing the nucleocapsid into the cytosol within 
10 seconds of exposure to acidic pH (164,165). 
 
Upon entry into the cytosol, the nucleocapsid is bound by the 60S ribosomal subunit, inducing 
uncoating within 1-2 minutes. Each 60S subunit irreversibly sequesters 3-6 capsid monomers, 
resulting in rapid disassembly of the nucleocapsid and releasing the viral genome for translation 
(166,167). Several capsid monomers are thought to remain associated with the viral genome, as 
specific capsid-binding sites within the viral RNA are necessary for efficient early translation. The 
mechanisms behind this enhancement are currently not well understood (168). The CHIKV 
genome undergoes canonical cap-mediated translation of ORF1 to produce the non-structural 
polyprotein variants, P123 and P1234. An opal stop codon between nsp3 and nsp4 regulates the 
expression of P1234 via termination codon readthrough, resulting in ~10% frequency of 
expression of the RNA-dependent RNA polymerase (RdRp) nsP4 (169). Efficient translation of 
the viral genome in mosquito cells has an additional requirement for a triple tandem sequence 
motif in the 3′ UTR (170). Nascent P1234 is anchored to proximal endosomal membranes by nsP1 
and efficiently cleaved by nsP2 in cis to produce a complex of P123 and nsP4 (171,172). Cleaved 
nsP4 is highly unstable in the cytosol and is stabilised by inclusion in the replication complex 
(173). nsP3 enzymatically activates the P123/nsP4 complex to form a functional replicase which 
is competent for negative strand synthesis (174). The initiation of negative strand synthesis is 
concurrent with the formation of membrane invaginations termed spherules and the recruitment of 
cellular factors (175–177). In mammalian cells, the P123/nsP4 complex traffics to the plasma 
membrane for spherule formation. In mosquito cells, live cell imaging, fluorescent reporter viruses 
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and transmission electron microscopy (TEM) analysis demonstrate that replication occurs in 
spherules exclusively on intracellular cytopathic vacuoles (178,179). The key differences between 
CHIKV replication in mammalian and insect cells are highlighted below; the most important 
differences involve sites of spherule formation, specialization of cytopathic vacuoles and the extent 
of internal budding (Fig 1.14). 
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Figure 1.13: CHIKV replication cycle (redrawn from (180)). CHIKV binds to cellular receptors 
(pink Y shapes) via glycoprotein spikes (black) and is endocytosed. Decreasing pH (H+) in the 
endosome (dark green circle) results in membrane fusion and release of the nucleocapsid into the 
cytosol. Capsid (C) monomers (green) associate with ribosomal subunits (grey) and release the 
viral genome (49S gRNA) (pink line). Translation of the viral genome yields the non-structural 
polyproteins P123 and P1234 which are processed into P123 and nsP4. P123 and nsP4 form the 
negative strand replicase which binds to the 3′ of the 49S gRNA before internalisation into 
invaginations at the plasma membrane where negative strand synthesis occurs. When the cytosolic 
concentration of P123 is high enough to support an efficient reaction in trans, P123 cleaved into 
mature non-structural proteins: nsP1-4. Cleavage of P123 rearranges the replicase to favour 
binding to the negative strand (purple line), resulting in positive strand synthesis. The 49S gRNA 
and a 26S sub-genomic (sg) RNA which encodes the structural polyprotein are released into the 
cytosol. Translation of the sgRNA releases the C protein by autoproteolysis, followed by co-
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translational translocation of precursor of envelope protein 2 (pE2), 6K, and E1 into the 
endoplasmic reticulum (ER). The C proteins and 49S gRNA accumulate in the cytoplasm and 
assemble into nucleocapsids (green hexagons). The envelope proteins E1-3 are modified during 
transit through the secretory pathway and form E1-E2 heterodimers with E2-associated E3. 
Glycoprotein spikes accumulate on the plasma membrane and E2 cytoplasmic domains interact 
with the nucleocapsid. CHIKV virions bud from the membrane and undergo maturation soon after 
release, shedding E3. 
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Figure 1.14: Differences in CHIKV replication in mammalian and mosquito cells. Expression 
of CHIKV non-structural proteins in mammalian cells (A) results in spherule formation on the 
plasma membrane followed by internalization of spherules onto the surface of specialized 
cytopathic vacuoles (dark blue) (CPV-I). Expression of structural proteins results in accumulation 
of viral glycoproteins on the plasma membrane and in arrays on the surface of a second type of 
cytopathic vacuole (CPV-II). Expression of CHIKV non-structural proteins in Aedes mosquito 
cells (B) results in spherule formation directly on the surface of cytopathic vacuoles (dark blue) 
(CPV). Expression of structural proteins results in accumulation of viral glycoproteins on the 
plasma membrane and in arrays on the surface of the same type of cytopathic vacuole. Extensive 
budding of virions into the lumen of the CPV is observed in mosquito cells, a process which is 
much more limited in mammalian CPV-II. The figure uses the same key as Fig1.13, using data 
drawn from (179). 
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Negative strand synthesis is regulated by interactions between the N-terminal domain of the RdRp 
nsP4 and each of the components of P123. Mutations in the N-terminus of nsP4 which diminished 
negative strand synthesis were suppressed by mutations in nsP1-3 (181). Similarly, mutations in 
nsP2 and nsP3 can reduce or abolish negative strand synthesis (182,183). During replication, nsP1 
catalyses the addition of a cap to nascent RNA, nsP2 acts a helicase to unwind RNA secondary 
structures and nsP3 plays an ill-defined role, potentially via zinc-binding or adenosine 
monophosphate (AMP) binding. P123-associated nsP4 is restricted to negative strand synthesis. 
Expression of uncleavable P123 results in negative strand synthesis only, without subsequent 
synthesis of genomic and sub-genomic positive RNAs. Extraction of nsP4 from uncleavable P123 
complexes by fractionation demonstrated that nsP4 is capable of synthesising genomic RNA of 
both polarities in isolation and thus P123 locks nsP4 into a restricted conformation. In this context, 
nsP4 binds efficiently to the 3′ negative strand promoter in the positive genomic RNA, as 
demonstrated by electrophoretic mobility shift assay (EMSA) and RNA cross-linking assays, and 
produces negative strand genomic RNA (184,185). The negative strand intermediate does not 
contain a 3′ polyA tail but contains a 5′ polyU transcribed from the 3′ polyA of the positive-sense 
genomic RNA. The addition of a 5′ methylguanylyl cap to the negative-sense intermediate has not 
been investigated (186). 
 
Sequential cleavage of P123 to nsP1/2/3 regulates the switch from negative to positive strand 
synthesis (187) (Fig 1.15). Mutational analyses demonstrated that nsP2 must cleave junctions 1/2 
and 3/4 sequentially at conserved residues (188,189). In vitro analysis using uncleavable 
polyproteins and deletion mutants revealed that junction 1/2 was cleaved in cis, within 20-30 
minutes, exposing an activator sequence which promotes cleavage of 2/3. Junction 2/3 is 
subsequently cleaved in trans, dependent on prior release of nsP1 (172,190). Thus, negative strand 
synthesis is time-limited by spontaneous cleavage of nsP1 in cis and sensitive to increasing 
concentrations of nsP2 capable of cleavage in trans. The transition from the P123 to nsP1/2/3 
replicase is irreversible and permanently prevents negative strand synthesis, indicating extensive 
rearrangement within the complex (191). The structure of uncleaved P23 displays a highly charged 
interface, suggesting an electrostatic interaction post-cleavage (192). nsP1/2/3-associated nsP4 is 
restricted to positive-strand synthesis and recognises the genomic and sub-genomic promoters in 
the negative strand via two distinct RNA-binding sites on nsP4 (184,193). Isolated nsP4 is 
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incapable of synthesising sub-genomic RNA in isolation and requires cleaved nsP1/2/3 (185). In 
particular, mutations in nsP2 often result in defects in sub-genomic RNA synthesis, indicating that 
it plays a key role as a transcription factor for nsP4 (194,195). Similar phenotypes have been 
observed for nsP3 mutants, although genomic RNA synthesis is also affected (196,197). The 
nsP1/2/3/4 complex synthesises full length positive-sense RNA and sub-genomic 26S RNA 
encoding the structural proteins of ORF2. As replication progresses, cleaved nsP1 and nsP3 direct 
internalisation of spherules from the plasma membrane onto the surface of cytopathic vacuoles 
similar to those utilised in mosquito cells (198). 
As the concentration of non-structural polyproteins in the cytosol increases, rapid cleavage occurs 
in trans which releases nsP1, nsP2 and nsP3 for non-replicative functions. nsP1 remains 
membrane-associated and induces formation of short extensions from the membrane involved in 
pathogenesis. Release of nsP2 is essential for nuclear localisation, transcriptional and translation 
shut-off and interference with innate immunity (199). nsP3 localises to cytoplasmic foci where it 
sequesters stress granule components such as GTPase Activating Protein (SH3 Domain) Binding 
Protein (G3BP) proteins and the mosquito homologue Rasputin (199,200). 
Late during infection, viral genome replication initiates translational shutoff via activation of 
protein kinase R (PKR) and subsequent phosphorylation of eukaryotic translation initiation factor 
2α (eIF2α) (201). Translation of the 49S genomic RNA is inhibited but translation of the sub-
genomic 26S messenger RNA (mRNA) continues efficiently via a cap-independent mechanism, 
favouring production of structural proteins (202,203). During translation of the 26S RNA, 
autoproteolysis of the nascent capsid protein exposes a signal sequence in E3, directing the 
ribosome to the ER membrane. Signal peptidase cleaves 6K from pE2 and E1 upon translocation 
into the lumen (204). The proteins are trafficked through the secretory pathway where they 
undergo a series of complex folding events and acquire post-translational modifications such as 
palmitoylation and glycosylation (205). Furin cleavage of pE2 occurs in a post-Golgi compartment 
to form non-covalently associated E2 and E3 (206). E3 stabilises the interaction of E2 with the 
fusion loop of E1, preventing premature exposure in acidic pH (152). 
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Figure 1.15: Regulation of CHIKV genome replication. (A) Processing of the replicase complex 
over the viral replication cycle and its relation to (B) negative strand synthesis and (C) positive 
strand synthesis. (i) P1234 is initially cleaved into P123 and nsP4 by nsp2 in cis (red arrow and 
dashed line), forming (ii) a negative strand-competent replicase. The P123/nsP4 complex binds 
(grey arrow) to the 3′of positive-sense 49S genomic RNA (gRNA) (pink line) to produce a full 
length negative-sense strand (purple line). (iii) Within ~30 minutes of translation, P123 is cleaved 
into nsP1 and P23 by nsp2 in cis. (iv) A final cleavage between nsP2 and nsP3 occurs in trans and 
depends upon increasing non-structural protein expression in the cytosol. (v) Fully cleaved, mature 
nsP1-4 forms the positive strand-competent replicase which binds (grey arrow) to the of the 
negative strand at two distinct sites: the 3′ genomic promoter and intergenic sub-genomic 
promoter. Recognition of the intergenic promoter requires nsP2. Positive strand synthesis produces 
genomic and sub-genomic RNA species (pink lines). Black arrows indicate direction of RNA 
synthesis. Black outline around nsPs indicates maturation and cleavage from the polyprotein. Data 
drawn from: (172,184,185,190). 
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Interaction between the capsid protein and an SFV-like packaging signal in nsp2 nucleates 
assembly of the CHIKV nucleocapsid, followed by rapid dimerisation of bound capsid via N-
terminal α-helices (207,208). A hydrophobic pocket of the capsid protein binds the phosphorylated 
cytoplasmic tail of E2 and mediates acquisition of the lipid envelope (209,210). Despite the ability 
of the nucleocapsid to assemble in vitro in the absence of E2, disruption of E2-C interactions 
resulted in aberrant capsid formation and non-budding phenotypes in vivo (211,212). An early 
interaction between C and E2 may direct formation of the nucleocapsid (NC) and tight interactions 
with E2 necessary for budding (213). 6K and TF proteins also influence virion stability, association 
of C-E2 and budding (214,215). 
 
Arrays of glycoprotein spikes accumulate on the plasma membrane and on the internal side of 
cytopathic vacuoles (216). In mammalian cells, virions bud from the plasma membrane. However, 
in mosquito cells, budding also occurs into the lumen of cytopathic vacuoles. Intra-luminal 
budding is associated with cell-to-cell spread through the secretory pathway, evading immune 
recognition and aiding dissemination (178). Persistently infected mosquito cells appear to increase 
lysosomal degradation of vacuole-associated spherules and intra-luminal virions (179). 
 
1.2.4  Structural proteins  
The structures of the CHIKV capsid and envelope proteins have been recently resolved by X-ray 
crystallography (149,210). There have been no structural studies of CHIKV 6K or TF proteins and 
very few direct studies of CHIKV structural protein functions. Parallels must be drawn with related 
alphaviruses which have been studied in detail, particularly SFV and SINV. CHIKV structural 
proteins contain a high degree of protein sequence homology with known functional regions of 
SFV. Cryo-EM reconstruction of the CHIKV virion demonstrates high concordance between the 
structures of CHIKV, SFV, SINV and VEEV (151,217–219). 
 
1.2.4.1 Capsid 
The CHIKV capsid protein (CP) is a multi-functional 29 kDa protein which forms pentameric and 
hexameric capsomeres during nucleocapsid assembly. The CP consists of an N-terminal RNA-
binding domain and a C-terminal serine protease domain (Fig 1.16) (220). The N-terminal domain  
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Figure 1.16: Structural protein domain organisation  
Domain organisation of the alphaviral structural proteins: capsid (CP), envelope proteins 1-3 (E1-
3), 6K and trans-frame (TF) protein. Recognised domains, in terms of either structural or genetic 
evidence, are indicated as grey boxes. Specific features, as indicated on their respective proteins, 
are briefly listed below. CP: NLS and NES denote nuclear localization and nuclear export 
sequences. E2: immunoglobulin domains A,B and C are labelled; ASR indicates the acid sensitive 
region of domain B. 6K: TM1 and TM2 indicate transmembrane domains 1 and 2; TM2 contains 
the signal sequence for co-translational translocation of E2. TF: TM1 indicates transmembrane 
domain 1; diagonal lines depict the +1 frameshift during translation, leading to a unique C-
terminus for TF compared to 6K. E1: β-barrel domains I-III are labelled; FP denotes the fusion 
peptide. 
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is highly positively charged and intrinsically disordered (221,222). Deletion of the N-terminal 
domain reduces the specificity of genomic RNA encapsidation in VEEV and enables promiscuous 
capsomere dimerisation between the heterologous alphaviruses SINV, WEEV and RRV 
(223,224). The C-terminal domain of the CP is autoproteolytic, acting in cis to release itself from 
the N-terminus of the nascent structural polyprotein during translation of the 26S RNA (225,226). 
The crystal structure of the CHIKV C-terminal protease domain of CP has been resolved at 2.2 Å, 
revealing a chymotrypsin-like protease and a hydrophobic pocket capable of interacting with the 
cytoplasmic domain of E2 (210). In addition, the CHIKV CP contains sequences for nuclear import 
and export at the N- and C- termini respectively (227). Nuclear-cytoplasmic shuttling of the 
CHIKV CP relies on karyopherin-α-mediated import and chromosomal maintenance 1 protein 
(CRM1)-mediated export, but the function of nuclear localisation is unknown.  
 
1.2.4.2 Envelope (E1-3) proteins 
The mature CHIKV virion contains 240 heterodimers of envelope glycoproteins E1 and E2, 
arranged in 80 trimeric spikes (149,228). Cryo-EM reconstruction suggests that monomers of E1 
form the base of each trimeric spike, creating an icosahedral lattice across the virion surface 
(229,230). Crystallographic studies of the E1-E2 heterodimer reveal that the extended stem and 
apex of each glycoprotein spike is composed of E2 (149). E2 interacts with host receptors to initiate 
endocytosis and E1 contains the hydrophobic peptide necessary for fusion of viral and endosomal 
membranes (230,231). E1 and E2 are both ~430 aa in length, glycosylated and palmitoylated (232). 
E1 contains three β-barrel domains; domain II contains the fusion peptide and domain III 
terminates in a transmembrane helix which extends through the lipid bilayer by 6 aa (Fig 1.16) 
(218). E2 is composed entirely of β sheet, with three immunoglobulin domains; domain B contains 
the highly-exposed apical structure suitable for receptor binding and domain C contains the 
transmembrane (TM) helix (149). The E2 TM helix extends 33 aa into the inner cavity of the 
virion, interacting with the hydrophobic pocket of the capsid protein. Each E2 cytosplasmic tail 
contacts a capsomere, forming 240 1:1 interactions which enable tight pairing of the envelope and 
the nucleocapsid (210). Dissociation of the E1-E2 heterodimers is induced by low pH, resulting in 
homotrimers of E1 with exposed fusogenic peptides (233,234).  
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Cryo-EM reconstruction of immature CHIKV virions reveals envelope protein E3 in complex with 
E2 (152). The 64 aa E3 protein contains an N-terminal β-hairpin and three α-helices (149). E2 and 
E3 are translated as the precursor polyprotein pE2, sometimes called p62. The precursor is 
necessary for correct folding of the pE2-E1 heterodimer during co-translational insertion into the 
endoplasmic reticulum membrane (235). The E3-E2 junction of pE2 is an exposed loop which is 
cleaved by furin during traffic through the secretory pathway (149). E3 is lost during maturation 
of the CHIKV virion post-egress and can be found in extracellular fluid but not purified mature 
virus (150,151). 
 
1.2.4.3 Protein 6K/TF protein 
6K is a small, hydrophobic, cysteine-rich protein of 61 aa amino acids in length, consisting of two 
transmembrane domains joined by an 8 aa cytoplasmic linker (Fig 1.16) (236). The first domain is 
thought to act as an ion channel via oligomerisation within the membrane. Insertion of bacterially 
expressed 6K proteins into planar lipid bilayers has demonstrated cation-selective ion channel 
activity of 6K, indicating that it may function as a viroporin (155). The second transmembrane 
domain of 6K is the signal sequence for E1 (236). Deletion or mutation of 6K is associated with 
decreased virion stability, release of multi-cored virions and accumulation of nucleocapsids at the 
plasma membrane with impaired budding (237–239).  
 
A second accessory protein, the 8 kDa transframe (TF) protein, is encoded within the 6K gene. 
The TF protein represents the N-terminal 70-80% of 6K with a C-terminal elongation of ~30 
codons in the -1 reading frame. Frameshifting frequency is ~2% (240). The TF protein was 
identified in purified CHIKV virions using mass spectrometry. Phenotypic studies in SINV 
indicate functionality of TF as an ion channel and in virion budding in a similar manner to 6K 
(215). This is not surprising given that TF retains ~80% of the 6K primary sequence, but the unique 
functions of TF remain to be established. 
 
1.2.5  Non-structural proteins 
 
1.2.5.1 Non-structural protein 1 (nsP1) 
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Non-structural protein 1 (nsP1) is a 58 kDa protein with two primary functions (Fig 1.17). The N-
terminal domain of nsP1 directs capping of nascent positive-sense viral RNA, which is essential 
for viral mRNA translation and successful replication (241) (Fig 1.18A). The guanine-7-
methyltransferase (MTase) and guanylyltransferase (GTase) activities of nsP1 were first identified 
by biochemical assays (242,243). Subsequent studies using [α-32P]GTP revealed cross-linking of 
nsP1 to the methyl donor S-adenosylmethionine and m7Gp (244,245). Reverse genetic analysis 
revealed that successful MTase activity is a prerequisite for GTase activity, thus methylation of 
GTP precedes guanosine monophosphate (GMP)-transfer to the disphosphate mRNA (245). This 
is in contrast to canonical capping mechanisms where methylation occurs after transfer of the 
guanylyl moiety to diphosphate RNA (246). The MTase motif transfers a methyl group from S-
adenosylmethionine to GTP, producing m7Gppp. Subsequently, the GTase motif covalently binds 
m7Gppp, releasing pyrophosphate (PPi) (244). The m7Gp moiety is then transferred from the 
catalytic GTase residue to the 5′ pp-RNA generated by nsP2 triphosphatase activity (247). Reverse 
genetic analysis revealed that both MTase and GTase activities are necessary for successful SINV 
replication (241). 
 
nsP1 is also responsible for anchoring the replication complex to cellular membranes, a process 
which is essential for productive SFV infection (248) (Fig 1.18B). The enzymatic activity of SFV 
nsP1 depends on association with anionic phospholipids such as phosphatidylserine and can be 
disrupted by the addition of detergents (171). nsP1 membrane-binding maps to a 20 aa sequence 
which is highly conserved across the Alphavirus genus (171). Nuclear magnetic resonance (NMR) 
studies of this peptide revealed a structural transition in the presence of anionic phospholipids, 
from a random coil to an amphipathic alpha-helix (248). Green fluorescent protein (GFP)-SFV 
localisation studies demonstrated that two tandem copies of the amphipathic peptide sequence are 
necessary for membrane-association (249). SFV nsP1 localises to the plasma membrane even in 
mutants deficient in spherule formation, suggesting that nsP1 anchoring is not sufficient for 
spherule biogenesis (250).  
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Figure 1.17: Non-structural protein domain organisation (adapted from (251)) 
Domain organisation of the alphaviral non-structural proteins nsP1-4. Recognised domains, in 
terms of either structural or genetic evidence, are indicated as grey boxes. Specific features, as 
indicated on their respective proteins, are briefly listed below. nsP1: H designates the catalytic 
histidine residue of the GTase domain; MB1 and MB2 indicate the sites of the membrane-binding 
amphipathic helix and the palmitoylation site of nsP1, respectively. MTase, methyltransferase; 
GTase, guanylyltransferase. nsP2: NLS1 and NLS2 indicate nuclear localisation sequences; the 
catalytic residues of the protease active site are indicated with a C and H, respectively. NTPase, 
nucleoside triphosphatase. nsP3: the location of the zinc ion coordination site is denoted with Zn; 
the presence of ampiphysin interaction sites is denoted with Ampi. AUD, alphavirus unique 
domain. nsP4: the functional GDD catalytic triad of RdRp is shown. 
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Figure 1.18: Functions of nsP1. (A) The alphaviral mechanism of capping requires nsP1 (pink) 
and nsP2 (orange). The methyl donor S-adenosylmethionine is labelled AdoMet and phosphate 
denoted by p. Guanine-7-methyltransferase (MTase) and guanylyltransferase (GTase) activities of 
nsP1 are labelled. Data from: (244,247). (B) Membrane-anchoring ability of nsP1 requires two 
amphipathic membrane-binding helices (purple) labelled α, which intercalate with the lipid bilayer 
(grey). Palmitate modification is shown in blue. The N- and C- terminals and cytosolic domains 
of nsP1 (pink) are displayed, with a dotted line representing the rest of the replicase complex. Data 
from: (249). C) Scanning electron micrograph of an SFV-infected baby hamster kidney (BHK-21) 
cell with short extensions of the membrane (bar represents 10 µm) (252). (D) Interaction of nsP1 
(in the context of P123) with nsP4 within the spherule (black line), directing negative strand 
synthesis. nsPs are labelled 1-4. Positive-strand (blue) and nascent negative-strand (yellow, 
dashed) genomic RNA is displayed. Data from: (241,253,254). 
  
(A) (B)
(C) (D)
cytosolic
extracellular
N
C
α
Palmitate
cytosolicextracellular
1
2
3
4
Negative strand
Positive strand
 59 
In addition to the well-studied functions above, nsP1 has been implicated two further processes. A 
palmitoylation site in nsP1 is associated with the induction of short projections from the plasma 
membrane (255,256) (Fig 1.18C). Real-time live imaging of fluorescent protein-tagged SINV 
demonstrated the formation of nsP1-positive filopodia in SINV-infected cells – in both mosquito 
and mammalian cells (179). These filopodia can be induced by expression of nsP1 alone and 
removal of the palmitoylation site C418-C420 residues of nsP1 in SINV and SFV prevented 
induction of filopodial extensions (257). Palmitoylation-defective SFV and SINV nsP1 exhibited 
wild-type enzymatic activity, spherule biogenesis and membrane association (252,258). The 
function of nsP1-induced filopodia is unknown but inhibition of SFV nsP1 palmitoylation 
decreased pathogenesis and neurovirulence in mice (258).  
 
The nsP1 palmitoylation site may be the site of nsP1-nsP4 contact, independent of the presence of 
palmitate. Removal of the 3 aa palmitoylation site resulted in attenuated negative strand synthesis 
but longer deletions of 7 aa replicate to wild-type levels, suggesting the existence of structural 
contacts necessary for nsP1-nsP4 association (259). Palmitoylation-defective nsP1 mutants which 
attenuated replication were associated with loss of nsP1-nsP4 binding and were restored by 
compensatory mutation in nsP1 which did not restore the palmitoylation site. Thus, palmitoylation 
is not thought to be necessary for viral replication of SFV (259). Disruption of the 3 aa site resulted 
in a serious functional defect in replication in mammalian and insect cells, with particularly severe 
reduction in sgRNA synthesis in insect cells (260). Interaction between nsp1 and nsp4 has been 
previously documented in genetic analysis of SINV and SFV and found to be related to negative 
strand synthesis (241,253,254) (Fig 1.18D). 
 
1.2.5.2 Non-structural protein 2 (nsP2) 
Nsp2 is a ~90 kDa protein with three essential catalytic functions. The N-terminal domain acts a 
helicase to unwind secondary RNA structures during replication. SFV nsP2 was capable of 
unwinding [α-32P]-labelled dsRNA in the presence of Mg2+ and NTPs. Mutation of the NTP-
binding domain prevented this activity (261). The N-terminal domain also possesses 5′ 
triphosphatase activity necessary for capping of viral mRNA (Fig 1.18A). Biochemical assays of 
CHIKV nsP2 using [γ-32P]RNA and [α-32P]NTPs demonstrated Mg2+-dependent 5′ triphosphatase 
activity and NTPase activity (262).  
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The C-terminal domain possesses protease activity essential for cleavage of the non-structural 
polyprotein (263). The C-terminal domain contains a novel α/β cysteine protease fold and an 
enzymatically inactive MTAse-like subdomain (264,265). Mutation of the nsP2 protease active 
site abolished polyprotein cleavage and productive replication in both SFV and SINV. 
Complementation in trans with protease-competent nsP2 demonstrated that nsP2 can cleave P123 
in cis and trans (266–268). As discussed in 1.2.3, sequential proteolytic processing of the replicase 
complex regulates the switch between negative and positive RNA synthesis. The requirement for 
sequential processing of junction 3/4, 1/2 and 2/3 was demonstrated by mutational analysis in 
SINV and SFV (173,189). In vitro analysis using uncleavable polyproteins and deletion mutants 
revealed that junction 3/4 was most efficiently cleaved and junction 1/2 was cleaved in cis within 
20-30 minutes, exposing an activator sequence responsible for promotion of 2/3 cleavage. Junction 
2/3 was cleaved in trans and was dependent on prior release of nsP1 (190,268) 
 
In addition to catalytic functions, nsP2 acts as a transcription factor for nsP4, aiding recognition 
of the sub-genomic promoter. Mutants defective in sub-genomic promoter recognition and sub-
genomic RNA synthesis map to nsP2 in SINV and SFV (183,194,195). nsP2 also modulates anti-
viral host responses via independent processes of transcriptional and translational shut-off (269–
271). CHIKV nsP2 induces degradation of a catalytic subunit of RNA polymerase II, resulting in 
transcriptional shut-off. Mutational analysis demonstrated that this activity depends on the helicase 
and MTase-like domains but not the protease function of nsP2 (272). In addition, nsP2 induces 
translational shut-off, contingent on the localisation of ~50% of nsP2 in the nucleoli (273,274). 
nsP2 translational shut-off depends on the MTase-like subdomain but the mechanisms behind this 
process are currently not well understood (183).  
 
1.2.5.3 Non-structural protein 3 (nsP3) 
nsP3 is a 60 kDa phosphoprotein with three distinct domains (Fig 1.15). The macrodomain of 
CHIKV nsP3 is an RNA-binding domain capable of recognising and removing adenosine 
diphosphate-ribose (ADP-ribose) from proteins (275). The crystal structure of the macrodomain 
in complex with either ADP-ribose or RNA revealed a binding pocket specific for ADP in ADP-
ribose and AMP in RNA (276). Mono- and poly-ADP-ribosylation is an indicator of cellular stress; 
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proteins in stress granules are often ADP-ribosylated (277). The nsP3 macrodomain may 
downregulate host cell stress responses via hydrolysis of ADP-ribose. The enzymatic activity of 
nsP3 is also critical for initiation of genome replication, although the mechanism of initiation is 
unknown. Catalytically inactive CHIKV nsP3 macrodomains cannot form functional replicase 
complexes and cannot replicate in mammalian or mosquito cells (174,278). Similarly, SINV 
macrodomain mutants exhibited severely reduced genomic and sub-genomic RNA synthesis, as 
measured by incorporation of [3H]uridine (182,196). nsP3 may regulate nsP4 during genome 
replication; mutants of nsP4 with defective negative strand synthesis were rescued by suppressor 
mutations in nsP3 (181).  
 
The function of the alphavirus unique domain (AUD) of nsP3 has not been well characterised. 
Crystallographic studies of the SINV AUD identified a zinc-binding domain. Substitution of any 
of the four cysteine residues which co-ordinate zinc binding was lethal (192). Recent mutational 
analysis of the CHIKV AUD suggested that the AUD plays a role in genome replication (197). 
This study demonstrated that mutations in the CHIKV AUD impaired sub-genomic RNA 
production or abolished viral genome replication in mammalian and mosquito cell lines. One AUD 
mutant (P247A/V248A) exhibited significantly decreased binding affinity for the sub-genomic 
promoter and the 3′ termini of positive and negative genomic RNAs in vitro.  
 
The hypervariable domain (HVD) is a hyperphosphorylated hub involved in multiple protein 
interactions, recruiting essential factors such as Four and a half LIM domain protein 1 (FHL1) to 
the replicase complex (279,280). The HVD binds to the membrane-associated adaptor proteins 
amphiphysin-1/2 and an abundance of cytoskeletal proteins, most strongly to CD2-associated 
protein (CD2AP) (175,281,282). The HVD also sequesters the components of stress granules in 
mammalian (G3BP1 and 3) and insect cells (Rasputin) into cytoplasmic foci (199,283). Several 
proteins including FHL1, G3BP1/3 and amphiphysin-1/2 have been demonstrated to co-localise 
with nsP3 in spherules at the plasma membrane and on cytopathic vacuoles, forming interactions 
that are essential to CHIKV genome replication (175,280,284). Although the mechanism of 
replication enhancement by HVD-interactors is currently unknown, loss of HVD:protein 
interactions prevents CHIKV replication in mammals and mosquitoes (175,177,284). Hosts and 
tissues which do not express homologues of certain HVD-interactors cannot support replication. 
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Consequently, the HVD is a major determinant of cellular permissivity to CHIKV infection 
(280,285).  
 
1.2.5.4 Non-structural protein 4 (nsP4) 
CHIKV nsP4 is a 70 kDa protein containing the RNA-dependent RNA polymerase (RdRp) GDD 
motif. Homology modelling and hydrogen-to-deuterium exchange (HDX)-mass spectrometry of 
the CHIKV nsP4 catalytic core predicted a classical RdRp structure with fingers, thumb and palm 
sub-domains (286). The C-terminal domain of nsP4 is solely responsible for RNA synthesis in the 
replicase; addition of purified SINV nsP4 to cell extracts containing uncleaved P123 resulted in 
de novo synthesis of negative strand RNA (287). In addition to de novo RNA synthesis, the GDD 
motif confers terminal adenosyl transferase (TATase) activity. GDD>GAA mutation prevented 
catalysis of both processes (287,288). SINV nsP4 catalyses the addition of non-templated 
adenosine residues to the 3′ terminus of positive-sense RNAs to create a polyA tail, dependent on 
the presence of divalent cations (287). Negative strand synthesis by SINV nsP4 requires the 19 nt 
3′ CSE negative strand genomic promoter and a polyA tail of at least 11-12 nt in length (289). 
Electrophoretic mobility shift assay demonstrated that nsP4 binds directly to the 3′ CSE (185). 
RNA cross-linking studies have also demonstrated direct binding of nsP4 to the negative strand 
sub-genomic promoter, dependent on the presence of the other nsPs. Mutational analysis revealed 
distinct binding sites in nsP4 for the negative strand sub-genomic promoter and genomic 
promoters, at 329-334 aa and 531-538 respectively (184,193).  
 
The N-terminus of nsP4 interacts with nsP1-3. Mutation of the N-terminus of SINV nsP4 resulted 
in defective production of sub-genomic and genomic RNA of both polarities. Suppressor mutations 
were found in nsP1-3, indicating that the N-terminal domain regulates protein-protein interactions 
within the replicase complex (181). In particular, lethal mutation of the N-terminal tyrosine (Tyr) 
residue of nsP4 is non-lethal in the context of nsP1 suppressor mutations, suggesting an important 
nsP1-nsP4 interaction (253,290). Complete deletion of the N-terminus precluded de novo negative 
strand RNA synthesis, even in the presence of P123 (288). 
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1.3 CHIKV RNA structure 
 
1.3.1 RNA structure 
In addition to coding sequences, the genomes of RNA viruses often contain cis-acting sequences 
and structures which act as activators, enhancers and repressors of fundamental processes such as 
translation, replication and evasion of host innate immunity (291). RNA viruses maximise the 
coding capacity of the genome by formation of intramolecular secondary and tertiary structures 
within and between coding regions. The most common RNA structural motifs in viral genomes 
are stem-loops, also known as hairpins, and pseudoknots (292).  
 
Stem-loops consist of a double-stranded RNA helix formed by base-pairing of adjacent regions on 
a single RNA molecule, with an intervening single-stranded loop (Fig 1.19A). Unpaired bulges 
along the stem may also form part of the structure. Pairing within the stem can exhibit canonical 
Watson-Crick or non-Watson-Crick pairing; G:U pairs are particularly common (293). The 
structure and sequence of the stem as well as the sequence of the exposed loop are important 
components of stem-loops which may be recognised by different interactors and via different 
mechanisms (294). Pseudoknots are formed when the single-stranded terminal loop of a hairpin or 
stem-loop base-pairs with a complementary single-stranded region elsewhere in the RNA, usually 
in proximal flanking regions (295) (Fig 1.19B). Pseudoknots are particularly well studied in the 
context of translational recoding (296,297). Besides local secondary structure formation, long-
range base-pairing is common in viral genomes, enabling critical conformational switching during 
viral replication and providing the striking flexibility characteristic of RNA viral genomes 
(298,299). Circularisation often depends on long-distance interactions between sequences such as 
cyclisation sequences which base-pair, or structures such as stem-loops which form kissing-loop 
interactions (300) (Fig 1.19C).  
 
1.3.2 RNA structure determination 
RNA structure can be determined experimentally using spectroscopic techniques such as X-ray 
crystallography and nuclear magnetic resonance (NMR) spectroscopy (301,302). These methods 
are based on the response of a sample to electromagnetic radiation. Fluorescence methods such as 
single-molecule spectroscopy can be used to measure dynamic RNA structures via the signal  
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Figure 1.19: Schematic representation of RNA secondary structural elements (adapted from 
(303)). Schematic representation of common RNA secondary structures. White circles represent 
nucleotides, blue circles represent base-pairing, Watson-Crick or otherwise, between nucleotides. 
Green and yellow circles denote interacting regions, interactions are represented by dotted lines 
(A) An RNA stem-loop consisting of a heteroduplex stem with an unpaired terminal loop. (B) A 
pseudoknot whereby the terminal loop of the hairpin base-pairs to the downstream single-stranded 
region. (C) Long-range interactions between complementary unstructured sequences (yellow) or 
transient kissing-loop interactions between stem-loops (green). 
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emission of fluorophores (304). Alternatively, RNA structure can be determined biochemically 
using such methods as dimethylsulphate (DMS) footprinting, hydroxy radical footprinting and 
enzymatic analysis (305–307). Biochemical methods typically involve structure-specific 
modification of RNA followed by the identification of modification sites, either by fragment 
analysis of cleaved end-labelled RNA directly or following modification-sensitive primer 
extension. Hydroxyl radical footprinting involves cleavage of the sugar-phosphate backbone 
(308). Hydroxyl radical-induced cleavage occurs within milliseconds in a base-independent 
manner. Enzymatic analysis methods, whereby structure-specific nucleases cleave single- or 
double-stranded RNA, are similarly base-independent (307). In contrast, DMS methylates the 
base-pairing faces of nucleotides at N1 of adenosine, N7 of guanosine and N3 of cytidine (309). 
Thus, DMS footprinting is sensitive to changes in both secondary and tertiary structure. 
 
Another such biochemical method of RNA structure determination, SHAPE mapping, can 
determine the likelihood of base-pairing at single nucleotide resolution. The reactivity of each 
nucleotide with the reagent NMIA is dependent on the availability of the 2′OH for acylation; only 
unpaired nucleotides become acylated. RNA is treated at sufficient concentration to achieve a 
single modification per RNA and reverse transcribed, producing a pool of cDNA fragments where 
reverse transcriptase cannot traverse the acyl adduct. Fragment analysis reveals the sites of NMIA 
modification. The proportion of fragments of each size generates a reactivity score for each 
nucleotide, giving the likelihood of base-pairing at that site in the average molecule (310). 
Reactivity data from biochemical methods such as SHAPE can be combined with computational 
approaches by assigning each nucleotide a relative reactivity score. In silico approaches to RNA 
structure determination typically rely on standard biochemical data obtained by melting 
oligonucleotides of known sequence. Reactivity scores for a specific RNA, such as those obtained 
via SHAPE, provide further constraints which can be introduced as a parameter during modelling, 
improving the prediction of parsimonious structures.  
 
1.3.2  Functions of viral RNA structures 
RNA structures regulate processes as diverse as packaging, translational initiation and recoding, 
genome replication and circularisation to regulate binding of trans-activating factors. Stem-loops 
impact RNA virus replication via sequence and/or structure-dependent mechanisms in a wide 
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range of virus families including Retroviridae (311), Picornaviridae (312), Flaviviridae (313), 
Bunyaviriridae (314) and Orthomyxoviridae (315). 
 
Many RNA viruses utilise secondary structures in the genome to ensure specific packaging of 
unspliced, full length genomes and where appropriate, the correct array of genome segments. 
Packaging signals are usually discrete and can confer packaging specificity to non-viral reporters 
such as GFP-RNA (316). One widely studied packaging signal is the Ψ site in the human 
immunodeficiency virus 1 (HIV-1) genome, which consists of four stem-loops (SL1-4) and is 
sufficient for packaging of a reporter RNA into virus-like particles (VLPs) (317,318). NMR studies 
of the Ψ site have revealed a tandem three-way junction between the stem-loops which sequesters 
the splice donor site and the translation initiation site by long-range interactions (319) (Fig 1.20A). 
The Ψ site binds to the viral Gag protein with high affinity via specific tetraloop GGGG sequences 
in SL2 and SL3 (320–322). Recent studies have demonstrated that stabilisation of SL3 by the drug 
NSC disrupts Gag binding and thus packaging of viral genomes. This study provides proof of 
principle that RNA structure can provide direct targets for anti-viral interventions (323). 
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The function of viral RNA structures in translation is well studied, particularly for internal 
ribosome entry site (IRES) structures which enable cap-independent translation by direct 
recruitment of ribosomal subunits (324). There are four classes of IRES, each with decreasing 
dependence on cellular factors for initiating translation. Class I IRESs such as that of Poliovirus 
require a wide range of host initiation factors including eIF1-3/eIF4F/eIF5, while Class 4 IRESs 
such as that of Cricket paralysis virus requires none (325–327). Class III IRESs such as the 
hepatitis C virus (HCV) IRES have a complex architecture involving multiple stem-loops and a 
pseudoknot with helical junctions (306) (Fig 1.20B). The structure of the HCV IRES in complex 
with the human 40S and 80S ribosome has been resolved at 3.9 Å, revealing that the HCV IRES 
binds directly to the 18S ribosomal RNA (rRNA) to recruit the 40S ribosomal subunit; an apical 
loop of the IRES forms a kissing-loop interaction, pairing viral GGG with rRNA CCC (328,329). 
Direct recruitment of translation machinery enables evasion of the translational shut-off induced 
by phosphorylation of eIF2α (330,331). 
 
5′ RNA elements are essential for genome replication during the lifecycle of many positive-sense 
RNA viruses including flaviviruses (332,333) and picornaviruses (334–336). The cloverleaf 
conserved replication element (CRE) of poliovirus (PV) is a well-known example, consisting of 
four stem-loops: a, b, c and d at the 5′ terminus of the genome (337,338) (Fig 1.20C). The 
cloverleaf was shown by foot-printing and EMSA to bind directly to the host protein PCBP2 via 
unpaired C nucleotides in stem-loop B and to the viral polymerase 3CDpol and protease 3Cpro via 
stem-loop D. The protein complex nucleated around the 5′ cloverleaf interacts with PABP bound 
to the 3′ polyA tail, directing circularisation of the genome, transfer of the polymerase to the 3′ 
and subsequent negative strand synthesis (339). Mutations in the cloverleaf designed to selectively 
disrupt base-pairing in the positive strand were lethal to poliovirus replication. Compensatory 
mutations restored wild-type replication in most cases, indicating that secondary structure rather 
than sequence is the determining factor in cloverleaf function. However, one well- conserved 
sequence within a stem could not be compensated for, indicating that it contains sequences 
essential for replication (340). 
 
 68 
In addition to local secondary structure formation, RNA structures can form between distant 
sequences and structures e.g. by kissing-loop interactions (341). Conformational switching is a 
common strategy during viral genome replication, whereby the global structure of the genome is 
regulated by competing local and remote interactions. In particular, long-range interactions can 
direct circularisation of the viral genome, bringing 5′ and 3′ elements into contact and enhancing 
translation and replication. The requirements for long-range interactions within the dengue virus 
(DENV) genome have been well-studied. Following interaction between the 5′ RNA stem-loop 
SLA and the viral RNA-dependent RNA polymerase (RdRp), long-range interactions and base-
pairing between the 5′ and 3′ termini stabilises circularisation of the virus genome and RdRp 
transfer to a 3′ promoter (298,299). Analysis of RNA binding by EMSA identified 5′ and 3′ 
inverted complementary sequences necessary for cyclisation of the DENV genome. Mutation of 
either 5′ or 3′ cyclisation sequences resulted in nonviable virus, whereas compensatory mutations 
restored base-pairing and wild-type replication. The cyclisation sequences can be separated into 
three distinct duplex regions; the circularised form contains duplexes of 5′-3′ upstream of AUG 
(UAR), 5′-3′ downstream of AUG (DAR) and 5′-3′ cyclisation sequences (342) (Fig 1.20D). Both 
genomic conformations are necessary for productive infection. A structural element, the small 
hairpin (sHP), exclusive to the linear form is essential for viral replication and altered stability of 
this element relative to the UAR and DAR duplexes is detrimental (343,344).  
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Figure 1.20: Examples of essential RNA structures in positive-sense viral genomes. RNA 
structures involved in (A) viral genome packaging, (B) cap-independent translation, (C) 
replication of the genome and (D) circularisation via long-range interactions. Figures adapted 
from: HIV-1 psi (345), HCV IRES (346), PV cloverleaf CRE (340) and DENV UAR/DAR/CS 
(347). 
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1.3.3  CHIKV RNA structures 
RNA structural elements investigated in alphaviruses include the packaging signal mapped in nsP2 
(208), translational regulation elements (348,349), replication elements (289,350,351) and an 
RNA stem–loop at the 5′ terminus of the 5′ UTR (SL3) which masks the alphavirus type-0 cap 
structure (352,353) (Fig 1.21). 
1.3.3.1 Translational regulation elements 
The mechanism of CHIKV genomic RNA translation is cap-dependent and does not require any 
RNA structures for initiation. However, RNA structures do contribute to translational recoding 
during expression of CHIKV proteins, specifically the nsP4 protein via readthrough and the TF 
protein via frameshifting. An opal stop codon (UGA) between nsp3 and nsp4 is responsible for 
termination codon readthrough, in combination with an elongated stem-loop (154,240). SHAPE 
analysis of the termination codon readthrough (TCR) element revealed a terminally forked stem-
loop at the 3′ of the UGA (240). Variation/polymorphism between CHIKV lineages was found to 
maintain the structure by co-variation. TCR occurred at ~10% and could be abolished by disruption 
of the secondary structure. Translation of the TF protein occurs by -1 frameshift during translation 
of the 6K gene and requires the programmed ribosomal frameshifting (PRF) stem-loop (240,354). 
SHAPE analysis determined that the PRF is a small, bulged stem-loop with homology to that 
observed in EEV (240,348). A slippery heptanucleotide sequence upstream of the PRF element is 
also necessary for frameshifting, which occurs at ~2% (355). Mutational analysis of the PRF 
element utilised dual luciferase replicons and western blot to show disruption of TF expression 
(240). 
Although the sub-genomic 26S RNA can undergo cap-dependent translation, this process is 
inhibited late during infection by phosphorylation of eIF2α during translational shut-off. eIF2α-
independent translation of the sub-genomic RNA requires a highly stable hairpin predicted to form 
downstream of the AUG codon, termed the downstream stable hairpin (DSH) (203). The DSH is 
thought to stall the ribosome 43S scanning complex at the AUG and induce the closed ribosomal 
complex, possibly by binding of the DSH in the P site to initiate translation. The DSH confers 
independence from eIF4G and eIF2 and may interact with eIF3 as an alternative cap-binding 
mechanism (202,356). This structure is only required when eIF2α is activated by PKR (349). 
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Figure 1.21: CHIKV RNA structural elements and related sequence requirements. 
Conserved RNA structural elements within the (A) positive-sense genome (+gRNA), (B) negative-
sense replication intermediate (-gRNA) and (C) sub-genomic (sgRNA) RNA. Translational 
enhancers (purple), replication elements (green) and other functional elements (blue) are labelled 
and the functions described briefly. The untranslated regions (UTR) and intergenic region (IGR) 
are denoted, along with the 5′ cap (black circle), polyA tail (AAA…) and the 5′-3′ polarity of each 
strand. The conserved sequence elements (CSE), termination codon readthrough (TCR) element, 
the downstream stable hairpin (DSH) element, programmed ribosomal frameshift (PRF) and direct 
repeats (DR) are shown. Red line and (*) indicate the region examined during this project. Data 
drawn from: (13,154,203,208,240,289,298,353,357–360). 
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1.3.3.2 Replication elements 
The information which follows was almost exclusively obtained from studies of VEEV, SINV and 
SFV. Much of what is known about CHIKV replication is assumed based on these related 
alphaviruses. 
1.3.3.2.1 Sub-genomic promoter 
The promoter for production of sub-genomic 26S RNA occurs in the intergenic region between 
ORF1 and ORF2 and is recognised by nsP4 in the negative strand. nsP4 is unable to bind the sub-
genomic promoter in isolation and requires nsP1-3 (361). Truncation analysis revealed that 19 nt 
upstream of the start site and 5nt downstream are necessary and sufficient to drive sub-genomic 
RNA synthesis (360). The complete promoter spans 98 nt upstream and 14 nt downstream of the 
start site, containing flanking elements which act synergistically. The essential promoter region 
and flanking enhancer elements were conserved during passaging studies in mosquito and 
mammalian hosts (362). SINV replicase can recognise all known alphaviral sub-genomic 
promoters with the exception of SFV, indicating that the sub-genomic promoter is functionally 
and structurally conserved despite some sequence variation (363). 
1.3.3.2.2 3′ UTR 
The 3′ UTR of the CHIKV genome is 500-900 nt in length and contains three non-essential direct 
repeat sequence elements (DR1-3) and a conserved sequence element (CSE) adjacent to the polyA 
tail. DR1 and DR2 are unstructured but DR3 is predicted to form a stable Y-shaped secondary 
structure (298). The number of direct repeat duplications in the CHIKV 3′ UTR is lineage-specific, 
with the Asian CHIKV genotype containing the most duplications. A greater number of 
duplications is associated with increased replication in mosquito cells and a corresponding fitness 
loss in mammalian cells. The DRs are utilised as sites of recombination during host switching, 
mitigating the high cost of adaptation to different hosts by increasing genetic flexibility (298). The 
DRs have also been demonstrated via riboprobes to bind to the La autoantigen of mosquitoes and 
the human-antigen R (HuR) protein. These interactions stabilise viral RNA, protect against 
deadenylation and sequester HuR in the cytoplasm which prevents post-transcriptional regulation 
and stabilisation of host mRNA (364,365). 
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The 3′ CSE is the core negative strand promoter, consisting of the terminal 19 nt of the 3′ UTR 
and a minimum of 11-12 adjacent adenosines in the polyA tail. Deletion or substitution of the 
terminal 13 nt severely reduced or abolished negative strand synthesis (289,366). The 19 nt 
element terminates in a conserved cytosine, which determines the initiation site for negative strand 
synthesis. Mutation of the minimal promoter resulted in initiation within the polyA tail, although 
the cytosine could be substituted with three uracils (351). The conserved cytosine can also be 
displaced by up to 7 nt in either direction without abolishing recognition of the promoter. In 
addition, replication of certain 3′ CSE mutants was inhibited in mosquito cells and others in avian 
cells, indicating host-specific elements within the 3′ UTR (367). 
Interestingly, SINV mutants with deletions of the 3′ CSE and polyA tail were found to be capable 
of genome replication when transfected into BHK-21 cells. Sequence analysis of eight isolates 
revealed insertion of AU rich sequences and restoration of a polyA tail, suggesting a repair 
pathway which likely involves the TATase activity of nsP4 (368). AU-rich sequences at the 3′ end 
conferred recognition and no novel compensatory mutations were detected in the rest of the 
genome during passaging (369). Furthermore, these repaired isolates can replicate to wild-type 
titres in neonatal mice, producing comparable viraemia and pathology. One isolate with UAUUU 
within the polyA tail maintained the motif for 9 passages in animals, indicating that it is relatively 
stable. The 3′ CSE is therefore not absolutely essential for SINV replication, stability and 
pathogenesis in animals (370). 
1.3.3.2.3 5′ UTR 
The 5′ UTR of the CHIKV genome is 76 nt in length with a 5′ AU dinucleotide, followed by a 
short GC-rich stem-loop (SL3 in CHIKV, labelled as SL1 in other alphaviruses). mFold-predicted 
structures of this stem-loop in alphaviruses suggest dramatic differences in the apical region, with 
conservation of the GC-rich base. For example, the terminal loop in SINV forms a pseudoknot 
with the upstream single-stranded sequence which is not seen in other alphaviruses (305,371). SL3 
has been shown to prevent translational inhibition by evading interferon-induced protein with 
tetratricopeptide repeats 1 (IFIT-1) recognition of the type-0 cap. Mutation of SL3 resulted in 
restriction by IFIT-1 in vivo and in vitro, with no effect in IFIT-1 knockout MEFS. Compensatory 
mutations in SL3 of a VEEV/SINV chimera allowed IFIT-1 evasion (353,371). 
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SL3 in the genomic RNA functions as part of the core promoter for negative strand synthesis, and 
its complement in the negative-sense genomic RNA acts as the core promotor for positive strand 
synthesis (357,366,372). Deletion of any of the first 5 nt of the SINV genome was lethal in vivo 
and mutations in the first 15 nt were either lethal or severely inhibited viral replication. The 
severity of SL3 mutations was host-dependent; deletions in the stem had a stronger negative effect 
on replication in mosquito cells compared to avian cells (372). 
 
SL3 is thought to interact with the 3′ CSE during negative strand synthesis. Panhandle structures 
have been observed between the 5′ and 3′ ends of the SINV genome by electron microscopy but 
there are no perfectly complementary regions which base-pair (373). SINV and SFV genomic 
RNA extracted from virions was shown to cyclise via biophysical assays. The linear and circular 
forms can be distinguished in a sucrose gradient and cyclisation was predicted to depend on a 10-
20 nt region (374). SINV constructs lacking the 3′ CSE inhibit negative strand replication in a 
dose-dependent manner during template competition assays, indicating that the 5′ of these 
templates can bind factors involved in negative strand synthesis. During studies of chimeric 
alphaviruses, homologous 5′ and 3′ UTRs could be used as a template by a variety of alphaviral 
replicases. One exception was the SFV 5′ UTR, which can only be utilised by the SFV replicase. 
The incompatibility of the SFV 5′ UTR and SINV replicase was used to design a series of chimeric 
5′ UTRs which identified the terminal dinucleotide and SL3 as the core elements necessary for 
recognition by SINV replicase (357). Mutations which disrupted the structure of SINV SL1 were 
found to improve translatability of the genome but decrease negative strand replication in BHK-
21 and C6/36 cells (305). 
 
Studies of the SL3 homologue in VEEV demonstrated that the stability and sequence of the stem 
rather than the loop sequence was necessary for promoter function. Compensatory mutations 
substituting a GC with a CG pair had a deleterious effect on replication. Passaging of deletion 
mutations yielded compensatory mutants with a 5′ addition of AU or AUG repeats similar to those 
seen for 3′ CSE deletion. Substitution of either a 5′ A or U was extremely deleterious and resulted 
in multiple AU additions at the 5′ terminus, indicating that the AU dinucleotide is critical for viral 
genome replication. Disruption of the short stem-loop also resulted in the addition to heterologous 
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sequences capable of forming secondary structure. Pseudorevertant mutations were detected in the 
non-structural proteins at the C-terminus of nsP1, the N-terminus of nsP2 and in nsP4 (358). 
Similarly, passaging of SINV 5′ mutants lacking the 5′ AU dinucleotide invariably resulted in 
regeneration of the 5′ AU. In one case, a deletion of 16nt restored a 5′ terminal AU. Some revertants 
with multiple AU repeats could replicate to higher than wild-type titres in mammalian cells but 
were inhibited in mosquito cells, indicating host-specific adaptive mutations (373). 
 
1.3.3.2.4 51 nt CSE 
Two stem-loops within the nsp1-coding region, collectively termed the 51 nt CSE, have been 
demonstrated to enhance SINV and VEEV replication. The sequence and structure of the 51 nt 
CSE are highly conserved; SL165 is identical in many alphaviruses and while there is a greater 
degree of sequence covariation within SL194, the structure is retained. SHAPE-constrained 
thermodynamic folding predictions for CHIKV, SINV and VEEV reveal remarkable conservation 
of the structures within the 51 nt CSE (13) (Fig 1.22). The 51 nt CSE is not essential for SINV 
replication in mammalian cells. Early work suggested that the SINV 51 nt CSE acts as a replication 
enhancer in vertebrate cells, whereby disruption reduced RNA replication 5-10 fold in BHK-21 
cells and resulted in lower viral titres during infection of mice (269,357). Enhancement of 
replication by the 51 nt CSE in mammalian cells was not recapitulated in later studies. Viral 
replication in BHK-21 cells was not affected by the introduction of 43 mutations in the nsP1-
coding region, producing similar viral titres to wild-type in a one-step growth assay and similar 
infectivity in an infectious centre assay (350). 
 
Mutation of the 51 nt CSE often results in host-specific phenotypes in SINV. One double mutant 
of SL165 which retained base-pairing in the stem replicated to wild-type titres in chicken 
embryonic fibroblasts but exhibited a 90% reduction in replication in mosquito cells. Another 
SL165 stem mutant significantly reduced replication in both host species. Compensatory mutants 
designed to retain base-pairing in SL194 grew poorly in chicken cells but slightly better than the 
single mutants. Single mutants in mosquito cells grew ten-fold better than double mutants, 
suggesting that the sequence of SL194 is required. Substitutions in the terminal loop regions of the 
51 nt CSE resulted in a 100-fold decrease in replication in avian and mosquito cells, suggesting 
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sequence-specific binding during replication (375). Generally, disruption of the 51 nt in SINV 
produces a more severe replication defect in mosquito cells than in vertebrate cells (350). 
 
The ability of SINV 51 nt CSE mutants to act as templates was analysed by addition of the replicase 
in trans and detection of via [α-32P]-labelled positive strands in infected cell lysates. 
Complementing this approach, an uncleavable P123/nsP4 replicase was used to assess the ability 
of the constructs to template negative strand synthesis in vitro. Deletion of SL165 or SL194 
resulted in defective negative strand synthesis. Individual deletions of SL165, SL194 and an 
elongated upstream stem-loop (SL85/102) did not decrease RNA replication in vivo but deletion 
of both stem-loops of the 51 nt CSE reduced replication 3-10 fold. Synonymous mutation of the 
51 nt CSE and SL85/102 in combination resulted in 50-fold lower replication in vivo and 4-6 fold 
lower negative strand synthesis in vitro. Thus, structures within nsp1 are necessary for enhancing 
production of both positive and negative strands in SINV and the complement of this region in the 
negative strand likely influences the production of positive strand genomic RNA (357). 
 
During one study of the 51 nt CSE in VEEV, the presence of secondary structure and the 
expression of nsP1 were uncoupled by extensive synonymous mutation to remove secondary 
structure in the coding region, followed by incremental re-addition of structural elements into the 
5′ UTR. Deletion of the entire 51 nt CSE reduced viral replication to a barely detectable threshold. 
None of the individual deletions prevented replication, although the greatest reduction in viral titre 
was caused by deletion of SL165. The same phenotypes were observed in BHK-21 and C7/10 
mosquito cells. Two passages in BHK-21 cells produced several pseudorevertants: in SL85/102 
downstream of the initiating AUG, in the N-terminal domain of nsP2 and in nsP3. When reverse 
genetically reincorporated into VEEV, mutations in nsP2 and SL2 were additive and not 
synergistic, possibly affecting different processes (376). During similar passaging studies in SINV, 
suppressor mutations also arose in nsP2 and nsP3, indicating that these regions or proteins interact. 
Each of the pseudorevertants contained the same mutation at the N-terminus of nsP2 (E118K), one 
had a mutation in nsP3 and two had mutations in the 5′ UTR whereby the terminal 9nt were 
replaced with ~50nt from the sub-genomic promoter. Each of the revertants also contained 
mutations in E2. Reincorporation of the nsP2 mutant in isolation did not restore wild-type 
replication but double mutants of nsP2-nsP3 or nsP2-UTR had a strong synergistic effect restoring 
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SINV replication, in the absence of the E2 mutations. The suppressor mutations which restored 
replication in C7/10 cells resulted in replication defects in BHK-21 cells, again suggesting host-
specific interactions (350). 
  
 78 
 
 
 
 
Figure 1.22: SHAPE-constrained thermodynamic folding prediction of the 51 nt CSE in 
CHIKV, SINV and VEEV (13). SHAPE reactivities are shown as a heat map:  black SHAPE 
reactivities between 0–0.5 and increasing intensities from orange to red indicate increasing SHAPE 
reactivities, as denoted by the key. High reactivity (red) denotes unpaired nucleotides whereas low 
reactivity (black) denotes base-paired nucleotides. Stem-loop 3 (SL3) and stem-loop 4 (SL4), as 
labelled by Kutchko and colleagues based on the number of stem-loops in the 5′ region, correspond 
to SL165 and SL194 during later labelling schemes based on the first nucleotide of the structure. 
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1.4  Aims of the project 
 
As discussed, there are no currently available vaccines or antiviral therapies for CHIKV; infection 
cannot be treated or prevented except by control of vector populations. A greater understanding of 
the viral replication cycle in both human and mosquito hosts is essential for the development of 
prophylactics and treatments. Recent work by A. Tuplin (University of Leeds) provided a 
preliminary SHAPE map of the 5′ terminus of the CHIKV genome, demonstrating the existence 
of several distinct RNA secondary structures, some novel and some with homology to previously 
described replication elements. These RNA structures may be necessary for productive replication 
of the virus and represent direct drug targets for intervention, as has been demonstrated for NSC-
mediated disruption of the Ψ-site which inhibits HIV-1 replication.  
 
Therefore, the aim of this PhD project is to investigate the importance of each of these structures 
during the CHIKV lifecycle in human and mosquito hosts. More specifically, the objectives of the 
project are:  
 
1. Determine the phenotypic importance of each stem-loop for the CHIKV lifecycle in human 
and mosquito cells at multiple stages of the viral replication cycle  
 
2. Investigate the sequence and structure requirements for functional interactions of the stem-
loops and explore the routes of reversion taken during prolonged passaging 
 
3. Identify potential tertiary interactions including pseudoknots 
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Chapter 2. Materials and Methods 
 
2.1  Materials 
   
2.1.1  Plasmids 
All CHIKV cDNA constructs are shown in Fig 2.1. The full-length virus ECSA strain infectious 
clone (CHIKV_IC) and CHIKV monoluciferase sub-genomic replicon construct (CHIKV_Rep) 
were kind gifts from Prof A. Merits, University of Tartu. The translation reporter replicon 
(CHIKV_Rep(GDD>GAA)) was adapted from the dual luciferase sub-genomic replicon by S. 
Bradley (University of Leeds). Mutations were designed in the active site of the RdRp 
(GDD>GAA) which abrogate replication, allowing measurement of translation of the first ORF. 
 
2.1.2  Primers 
All oligonucleotide primers are shown in the appendix (Table 1). Oligonucleotide primers were 
synthesised for use in sequencing, mutagenesis and polymerase chain reaction (PCR) (Integrated 
DNA Technologies). Primers were resuspended in nuclease-free H2O and stored at -20°C. 
 
2.1.3  Bacterial strains  
Supercompetent XL-1 Blue E. Coli (Agilent Technologies) were used for transformation of intact 
plasmids. Ultracompetent XL-10 Gold E. Coli (Agilent Technologies) were used for 
transformation of ligation products and mutagenized plasmids digested with DpnI. Mix and Go! 
E. Coli (Zymo Research) were adopted for all transformations from 2017 onwards. Glycerol stocks 
were made as follows: single colonies were shaken at 37°C in 5.5 mL LB containing amplicillin 
(80mg/L) overnight. 250 µL of the culture was added to 250 µL glycerol/LB 1:1 mixture in a 
sterile cryovial and stored at -80°C. 
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A) 
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B) 
 
Figure 2.1: CHIKV cDNA constructs. A) cDNA plasmid constructs for full length virus 
(CHIKV_IC), monoluciferase replicon (CHIKV_Rep) and dual luciferase translation reporter 
replicon (CHIKV_Rep(GDD>GAA)). NotI was used for linearization in all cases, NotI and XmaI 
were used for excision of mutated regions of interest for cloning. B) RNA synthesised from each 
plasmid. 
 
2.1.4  Cell culture 
Continuous mammalian and mosquito cell lines, along with specific culture conditions, are listed 
in Fig 2.2. Mammalian cells were passaged by treatment with trypsin (Sigma Aldrich) at 37°C for 
5-8 minutes. Insect cells were passaged by gentle scraping into 10 mL complete Leibovitz L-15 
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media (Gibco). Cells were centrifuged at 250 x g for 3 minutes, resuspended and diluted before 
seeding in T175 flasks in a total of 25 mL complete media.  
 
Cell stocks were produced by resuspending 1x107 cells in 900 µL foetal bovine serum (FBS) and 
100 µL dimethyl sulfoxide (DMSO) before cooling -1°C/minute using Mr Frosty (Thermo Fisher 
Scientific). Cells were stored at -80°C overnight and transferred to liquid nitrogen for long term 
storage. 
 
2.2  Methods in molecular biology 
 
2.2.1  Agarose gel electrophoresis 
The size and purity of plasmid DNA was determined by agarose gel electrophoresis, carried out 
using 1% agarose gels (1% analytical grade agarose (Sigma Aldrich), 1x TAE buffer (40 mM Tris-
Acetate, 1 mM EDTA), 1:10,000 dilution SYBR SAFE DNA stain (Life Technologies)). Samples 
were mixed with 6x Purple Gel Loading Dye (NEB) and loaded alongside 1 KB Plus DNA ladder 
(NEB). Gels were run in 1x TAE buffer at 100 V for 60 minutes before visualisation under UV 
transillumination. 
 
Larger gels were used for extraction of restriction fragments during cloning, these were run at 80 
V for a minimum of 2.5 hours for clear separation of fragments. Appropriate bands were excised 
from the gel and DNA purified using Wizard SV Gel and PCR Clean-Up System (Promega) 
according to the manufacturer’s instructions, eluting in 20 µL nuclease-free H2O. 
 
2.2.2  Denaturing MOPS agarose gel electrophoresis 
The purity, integrity and size of RNA products of in vitro transcription was determined by 
denaturing formaldehyde agarose gel electrophoresis in MOPS buffer. 1% agarose MOPS gels  
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Figure 2.2: Cell lines and culture conditions 
 
  
Cell line Species/Features Media Maintenance Seeding 
Dilutions 
C2C12 Murine embryonic 
myoblasts (muscle 
progenitor)  
(377) 
Dulbecco's modified eagle 
media (DMEM, Sigma 
Aldrich) + 20% (v/v) foetal 
bovine serum (FBS, Life 
technologies) + 1% 
penicillin/streptomycin 
(P/S)  
 
 
 
 
 
37°C 
5% CO2 
Passaged by 
trypsinisation 
 
 
 
1:5 to 1:20 
 
BHK-21 Baby Hamster 
Kidney fibroblast 
cell origin  
(378) 
DMEM + 10% FBS + 1% 
P/S  
Huh7 Human, 
hepatocellular 
carcinoma 
(379) 
DMEM + 10% FBS + 1% 
P/S  
 
 
 
1:4 to   1:8 
 
A549 Human lung 
carcinoma 
 
(380) 
DMEM + 10% FBS + 1% 
P/S 
U4.4 Mosquito 
embryonic cells, 
Ae. albopictus  
 
(381) 
Leibovitz's L-15 media 
(Gibco) + 10% FBS + 10% 
Tryptose phosphate broth 
(TPB)(Gibco) + 1% P/S  
 
 
28°C 
Passaged by 
mechanical 
scraping 
 
 
 
1:5 to 1:10 
 
C6/36 Mosquito 
embryonic cells, 
Ae. albopictus, 
impaired  RNA 
interference 
(RNAi) antiviral 
response  
(382) 
Leibovitz's L-15 media + 
10% FBS + 10% TBP + 
1% P/S  
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were prepared using 1% (w/v) analytical grade agarose (Sigma Aldrich), 1x MOPS buffer (40 mM 
MOPS pH 7.0, 10 mM NaAc, 1 mM EDTA pH 8.0), ddH2O and 1:10,000 dilution SYBR SAFE 
DNA stain (Life Technologies). After melting of the agarose, formaldehyde was added to a final 
concentration of 1.7% v/v. Samples were mixed with 2x denaturing RNA loading dye (NEB), 
heated to 65°C for 10 minutes and cooled on ice. Samples were loaded alongside Millenium RNA 
ladder (Ambion). Gels were run in 1x MOPS buffer at 100 V for 60 minutes before visualisation 
under UV transillumination. 
 
2.2.3  Bacterial transformation 
For plasmid DNA amplification, 500 ng DNA was mixed with 25 µL super-competent XL-1 Blue 
E. coli (Agilent Technologies) and cooled on ice for 30 minutes. Cells underwent heatshock at 
42°C for 30 seconds before recovery on ice for 2 minutes. 500 µL SOC media (2% (w/v) tryptone, 
0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 20 mM glucose) was added 
to the transformation mix and shaken at 37°C for 1 hour. 150µL transformation mix was then 
plated onto agar plates containing 1.5% bacteriological agar, Luria broth (LB) (10 g tryptone, 5 g 
yeast extract, 10 g NaCl, autoclaved in 1 L ddH2O) and antibiotic to a final concentration of 100 
µg/mL. Plates were incubated at 37°C for 16 hours until colony formation. 
 
For transformation of ligation products and mutagenized plasmids digested with DpnI following 
PCR, ultra-competent XL-10 Gold E. coli (Agilent Technologies) were used. 5 µL of ligation or 
PCR product was mixed with 50 µL ultra-competent cells and heatshock carried out as described 
above. Mix and Go! E. coli (Zymo Research) were adopted for all transformations from 2017 
onwards and used according to the manufacturer’s instructions. Briefly, the appropriate amount of 
DNA is mixed with 50 µL Mix and Go bacteria, incubated for 10 minutes on ice and plated directly 
onto pre-warmed 37°C LB-agar plates containing the relevant antibiotic. 
 
2.2.4  Plasmid DNA amplification 
Single colonies were picked from agar plates following transformation and cultured in an 
appropriate volume of LB. For small volume amplifications, single colonies were grown overnight 
at 37°C in 5.5 mL LB containing antibiotic to a final concentration of 100 µg/mL. Cultures were 
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pelleted at 4000 x g for 20 minutes at 4°C and plasmid DNA isolated and purified using the 
GeneJET Plasmid Miniprep kit (Thermo Fisher Scientific). 
For larger volume amplifications, single colonies were grown in 5.5 mL LB containing the 
appropriate antibiotic for 8 hours before transfer to a 250 mL culture overnight. Cultures were 
pelleted at 5000 x g for 10 minutes at 4°C and plasmid DNA isolated and purified using the 
GeneJET Plasmid Maxiprep kit (Thermo Fisher Scientific). Purified DNA concentration and 
quality was quantified using a Nanodrop1000 spectrophotometer (Thermo Fisher Scientific). 
Integrity, purity and concentration of plasmid DNA was then assessed via agarose gel 
electrophoresis. 
 
2.2.5  Restriction endonuclease digestion 
Restriction endonuclease digestion was used for linearization of plasmid DNA for diagnostic 
purposes, for use as a template during in vitro transcription and for cloning. Diagnostic digests 
were carried out in a total volume of 10 µL ddH2O, containing: 1 µg DNA, 1x Cutsmart buffer 
(NEB) and 0.1 µL (1-2 U) each enzyme (NEB). Diagnostic digests were incubated for 1 hour at 
the appropriate temperature and analysed by agarose gel electrophoresis without purification. 
Linearisation of plasmid DNA for use as a template for in vitro transcription was carried out in a 
total volume of 150 µL nuclease-free H2O, containing: 25 µg DNA, 25 µL 1x Cutsmart buffer 
(NEB) and 2.5 µL (50 U) NotI-HF (NEB). Linearisation reactions were incubated for 1 hour at 
37°C. Representative gel shown in Fig 2.3. Double digests to produce components necessary for 
cloning were carried out in a total volume of 150 µL nuclease-free H2O, containing: 25 µg DNA, 
1x Cutsmart buffer (NEB), 2.5 µL (50 U) NotI-HF (NEB) and 2.5 µL (25 U) XmaI (NEB). Double 
digests were incubated for 1 hour at 37°C. 
 
2.2.6  DNA purification 
Linearised plasmid DNA was purified using Wizard SV Gel and PCR Clean-Up System 
(Promega), eluting in 40 µL nuclease-free H2O. After 2017, ethanol precipitation was used for 
purification of linearised DNA. 2-3 volumes 100% EtOH and 1/10 volume 3 M NaAc pH 5.2 were 
added to each reaction and incubated at -20°C overnight. The reaction was centrifuged at 17,000 
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x g for 30 minutes at 4°C, washed 1x with 70% EtOH and dried for 10 minutes before resuspension 
in 40 µL nuclease-free H2O. 
Double digests for use in cloning were subjected to separation by agarose gel electrophoresis as 
described above and the appropriate bands excised with minimal agarose. Gel slices were melted 
and the DNA purified using Wizard SV Gel and PCR Clean-Up System (Promega), eluting in 20 
µL nuclease-free H2O. 
 
2.2.7  Site-directed mutagenesis 
Site-directed mutagenesis was carried out using the QuikChange XL Site-Directed Mutagenesis 
kit (Agilent). Primers were designed according to the manufacturer’s instructions. The protocol 
was amended as follows: reactions contained 10x reaction buffer (Agilent), 300 ng DNA, 125 ng 
forward primer, 125 ng reverse primer, 1 µL dNTP mix (Agilent), 3 µL QuikSolution (Agilent) 
and 1 µL (2.5 U) PfuTurbo DNA polymerase (Agilent). The cycling parameters were set to: 95°C 
for 2 minutes; 18 cycles of 95°C for 1 minute,  60°C for 50 seconds,  68°C for 25 minutes;  68°C  
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Figure 2.3: Linearised DNA. 1µg  NotI-linearised CHIKV_Rep DNA on 1% agarose gel 
alongside 1 µL 1 KB Plus DNA ladder (NEB). 
 
 
 
 
 
Figure 2.4: in vitro transcribed RNA. 500 ng in vitro transcribed CHIKV_Rep RNA on 1% 
MOPS gel alongside 1 µL Millenium RNA ladder (NEB). 
 
  
3 Kb -
10 Kb -
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for 13 minutes. Each reaction was then treated with 1 µL (10 U) DpnI to remove input DNA before 
transformation as described above. Several colonies were analysed via plasmid amplification, 
purification and sequencing to determine whether desired mutagenesis had occurred. Due to the 
error-prone nature of the PfuTurbo enzyme, correctly mutated regions were excised by double 
digest and ligated into the appropriate backbone which had not undergone mutagenesis. 
 
2.2.8  DNA ligation 
Ligation reactions were carried out at a 5:1 molar ratio of insert:vector. Ligation reactions 
contained 100 ng DNA backbone, 10x T4 DNA ligase buffer (NEB), 2 µL (800 U) T4 DNA ligase 
(NEB) and the appropriate amount of insert, made up to 20 µL total volume with nuclease-free 
H2O. Ligation reactions were incubated at room temperature overnight before transformation as 
described above. 
 
2.2.9  DNA Sequencing 
500ng DNA was sequenced with 25 pmol primer in a total volume of 10 µL using Eurofin 
Genomics (formerly GATC) Sanger sequencing service. 
 
2.3  Replicon production and transfection 
 
2.3.1  In vitro transcription 
Capped RNA was synthesised for use in replicon transfections and generation of infectious virus. 
CHIKV replicon RNA was synthesised using the mMessage mMachine SP6 Transcription kit 
(Thermo Fisher Scientific) according to the manufacturer’s instructions. Full-length infectious 
CHIKV RNA was synthesised using the Amplicap SP6 High Yield Message Maker kit (CamBio) 
according to the manufacturer’s protocol. 
 
Uncapped RNA was synthesised for use in SHAPE mapping. 2 µg DNA template was mixed with 
10x RNA pol buffer (NEB), 3.2 µL ATP (100 mM) (NEB), 3.2 µL UTP (100 mM) (NEB), 3.2 µL 
CTP (100 mM) (NEB), 3.2 µL GTP (100 mM) (NEB), 2 µL (80 U) RNasin RNase inhibitor 
(Promega), 3.2 µL (0.32 U) Yeast Inorganic Pyrophosphatase (YIPP)(NEB), 1.12 µL 1 M MgCl2 
 90 
and 4 µL (80 U) SP6 polymerase (NEB). The mixture was made up to 80 µL with nuclease-free 
H2O and incubated at 40°C for 3.5 hours. 1 µL (40 U) RNasin RNase inhibitor (Promega) and 2 
µL (4 U) DNAseI (NEB) were added and incubated at 37°C for 30 minutes. 
 
2.3.2  RNA purification 
RNA was purified using the RNeasy Mini kit (QIAGEN) according to the manufacturer’s protocol, 
eluting in 40 µL nuclease-free H2O. From 2017, RNA was purified by Lithium Chloride (Thermo 
Fisher Scientific) precipitation according to the manufacturer’s instructions. Purified RNA 
concentration and quality was quantified using a Nanodrop1000 spectrophotometer (Thermo 
Fisher Scientific). Integrity, purity and concentration of all transcripts was then assessed via 
denaturing formaldehyde gel electrophoresis. 
 
2.3.3  Replicon transfection of mammalian cells 
Lipofectamine transfection was used for replicon assays to allow for standardisation of mammalian 
and insect cell transfection methods. Mammalian cells were seeded at 1x105 cells per well in 24 
well plates in 1 mL complete media until 70-80% confluent. For experiments longer than 12 hours 
duration, cells were seeded at 5x104 cells until 60-70% confluent. 500 ng CHIKV replicon RNA 
per well was mixed with 50 µL Optimem per well. 1 µL Lipofectamine2000 per well was mixed 
with 50µL Optimem per well and incubated at room temperature for 5 minutes. The RNA mix was 
gently mixed with the lipofectamine mix and incubated at room temperature for 20 minutes. Cells 
were washed 1x in PBS and media replaced with 500 µL Optimem per well. 100 µL per well of 
the RNA-liposome mix was added dropwise to each well and mixed by gentle swirling. Cells were 
incubated at 37°C for the appropriate duration. Monolayers were washed 1x in PBS, 100 µL 
passive lysis buffer (PLB, Promega) was added and rocked for 20 minutes at room temperature 
before harvest. Samples were stored at -80°C prior to analysis. 
 
2.3.4  Replicon transfection of insect cells 
Insect cells were seeded at 1x105 cells per well in 24 well plates in 1 mL complete media until 70-
80% confluent. 250ng CHIKV replicon RNA per well was mixed with 50 µL Optimem per well. 
1 µL Lipofectamine2000 per well was mixed with 50 µL Optimem per well and incubated at room 
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temperature for 5 minutes. The RNA mix was gently mixed with the lipofectamine mix and 
incubated at room temperature for 20 minutes. Cells were washed 1x in PBS and media replaced 
with 500 µL Optimem per well. 100 µL per well of the RNA-liposome mix was added dropwise 
to each well and mixed by gentle swirling. Cells were incubated at 28°C for the appropriate 
duration. Monolayers were washed 1x in PBS, 100 µL PLB was added and rocked for 20 minutes 
at room temperature before harvest. Samples were stored at -80°C prior to analysis.] 
 
2.3.5  Luciferase assay 
Lysates resulting from replicon transfections were analysed for luciferase activity using a 
FLUOstar microplate reader (BMG LABTECH). 10 µL lysate was analysed for each replication-
competent replicon. 30 µL lysate was analysed for the replication-deficient GAA translation 
reporter replicon due to low signal. Lysates were transferred into a white-bottomed 96 well plate 
and luciferase activity measured by auto-injection of LARII and Stop & Glo reagents (Promega) 
at 50 µL per well.  
 
  
 92 
2.4  Virus production and infection 
All virus work was carried out under BSL3 containment conditions, in accordance with the 
classification of CHIKV as a Category 3 virus. Permission was obtained from the Health and 
Safety Executive.  
 
2.4.1  Electroporation with viral RNA 
Electroporation transfection was used for production of viral stocks in BHK-21 cells and in other 
cell types where viral stocks could not be produced in BHK-21 cells. Mammalian cells were 
trypsinised, centrifuged for 3 min at 1000 x g and washed 2x in ice cold DEPC PBS before 
resuspension at 3x106 cells/mL in DEPC PBS. 1.2x106 cells were added to 1 µg purified RNA in 
a pre-cooled 4mm cuvette and electroporated using a Gene Pulser Xcell (BioRad) with a square-
wave protocol: 260 V for 25 Ms. Electroporated cells were resuspended in 10 mL complete media 
and incubated in a T75 flask at 37°C for a minimum of 24 hours. 
Insect cells were harvested via scraping, washed 1x in ice-cold DEPC PBS and resuspended at 
1x107 cells/mL in cold cytomix (2 mM EGTA pH 7.6, 120 mM KCl, 0.15 mM CaCl2, 10mM 
K2HPO4/KH2PO4 pH 7.6, 25 mM HEPES pH 7.6, 5 mM MgCl2.6H2O, 0.5% Dextrose, 200 µg/mL 
BSA, 2 mM ATP; pH 7.6 and filter sterilised). 1x107 cells were added to 8 µg purified RNA in a 
pre-cooled 4mm cuvette and electroporated three times using an exponential protocol: 850 V, 25 
uF capacitance, with 3 second pause between pulses. Electroporated cells were incubated at room 
temperature for 15 minutes, resuspended to 10 mL in complete media and incubated in a T75 flask 
at 28°C for a minimum of 24 hours. The protocol for electroporation of insect cells was adapted 
from (383). 
 
2.4.2  Lipofectamine transfection with viral RNA 
Lipofectamine transfection of insect cells with viral RNA was carried out where virus could not 
be produced by electroporation. Insect cells were seeded at 4x105 cells per well in 6 well plates in 
2 mL complete media until 70-80% confluent. 2 µg RNA per well was mixed with 250µL 
Optimem per well. 5 µL Lipofectamine2000 per well was mixed with 250 µL Optimem per well 
and incubated at room temperature for 5 minutes. The RNA mix was gently mixed with the 
lipofectamine mix and incubated at room temperature for 20 minutes. Cells were washed 1x in 
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PBS and media replaced with 2.5 mL Optimem per well. 500 µL per well of the RNA-liposome 
mix was added dropwise to each well and mixed by gentle swirling. Cells were incubated at 28°C 
until supernatant was harvested for plaque assay. 
 
2.4.3  Plaque assay 
BHK-21 cells were seeded at 3x105 cells per well in 6 well plates and incubated in 2 mL complete 
media until 70-80% confluent. Virus stocks were thawed at room temperature and serial ten-fold 
dilutions were prepared in complete media. Cells were washed 1x in PBS before the addition of 
200 µL diluted virus per well. Cells were rocked for 10 minutes at room temperature to ensure 
even coverage of the monolayer, incubated at 37°C for 50 minutes to allow virus entry and washed 
1x in PBS to remove virus. 2 mL 0.8% MC overlay (50:50 1.6% MC in water to complete media) 
was added to each well. Plates were incubated for 48 hours until plaque formation. MC overlay 
was replaced with 10% formaldehyde and fixed at room temperature for 15 minutes. The fixative 
was removed and 2 mL per well crystal violet dye solution (0.25% crystal violet, 10% EtoH, 5 
mM CaCl2, 25 mM Tris in water) was used to stain each well for 15 minutes at room temperature 
before gentle washing in water. Plaques were counted in an appropriate dilution and titre calculated 
according to the following equation: 𝑃𝐹𝑈/𝑚𝐿 = 𝑁𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑝𝑙𝑎𝑞𝑢𝑒𝑠(𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛	𝑓𝑎𝑐𝑡𝑜𝑟	10>?	𝑥	𝑣𝑜𝑙𝑢𝑚𝑒	𝑎𝑑𝑑𝑒𝑑	𝑝𝑒𝑟	𝑤𝑒𝑙𝑙	𝑖𝑛	𝑚𝐿) 
 
Multiplicity of infection, the number of infectious virions added per cell during an infection, can 
then be calculated using the following equation: 
 𝑀𝑂𝐼 = 	𝑃𝐹𝑈	𝑝𝑒𝑟	𝑚𝐿	𝑥	𝑚𝐿	𝑢𝑠𝑒𝑑	𝑝𝑒𝑟	𝑤𝑒𝑙𝑙𝑛𝑢𝑚𝑏𝑒𝑟	𝑜𝑓	𝑐𝑒𝑙𝑙𝑠	𝑝𝑒𝑟	𝑤𝑒𝑙𝑙  
 
2.4.4  Virus infection 
For one-step growth assays, mammalian and insect cells were seeded at 1x105 cells per well in 24 
well plates and incubated in 1 mL complete media until 70-80% confluent. Virus stocks were 
thawed at room temperature and dilutions were prepared in complete media to a final concentration 
of 5x105 plaque-forming units (PFU)/mL. Cells were washed 1x in PBS before the addition of 200 
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µL diluted virus per well, giving a final multiplicity of infection (MOI) of 1. Cells were rocked for 
10 minutes at room temperature to ensure even coverage of the monolayer, incubated at 37°C or 
28°C for 50 minutes to allow virus entry and washed 1x in PBS to remove virus. 500 µL complete 
media was added per well and plates were incubated at 37°C or 28°C for the appropriate duration. 
The supernatant was harvested and titre calculated by plaque assay. Samples were stored at -80°C. 
 
For passaging infectious virus, mammalian and insect cells were cultured in T75 flasks until 60% 
confluent. Monolayers were washed 1x in PBS. 1 mL passaged virus media was thawed at room 
temperature and added to each flask before rocking for 10 minutes at room temperature. The 
monolayer was incubated at 37°C or 28°C for 50 minutes before washing 1x in PBS. 10 mL 
complete media was added per flask and each monolayer was incubated for 48 hours at the 
appropriate temperature before supernatant was harvested and 1mL used for the subsequent 
passage. For growth of confirmed escape mutants, the incubation time was shortened to 24 hours 
and the monolayer was harvested in 6 mL Tri-Reagent (Sigma Aldrich). Samples were stored at -
80°C. 
 
For extraction of viral RNA for single-stranded qPCR, Huh7 cells were seeded at 1x105 cells per 
well in 12 well plates and incubated in 1 mL complete media until 70-80% confluent. C6/36 cells 
were seeded at 6x105 cells per well in 12 well plates and incubated in 2 mL complete media until 
70-80% confluent. Cells were washed 1x in PBS before the addition of 200 µL diluted virus per 
well, giving a final MOI of 1. Cells were rocked for 10 minutes at room temperature to ensure 
even coverage of the monolayer, incubated at 37°C or 28°C for 50 minutes to allow virus entry 
and washed 1x in PBS to remove virus. 1mL complete media was added per well and plates were 
incubated at 37°C or 28°C for 24 hours. Supernatant was harvested after 24 hours. Monolayers 
were washed 1x in PBS before harvest in 500 µL Tri-Reagent (Sigma Aldrich) per well. RNA was 
extracted from these samples according to the manufacturer’s instructions and resuspended in 
20µL water, stored at -80°C. Positive and negative strand genome copy number was quantified via 
quantitative reverse transcription polymerase chain reaction (qRT-PCR) by M. Müller (University 
of Leeds).  
 
 
 95 
2.5  Passaging methods 
Passaging began with virus stocks generated via electroporation of BHK-21 cells with RNA 
transcribed in vitro from an infectious clone. Virus was harvested after 24 hours and titred in 
triplicate (P0). For each passage, a T75 flask of the appropriate cell type was cultured to 60% 
confluency before infection. The passage 1 (P1) monolayer was infected at MOI 1, passages 
thereafter were infected using 1 mL of the previous passage media. Following several passages, 
the supernatant was titred. If titres for WT and a mutant indicated possible reversion, infections 
were carried out at in 24 well plates at MOI 1 for 24 hours and the resulting supernatant titred. 
Where one-step growth curves indicated reversion of mutant phenotype, the genetic basis of 
reversion was investigated by RNA extraction and sequencing. 
 
2.5.1  RNA extraction 
Once phenotypic reversion was seen, confirmed escape mutants were used to infect a monolayer 
for 24 hours and harvested with 6 mL Tri-Reagent (Sigma Aldrich). RNA was extracted from these 
samples according to the manufacturer’s instructions and resuspended in 20 µL water, stored at -
80°C.  
 
2.5.2  Reverse transcription 
4 µL RNA sample extracted from each monolayer/9µL if extracted from infection supernatant was 
combined with 10µL RT buffer and 1µL enzyme mix from the High Capacity RNA-to-cDNA Kit 
(Life Technologies). Reaction volume was made up to 20 µL with H2O, centrifuged briefly and 
incubated for 60 minutes at 37°C. Samples were then heated to 95°C for 5 min and stored at -20°C. 
 
2.5.3  Polymerase Chain Reaction 
PCR was used to amplify cDNA products for sequencing in order to identify mutations responsible 
for phenotypic reversion in passaged mutants. Reactions were performed in a thermocycler 
(ProFlex PCR system, Thermo Fisher Scientific). 
 
For the first kb of the CHIKV genome, primers were designed for hemi-nested PCR. PCR reactions 
were performed in a total volume of 50 µL containing: 2 µL cDNA produced by reverse 
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transcription, 2 µL 10 mM forward primer, 2 µL 10 mM reverse primer, 0.6 µL 25 mM dNTPs, 5 
µL 10x ThermoPol reaction buffer (NEB) and 0.5 µL Vent polymerase (NEB). Primary PCR was 
performed as follows: 95°C 5 minutes denaturation; 20 cycles of 95°C 30 seconds, 51°C 30 
seconds, 72°C 1 minute elongation; 72°C 5 minutes extension. Secondary PCR reactions were 
made up as previously, containing 1 µl cDNA from the primary reaction. Secondary PCR was 
performed as follows: 95°C 5 minutes denaturation; 35 cycles of 95°C 30 seconds, 70°C 30 
seconds, 72°C 1 minute elongation; 72°C 5 minutes extension. 
 
For the entire non-structural region of the CHIKV genome, primers were designed to span the 
region in 1 kb overlapping sections. PCR reactions were performed in a total volume of 50 µL 
containing: 2 µL cDNA produced by reverse transcription, 2 µL 10 mM forward primer, 2 µL 10 
mM reverse primer, 0.6 µL 25 mM dNTPs, 5 µL 10x ThermoPol reaction buffer (NEB) and 0.5 
µL Vent polymerase (NEB). Primary PCR was performed as follows: 95°C 5 minutes 
denaturation; 30 cycles of 95°C 30 seconds, 55°C 30 seconds, 72°C 1 minute elongation; 72°C 5 
minutes extension. 
 
PCR products were stored at 4°C and amplification from the cDNA was confirmed by agarose gel 
electrophoresis. PCR products were purified using Wizard SV Gel and PCR Clean-Up System 
(Promega), eluting in 20 µL nuclease-free H2O. 
 
2.6  Statistical analysis 
Statistical analysis was carried out using two-tailed Student's t-tests for unpaired samples of equal 
variance. P values of ≤0.05 (*), ≤0.01 (**), ≤0.001 (***), ≤0.0001 (****)  were used to represent 
degrees of significance for each mutant compared to wild-type. A minimum of three independent 
biological repeats was performed for each experiment. 
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Chapter 3. RNA stem-loops within the 5′ region of the CHIKV 
genome enhance viral genome replication 
 
3.1  Introduction 
5′ RNA secondary structure in the untranslated regions and adjacent coding sequence of mRNA 
impacts the stability of the molecule and the efficiency of translation, for both host and viral 
transcripts (384,385). Furthermore, viral RNA secondary structures modulate packaging of viral 
genomes during infection (208,319) and may interfere with host immune mechanisms (353). 
Importantly, 5′ RNA structures play a role in the transition between translation and replication of 
RNA virus genomes and as a sampling mechanism, ensuring the integrity of the 5′ UTR in each 
template (339). Although replication of positive-sense RNA virus genomes initiates at the 3′ end 
of the molecule, 5′ RNA elements are demonstrably essential to this process during the lifecycle 
of several well-studied RNA viruses including various flaviviruses (332,333) and picornaviruses 
(334–336). For example, the RNA stem–loop SLA located in the 5′ UTR of flaviviruses such as 
DENV is an essential promoter for initiation of genome replication (386). Following interaction 
between SLA and the viral RNA-dependent RNA polymerase (RdRp), long-range interactions 
between the 5′ and 3′ ends stabilise circularisation of the virus genome and RdRp transfer to a 3′ 
promoter (298,299).  
The stability of RNA secondary structure varies with several factors including temperature, salt 
concentration and protein binding (387,388). The temperature-sensitivity of RNA secondary 
structure is of particular relevance in the study of arthropod-borne RNA viruses. Arboviruses must 
maintain a productive replication cycle in mammalian and invertebrate hosts, each with vastly 
different temperatures, immune mechanisms and intracellular protein milieu. As a consequence, 
host-specific viral adaptations are highly constrained due to constant dichotomous selection 
pressure, as demonstrated in flaviviruses (389) and alphaviruses (390–392). Arboviral elements 
which enhance replication exclusively in a single host have been observed, including genome 
sequences (294) and RNA structures (350,393). For example, nsP3 of EEEV contains a stop codon 
which enhances viral replication in human cells, while being dispensable to replication in Ae. 
albopictus cells (394). Conversely, two stem-loops in the 3′ UTR of DENV, SL-I and SL-II, each 
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impact viral replication in mosquito cells but are functionally redundant in the human host (393). 
In addition to host-specific viral elements, multi-purpose pro-viral factors exist which utilise host-
specific mechanisms. For example, a small hairpin structure (sHP) in the 3′ of the DENV genome 
is necessary for replication in both mosquito and human cells, enhancing replication via structure- 
and sequence-dependent mechanisms in human and mosquito cells respectively (294). 
Relatively little is known about the structure and function of RNA secondary or tertiary structures 
within the CHIKV genome or their potential function as RNA replication elements. Therefore, 
parallels must be drawn with related alphaviruses which have been studied in greater detail. The 
5′ terminal dinucleotide AU is highly conserved in alphaviruses including CHIKV (358) and is 
thought to play a role in binding of the RdRp to the 3′ end of the negative-sense genomic copies 
during positive-strand synthesis in conjunction with the adjacent stem-loop SL3. Other RNA 
structural elements investigated in alphaviruses include the packaging signal mapped in nsP2 
(208), the 3′ replication element (289,351) and SL3 in the context of innate immune evasion 
(352,353). 
A 51 nt conserved sequence element (CSE) consisting of two short stem–loops within the 5′ nsP1-
encoding region was predicted to be highly conserved following multiple sequence alignment 
across a range of alphaviruses and SHAPE-constrained modelling in CHIKV, SINV and VEEV 
(13) (Fig 3.1). Reverse-genetic analysis has demonstrated that the 51 nt CSE enhances replication 
of SFV, SINV and VEEV (13,350,357,375,376). For SINV, disruption of the 51 nt CSE severely 
impaired replication in mosquito and avian cells (350,375), with a more moderate and variable 
effect on replication in mammalian cells (350,357). Mutation or deletion of the VEEV 51 nt CSE 
severely diminished or abolished RNA synthesis respectively in BHK-21 cells (352). However, 
another study indicated that deletion of either of the two stem–loops of the 51 nt CSE was well 
tolerated in BHK-21 or mosquito-derived cells, but deletion of both structures prevented VEEV 
replication (376).  
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Figure 3.1: The 51 nt CSE (adapted from (13)). SHAPE map labelling as seen in Fig 1.22. A 
schematic of the CHIKV genome displays the position of the 51 nt CSE (dashed lines) within nsp1. 
  
A) 
 
B) 
 
Figure 2: A) Schematic representation of individual RNA stem-loops and associated 
mutations (red) designed to destabilise the base-pairing of the heteroduplex stem. B) 
Schematic of CHIKV infectious clone (CHIKV_IC) and replicon constructs reporting 
genome replication through a Firefly luciferase reporter (CHIKV_Rep) or translation 
through a Renilla luciferase reporter (CHIKV_Rep(GDD>GAA)). Delta (red) indicates 
mutation in the active site of the RdRp preventing genome replication. 
 
Destabilisation of stem-loops inhibits virus replication in a host cell-dependent manner 
Mammalian cell lines representing naturally infected tissues in humans, and invertebrate cell lines 
representing the vector species Ae. albopictus, were selected for screening with RNA structural 
mutants. Infections were carried out using stem-destabilised mutant virus alongside virus of WT RNA 
structure. Supernatant was collected 24-hours post-infection and titred as a measure of viral 
replication (Fig 3). The stem-loop within the untranslated region of the genome, SL47, was the only 
ORF1 ORF2
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3.1.1 Preliminary data 
In silico thermodynamic folding predictions and biochemical SHAPE mapping carried out by 
A. Tuplin (University of Leeds) suggested a highly ordered structured region at the 5′ of the 
CHIKV genome, spanning ~300 nt including the 5′ UTR and the 5′ coding sequence of nsp1 (Fig 
3.2). During recent outbreaks, synonymous site variability within this ~300 nt region was restricted 
in CHIKV isolates from the sera of infected individuals, indicating strong constraints on sequence 
variability, such as those imposed by functional RNA elements (395). In conjunction with 
phylogenetic analysis across the alphaviruses, which demonstrates the potential for structure 
conservation in this region via co-variation, these data suggest a function for the structured region 
during in the CHIKV lifecycle. 
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Figure 3.2: Thermodynamic folding model of CHIKV 5′ 300 nt overlaid with SHAPE 
reactivity data. 37°C SHAPE reactivities (n=3) for individual nucleotides overlaid onto a 37°C 
thermodynamically-derived model of RNA folding, generated using SHAPE-directed constraints. 
The AUG start codon of nsP1 is denoted by a grey arrow. SHAPE reactivities are shown as a heat 
map: grey indicates no data, white SHAPE reactivities between 0–0.3 and increasing intensities 
from light pink to dark red indicate increasing SHAPE reactivities, as denoted by the key. High 
reactivity (red) denotes unpaired nucleotides whereas low reactivity (white) denotes base-paired 
nucleotides. Predicted stem–loops are labelled SL3, SL47, SL85, SL102, SL165, SL194 and 
SL246. PK denotes a putative pseudoknot (PK) structure, where dotted lines represent potential 
base-pairing (A. Tuplin, University of Leeds). 
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SHAPE-constrained thermodynamic folding analysis predicted seven discrete stem-loop structures 
– two within the 5′ UTR (SL3 and SL47) and five within the adjacent nsP1-encoding region of 
ORF1 (SL85, SL102, SL165, SL194 and SL246) (Fig 3.2). SL3 has previously been predicted to 
form in CHIKV and demonstrated to mimic the methylated cap structure and function in viral 
immune evasion, avoiding recognition by IFIT-1 (371). Consequently, it was not investigated 
further. Whilst SL165 and SL194 correspond to the 51 nt nsP1 CSE investigated in VEEV and 
SINV, SL47, SL85, SL102 and SL246 are novel structures and their potential functions have not 
previously been investigated. 
For six of the seven structures (SL3, SL47, SL102, SL165, SL194 and SL246) there was a high 
degree of concordance between the structural prediction and NMIA reactivity. Interestingly 
however, this was not the case for SL85 – located directly down-stream of the AUG start codon. 
SHAPE reactivities within SL85 indicated a high degree of exposure for nucleotides of the stem 
and low reactivity within nucleotides of the predicted terminal loop. Contradiction between the 
raw SHAPE reactivity values and SHAPE-constrained thermodynamic structure predictions may 
indicate that SL85 and its adjacent sequence are involved in dynamic secondary and higher-order 
RNA-RNA interactions. One such potential pseudoknot (PK) annotated in Figure 3.2 is explored 
further in Chapter 5. For initial reverse genetic analysis, SL85 was assumed to form according to 
the SHAPE-constrained prediction as shown in Figure 3.2. 
 
The aim of the work described in this chapter was to investigate the phenotypic importance 
of RNA structures within the upstream region of the CHIKV genome; analysing stem-loop 
mutant phenotypes in human and mosquito cells and determining at which stage of the viral 
replication cycle these effects are exerted.  
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3.2  Results 
 
3.2.1 Design of mutations for phenotypic analysis 
In order to determine the phenotypic consequences of disrupting predicted RNA stem-loops 
mapped by SHAPE, a reverse genetic approach was taken. Individual stem-loops (SL47, SL85, 
SL102, SL165, SL194 and SL246) were disrupted via synonymous site mutagenesis (preliminary 
mutagenesis undertaken by D. Banda and A. Tuplin (University of Leeds)) (Fig 3.4A). Resulting 
phenotypic changes, to different stages of the virus replication cycle, were then assayed in human- 
and mosquito-derived cell lines.  
 
A systematic and rational approach was taken to mutagenesis design, in which synonymous 
substitutions were designed to disrupt the predicted base-paired duplex stems of individual mutants 
in such a way that further synonymous mutations could then be incorporated to restore predicted 
base-pairing. The intention of this approach was that by phenotypic comparison of a stem-loop 
mutant with a disrupted duplex stem to one in which base-pairing was restored, phenotypic 
changes due to disruption in stem-loop structure could be distinguished from those due to 
alterations in primary synonymous nucleotide sequence. This approach precluded the use of codon 
shuffle algorithms which reshuffle codons to create mutant sequences of equivalent codon usage 
and dinucleotide frequency among other features. Although codon shuffling would disrupt the 
stem-loop structures while maintaining other characteristics of the region of interest, it would 
complicate the design of compensatory mutants which restore stem-loop base-pairing. Thus, 
mutations were designed to maintain synonymy and prioritise the possibility of structure 
reformation while preserving the degree of codon usage bias and dinucleotide frequencies as much 
as possible. 
 
Furthermore, as compensatory mutations were designed based on a structural model of the 
positive-sense genomic copy of the CHIKV genome, rescue of wild-type (WT) phenotype by this 
approach would confirm the importance of a stem-loop in the positive-sense genomic strand - 
rather than due to unforeseen disruption of potential functional elements in the negative strand 
intermediate of the viral genome. The lack of structural similarity between the positive and 
negative strand can be seen in the UNAfold structural prediction of the 3′ 300nt of the negative 
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strand shown below, equivalent to the mutated region (Figs 3.2 & 3.3). The impact of mutations 
on this region is discussed further in later sections. 
 
Stem-loop mutants were incorporated into the full-length CHIKV infectious clone (CHIKV_IC) 
and corresponding CHIKV sub-genomic replicon systems (Fig 3.4B) via site-directed mutagenesis 
(as previously described in 2.2.7). The disruption of targeted structures was corroborated by 
UNAfold prediction of each mutant, which can be observed in the appendix (Table 2). The 
outcome of CHIKV genome replication events was measured using a sub-genomic replicon, which 
encodes viral non-structural proteins nsP1-nsP4 and a Firefly luciferase reporter in place of ORF-
2 (CHIKV_Rep).  
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Figure 3.4: RNA secondary structure mutants and constructs. (A) Schematic representation 
of individual RNA stem–loops and associated mutations (red) designed to destabilise the base-
pairing of the heteroduplex stem. All mutations in the nsp1-encoding region are synonymous. 
Mutations are labelled on the outside of the stem, while the wild-type sequence is displayed as part 
of the stem; for example, in SL85 A88G denotes a G>A mutation at nt 88 while A100C on the other 
side of the stem denotes an A>C mutation at nt 100.  (B) Schematic representation of CHIKV 
infectious clone (CHIKV_IC) and sub-genomic replicon construct reporting genome replication 
through expression of Firefly luciferase (CHIKV_Rep). Non-structural proteins nsp1–4 are 
encoded by the first ORF. Structural proteins C, E1–3 and 6K are translated from a sub-genomic 
RNA, termed 26S RNA (black arrow), encoded by the second ORF. 
A)
B)
SL47mut SL85mut SL102mut SL165mut SL194mut SL246mut
Fig 2.
A) 
 
B  
 
Figure 2: A) Schematic representation of individual RNA stem-loops and associated 
mutations (red) d sign d to destabilise the base-pairing of the hete oduplex stem. B) 
Schematic of CHIKV infectious clone (CHIKV_IC) and replicon constructs reporting 
genome replication through a Firefly luciferase reporter (CHIKV_Rep) or translation 
through a Renilla luciferase reporter (CHIKV_Rep(GDD>GAA)). Delta (red) indicates 
mutation in the active site of the RdRp preventing genome replication. 
 
Destabilisation of stem-loops inhibits virus replication in a host cell-dependent manner 
Mammalian cell lines representing naturally infected tissues in humans, and invertebrate cell lines 
representing the vector species Ae. albopictus, were selected for screening with RNA structural 
utants. Infections were carried out usi g stem-destabilised mutant virus alongside virus of WT RNA 
structure. Supernatant was collected 24-hours post-infection and titred as a measure of viral 
replication (Fig 3). The stem-loop within the untranslated region of the genome, SL47, was the only 
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3.2.2 SL47, SL85, SL102, SL165 and SL194 enhance CHIKV replication in human 
hepatocytes 
To determine the importance of each mapped stem-loop during the CHIKV lifecycle, mutant 
viruses were generated by electroporation of BHK-21 cells with capped in vitro transcribed viral 
RNA (Fig 2.4). Huh7 cells were infected with either WT CHIKV or mutant virus with disrupted 
RNA structure at an MOI of 1 for 24 hours. In order to assess the impact of each set of mutations 
on CHIKV replication, the number of infectious virions released was determined by plaque assay 
(Fig 3.5A). CHIKV replication was significantly reduced upon disruption of SL47 in the 5′ UTR 
(p<0.005). Of the stem-loops in the coding sequence of nsP1, four had an impact on viral 
replication in human hepatocytes. SL85 and SL102 each significantly decreased viral titre when 
disrupted (p<0.005). SL165 and SL194, the equivalent of the 51 nt CSE investigated in VEEV and 
SINV, also significantly decreased CHIKV replication when disrupted (p<0.005 and p=0.0001 
respectively). SL246 had no significant impact on CHIKV replication (p=0.71). This data suggests 
that SL47-SL194 enhance CHIKV replication in human hepatocytes. Interestingly, the reduction 
in viral replication was greater for SL85mut, SL165mut and SL194mut (~100-fold) than for 
SL47mut and SL102mut (~10-fold). 
 
In order to confirm these results, intracellular viral genome copy number was determined by 
extraction of RNA from infected Huh7 cells. The qRT-PCR strategy, optimised and carried out by 
M. Müller (University of Leeds), measured the number of positive-sense genome copies and 
negative-sense replication intermediates in order to quantify viral genome replication. Disruption 
of SL47 in the 5′ UTR and SL85, SL102, SL165 and SL194 in the nsP1-encoding sequence 
significantly decreased the number of positive-sense CHIKV genome copies present in infected 
Huh7 cells (p<0.005) (Fig 3.5B). Similarly, disruption of SL47-SL194 significantly decreased the 
number of negative-sense CHIKV genome copies present in infected Huh7 cells (p<0.005) (Fig 
3.5C). The greater reduction in viral titre for SL165mut and SL194mut (~100-fold) relative to 
SL47mut and SL102mut (~10-fold) was recapitulated at the level of positive sense genome copies. 
However, the number of positive sense genome copies for SL85mut (~25 fold) was closer to that 
of SL102mut. While disruption of SL47-SL194 significantly decreased the number of negative-
sense CHIKV genome copies, differences between the mutants were not detected, possibly due to 
the smaller population of negative strand genome copies. Together, these results demonstrate that 
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SL47-SL194 enhance CHIKV replication in human hepatocytes; disruption of these stem-loops 
results in a decrease in viral genome replication and number of infectious virions released.  
 
 
3.2.3 SL47 and SL246 enhance CHIKV replication in Ae. albopictus cells 
 
The phenotypes presented in Figure 3.5 were observed in a human-derived cell line. As a 
mosquito-borne arbovirus, CHIKV must replicate in human and mosquito cells. Thus, it was 
important to investigate the impact of each set of mutations on CHIKV replication in Ae. albopictus 
cells. C6/36 cells were infected with either wild-type CHIKV or virus with disrupted RNA 
structure at an MOI of 1 for 24 hours. The resulting supernatant was titred by plaque assay (Fig 
3.6A). CHIKV replication in C6/36 cells was significantly reduced by disruption of SL47 
(p<0.0001). This suggests that SL47 enhances CHIKV replication in mosquitoes. Disruption of 
SL85, SL102, SL165 and SL194 had no effect on CHIKV replication in mosquito cells. 
Interestingly, CHIKV replication in C6/36 cells was significantly reduced by disruption of SL246 
(p<0.0005), which had no impact in Huh7 cells, although the effect size was small. Strand-specific 
qRT-PCR was then carried out on RNA extracted from infected C6/36 cells to quantify the 
differences in viral genome replication between wild-type CHIKV and mutants exhibiting 
replication phenotypes. Disruption of SL47 in the 5′ UTR and SL246 in the nsP1-encoding 
sequence significantly decreased the number of both positive- and negative- strand CHIKV 
genome copies present in infected C6/36 cells (p<0.002) (Fig 3.6B & C). This data demonstrates 
that SL47 in the 5′ UTR enhances CHIKV replication in both human and mosquito hosts, while 
stem-loops SL85-SL246 in the coding sequence act in a host-specific manner. 
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Figure 3.5: Stem-loops SL47-SL194 enhance viral replication in Huh7 cells. (A) Replication 
phenotype of WT CHIKV (black bar) compared to virus bearing mutations predicted to destabilise 
the heteroduplex stem RNA structures (hatched bars), in Huh7 human cells. Viral genome copy 
number is shown for (B) positive strands and (C) negative strand intermediates of the CHIKV 
genome following infection of Huh7 cells for 24 h with WT and destabilised mutants (n=3). qRT-
PCR data from (B) and (C) obtained by M. Müller (University of Leeds). A schematic of the 
structured region (dashed box) is displayed for reference. * represents statistical significance for 
each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), 
≤0.001 (***). Data shown is the mean of three independent biological replicates, with the error 
bar representing the standard deviation of the mean. 
W
T
S L
4 7
S L
8 5
S L
1 0
2
S L
1 6
5
S L
1 9
4
S L
2 4
6
1 0 3
1 0 4
1 0 5
1 0 6
H u h 7
S te m -lo o p  m u ta n t
C
H
IK
V
 t
it
re
 (
P
F
U
/m
L
)
**
**
** ***
**
A)
W
T
S L
4 7
S L
8 5
S L
1 0
2
S L
1 6
5
S L
1 9
4
1 0 5
1 0 6
1 0 7
1 0 8
1 0 9
1 0 1 0
1 0 1 1
C
H
IK
V
 g
e
n
o
m
e
 c
o
p
ie
s
p lu s  s t ra n d
*
*
** *
W
T
S L
4 7
S L
8 5
S L
1 0
2
S L
1 6
5
S L
1 9
4
1 0 3
1 0 4
1 0 5
1 0 6
1 0 7
C
H
IK
V
 g
e
n
o
m
e
 c
o
p
ie
s
m in u s  s tra n d
*
**
* *
B) C)
W
T
S L
4 7
S L
8 5
S L
1 0
2
S L
1 6
5
S
9 4
S L
2 4
6
1 0 3
1 0 4
1 0 5
1 0 6
H u h 7
S te m -lo o p  m u ta n t
C
H
IK
V
 t
it
re
 (
P
F
U
/m
L
)
**
**
** ***
**
W
T
S L
4 7
S L
8 5
S L
1 0
2
S L
1 6
5
S L
1 9
4
S L
2 4
6
1 0 3
1 0 4
1 0 5
1 0 6
H u h 7
S te m -lo o p  m u ta n t
C
H
IK
V
 t
it
re
 (
P
F
U
/m
L
)
**
**
** ***
**
Virus replication phenotype
Huh7 37C
Fig 3.
SL47SL85
SL102
SL165
SL194
SL246
5´ 3´
Schematic representation of 5′ 300nt
 110 
 
 
 
Figure 3.6: Stem-loops SL47 and SL246 enhance viral replication in Ae. albopictus cells. (A) 
Replication phenotype of WT CHIKV (black bar) compared to virus bearing mutations predicted 
to destabilise the heteroduplex stem RNA structures (hatched bars), in C6/36 Ae. albopictus cells. 
Viral genome copy number is shown for (B) positive strands and (C) negative strands of the 
CHIKV genome following infection of C6/36 cells for 24 h with WT and destabilised mutants 
(n=3). qRT-PCR data from (B) and (C) obtained by M. Müller (University of Leeds). A schematic 
of the structured region (dashed box) is displayed for reference. * represents statistical significance 
for each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), 
≤0.001 (***). Data shown is the mean of three independent biological replicates, with the error 
bar representing the standard deviation of the mean. 
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3.2.4 Host-specific replication phenotypes are not temperature-dependent 
RNA structure is temperature-sensitive and structures may unfold at higher temperatures. 
Conversely, stable RNA secondary and tertiary structures may form at lower temperatures which 
would not be thermodynamically favourable at higher temperatures. Consequently, the effect of 
temperature on the stability of RNA secondary structure cannot be disregarded in the study of 
arbovirus replication, where host species vary in body temperature so widely. The different 
replication phenotypes observed for stem-loops in nsp1 during infection of Huh7 and C6/36 cells 
may be a product of the temperature difference between these cells: 37 and 28ºC respectively. 
Temperature-dependent structural conformations could be exploited by CHIKV as a strategy to 
mediate viral replication in the two host cell types. Dynamic formation of two alternative structures 
may occur, with different functional elements suitable for each host. If SL85, SL102, SL165 or 
SL194 form differently at 28ºC, substitutions made to disrupt these structures as they are predicted 
to form at 37ºC would not target base-paired stems at the lower temperature. Alternatively, the 
structural mutants may be temperature-sensitive. Due to the relatively small number of 
substitutions per mutant, stabilisation of the heteroduplex stem at low temperatures is possible. 
The lack of phenotype for SL85, SL102, SL165 and SL194 in C6/36 cells could be due to the 
retention of wild-type structure at 28ºC.  
 
Two experiments were conducted to investigate this. Firstly, SHAPE mapping was carried out by 
A. Tuplin (University of Leeds) on RNA folded at 28ºC to demonstrate that the wild-type RNA 
structured region exists at insect cell temperatures (396). The structured region shows remarkably 
little structural deviation at lower temperatures. Secondly, Huh7 cells were infected with mutant 
virus at the lower temperature, to determine whether the phenotypes seen at 37ºC were a result of 
the higher temperature (Fig 3.7A & B). At 24 hours post-infection, the phenotypes were consistent 
with those observed at 37ºC, although a significant improvement (p<0.001) was seen in SL85 
replication. These results suggest that the effect of SL85 in Huh7 cells is partially temperature-
dependent. The potential for dynamic structure formation around SL85 is explored in Chapter 5. 
The observed replication phenotypes at 28ºC argue against temperature-sensitivity of mutants in 
nsp1. Taken together, these experiments suggest that the effect on CHIKV replication seen in Huh7 
cells for SL85, SL102, SL165 and SL194, which was not seen in C6/36 cells, is cell-type dependent 
rather than temperature-dependent, with the partial exception of SL85.  
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Figure 3.7: Stem-loops SL47-SL194 enhance viral replication in Huh7 cells in a temperature-
independent manner. Replication phenotype of WT CHIKV (black bar) compared to virus 
bearing mutations predicted to destabilise the heteroduplex stem RNA structures (hatched bars), 
in Huh7 cells grown at (A) 37°C and (B) 28°C (n=3). * represents statistical significance for each 
mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), ≤0.001 
(***). Data shown is the mean of three independent biological replicates, with the error bar 
representing the standard deviation of the mean. 
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3.2.5 SL47, SL85, SL102, SL165 and SL194 enhance CHIKV genome replication in 
human hepatocytes  
Following the results of infection studies, whereby disruption of individual RNA structures in the 
genome were shown to inhibit CHIKV replication, further investigation was carried out to 
determine at which stage of the viral lifecycle they function. Strand-specific qRT-PCR suggested 
that CHIKV replication phenotypes were a result of inhibited genome replication. In order to 
examine the importance of each stem-loop during CHIKV genome replication, the effects of the 
stem-loop mutations on replication of a CHIKV sub-genomic replicon were measured over time. 
Mutations were cloned into a monoluciferase replicon CHIKV_Rep expressing the replicase 
polyprotein, with Firefly luciferase in place of the CHIKV structural proteins (Fig 3.4B). The sub-
genomic replicon allows isolated study of genome replication in the absence of mechanisms of 
entry, packaging and egress; the replicon is transfected into cells and lacks capsid and envelope 
genes necessary for virion formation and egress. 
 
Prior to the transfection of mutant sub-genomic replicon into cells, optimisation was carried out 
with WT replicon to determine the ideal time course for measurement of genome replication in 
several cell lines (n=1). The expansion of mammalian cell lines included those representative of 
human lung (A549), mouse muscle (C2C12) and human liver (Huh7 and Huh7.5) (Fig 3.8). As 
previously shown, A549 cells do not support CHIKV genome replication (397). C2C12 cells were 
permissive of WT CHIKV genome replication. However, high growth rates resulted in cell death 
from over-confluence by 48 hours post-transfection. Huh7 and Huh7.5 were permissive of CHIKV 
genome replication over 48 hours. Genome replication was therefore measured up to 24 hours 
post-transfection for mammalian cell lines: C2C12, Huh7 and Huh7.5. 
 
Results from these sub-genomic replicon studies in Huh7 cells recapitulated the stem-loop mutant 
phenotypes observed during the infectious virus assays. Compared to wild-type, disruption of 
SL47 in the 5′ UTR significantly inhibited replication in Huh7 cells over 24 hours (Fig 3.9A). 
Likewise, disruption of SL85, SL102, SL165 and SL194 significantly inhibited replication in Huh7 
cells (Fig 3.9B-E). Furthermore, in agreement with the infectious virus study, disruption of SL246 
had no significant effect on sub-genomic replicon replication in Huh7 cells (Fig 3.9F). These 
results suggest that the enhancement of CHIKV replication observed during infectious virus 
studies occurs at the level of genome replication in Huh7 cells. 
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Figure 3.8: Optimisation of WT sub-genomic replicon replication in mammalian cells. 
Replication level of WT sub-genomic CHIKV replicon over 48 hours post-transfection in various 
mammalian cell lines: A549 human lung carcinoma, C2C12 murine myoblasts, Huh7 human 
hepatocellular carcinoma and Huh7.5 RIG-I knock-out Huh7 cell line (n=1). 
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Figure 3.9: Stem-loops SL47-SL194 enhance viral genome replication in human hepatoma 
cells. Replication phenotype of sub-genomic CHIKV replicons in Huh7 human cells over 24 hours 
post-transfection. Replicons with wild-type RNA structure (black) compared to replicons bearing 
mutations predicted to destabilise the heteroduplex stem of RNA structures (grey) (A–F). 
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Significance (p<0.05) represented by red boxes for appropriate time-points (n=3). A schematic of 
the structured region (dashed box) is displayed for reference. * represents statistical significance 
for each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*). Data shown 
is the mean of three independent biological replicates, with the error bar representing the standard 
deviation of the mean. 
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3.2.6 SL47, SL85, SL102, SL165 and SL194 enhance CHIKV genome replication in 
murine myoblasts  
CHIKV replicates in several human tissues to high titre, including the liver. However, the 
pathology of infection is often associated with muscle and joint tissues. In order to investigate the 
function of the CHIKV structured region in muscle tissue, a mouse muscle progenitor cell line was 
used. C2C12 cells were transfected with sub-genomic replicon over 24 hours (Fig 3.10). The 
results re-capitulated those seen in hepatocytes; SL47, SL85, SL102, SL165 and SL194 enhanced 
CHIKV genome replication while SL246 had no significant role. These results suggest that the 
stem-loops function similarly in permissive mammalian tissues by enhancing CHIKV genome 
replication.  
 
3.2.7 SL47 and SL246 enhance CHIKV genome replication in Ae. albopictus cells 
As with mammalian cell lines, sub-genomic replicon assays were optimised with WT sub-genomic 
replicon in mosquito cell lines prior to mutant phenotyping (n=1). The Ae. albopictus cell lines 
C6/36 and U4.4 were transfected with WT replicon and measurements taken over 72 hours, longer 
than in mammalian cell lines due to the lifelong asymptomatic infection naturally acquired by 
mosquitoes. CHIKV genome replication did not peak until 24 hours post-transfection in Ae. 
albopictus cells, reaching a steady state in both cell lines (Fig 3.11). Measurements at 6 hours were 
below the threshold for accurate quantification. The luciferase signal was far higher in C6/36 cells 
than in U4.4 cells, likely due to the presence of Dicer-2 in U4.4 cells dampening CHIKV genome 
replication. Although the WT signal was above threshold in U4.4 cells, mutants displaying a 
replication phenotype may be indistinguishable from background signal. For these reasons, the 
C6/36 cell line was taken forward for measurement of genome replication up to 24 hours post-
transfection. Results from sub-genomic replicon studies in C6/36 cells recapitulated the stem-loop 
mutant phenotypes observed in the infectious virus assays. Compared to wild-type, disruption of 
SL47 significantly inhibited replication in C6/36 cells (Fig 3.11A), while disruption of SL85, 
SL102, SL165 and SL194 had no significant effect (Fig 3.12B-E). As in the infectious virus study, 
disruption of SL246 significantly inhibited sub-genomic replicon replication in mosquito cells, 
although the effect size was minor (Fig 3.12F). These results confirm those of the infectious virus 
study, whereby SL47 in the 5′ UTR significantly impacts CHIKV genome replication in a host-
independent manner, while stem-loops in the coding sequence of nsp1 have host-specific roles.  
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Figure 3.10: Stem-loops SL47-SL194 enhance viral genome replication in murine muscle 
progenitors. Replication phenotype of sub-genomic CHIKV replicons in C2C12 murine myoblast 
cells over 24 hours post-transfection. Replicons with wild-type RNA structure (black) compared 
to replicons bearing mutations predicted to destabilise the heteroduplex stem of RNA structures 
(grey) (A–F). Significance (p<0.05) represented by red boxes for appropriate time-points (n3). A 
schematic of the structured region (dashed box) is displayed for reference. * represents statistical 
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significance for each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*). 
Data shown is the mean of three independent biological replicates, with the error bar representing 
the standard deviation of the mean. 
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Figure 3.11: Optimisation of WT sub-genomic replicon replication in mosquito cells. 
Replication level of WT sub-genomic CHIKV replicon over 72 hours post-transfection in two Ae. 
albopictus cell lines: U4.4 mosquito embryonic cells and C6/36 cells, a Dicer-2 knock-out U4.4 
cell line (n=1). 
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Figure 3.12: Stem-loops SL47 and SL246 enhance viral genome replication in Ae. albopictus 
cells. Replication phenotype of sub-genomic CHIKV replicons in C6/36 Ae. albopictus cells over 
24 hours post-transfection. Replicons with wild-type RNA structure (black) compared to replicons 
bearing mutations predicted to destabilise the heteroduplex stem of RNA structures (grey) (A–F). 
Significance (p<0.05) represented by blue boxes for appropriate time-points (n3). A schematic of 
the structured region (dashed box) is displayed for reference. * represents statistical significance 
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for each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*). Data shown 
is the mean of three independent biological replicates, with the error bar representing the standard 
deviation of the mean. 
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3.2.8 Disruption of CHIKV 5′ RNA structure does not impact translation 
Whilst clearly demonstrating that the stem-loops function during CHIKV genome replication, the 
replication-competent sub-genomic replicon cannot distinguish between different stages of this 
process, such as initiation of transcription or translation of the ORF-1 non-structural polyprotein. 
Mutations inhibiting translation of ORF-1 would impair efficient production of replicase 
complexes, thereby inhibiting the down-stream process of genome replication.  ORF-1 translation 
phenotypes were measured using a replication-deficient dual luciferase replicon 
(CHIKV_Rep(GDD>GAA)) produced by S. Bradley (University of Leeds), in which an additional 
reporter gene (Renilla luciferase) was incorporated into ORF-1 as a fusion within nsp3 (Fig 3.13). 
CHIKV_Rep(GDD>GAA) undergoes initial translation to express the reporter in ORF-1 but 
subsequent transcription events cannot occur, allowing translation of the non-structural proteins to 
be studied in isolation from genome replication. In order to investigate the possibility that 
disruption of the stem-loops inhibited ORF-1 translation, the stem-loop mutations were 
incorporated into CHIKV_Rep(GDD>GAA). Using this construct, containing a mutation of the 
RdRp active site, the efficiency of ORF-1 translation alone was measured and compared between 
wild-type and stem-loop mutant transcripts, in the absence of subsequent genome replication. 
Translation of input sub-genomic replicon 5′-capped transcripts was measured at 6 hours for 
mammalian cell lines, Huh7 and C2C12, and 8 hours post-transfection into the mosquito cell line, 
C6/36. No significant differences in levels of translation were observed between the 
CHIKV_Rep(GDD>GAA) replication-deficient mutant encoding wild-type stem-loops to those 
encoding the mutant structures (Fig 3.14A-C). In combination with earlier results, from 
replication-competent sub-genomic replicon mutants, these results indicate that the individual 
stem-loops do not influence ORF-1 translation but rather function at the level of genome 
replication. 
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Figure 3.13: Translation reporter sub-genomic replicon 
Schematic representation of CHIKV sub-genomic replicon constructs—reporting genome 
replication through expression of Firefly luciferase (CHIKV_Rep) or translation through 
expression of Renilla luciferase, in the context of a replication deficient RdRp GDD>GAA mutant 
(indicated by red triangle) (CHIKV_Rep(GDD>GAA)). CHIKV_Rep(GDD>GAA) was produced 
by S. Bradley (University of Leeds). Non-structural proteins nsp1–4 are encoded by the first ORF. 
Firefly luciferase is translated from a sub-genomic RNA, termed 26S RNA (black arrow), encoded 
by the second ORF. 
  
A) 
 
B) 
 
Figure 2: A) Schematic representation of individual RNA stem-loops and associated 
mutations (red) designed to destabilise the base-pairing of the heteroduplex stem. B) 
Schematic of CHIKV infectious clone (CHIKV_IC) and replicon constructs reporting 
genome replication through a Firefly luciferase reporter (CHIKV_Rep) or translation 
through a Renilla luciferase reporter (CHIKV_Rep(GDD>GAA)). Delta (red) indicates 
mutation in the active site of the RdRp preventing genome replication. 
 
Destabilisation of stem-loops inhibits virus replication in a host cell-dependent manner 
Mammalian cell lines representing naturally infected tissues in humans, and invertebrate cell lines 
representing the vector species Ae. albopictus, were selected for screening with RNA structural 
mutants. Infections were carried out using stem-destabilised mutant virus alongside virus of WT RNA 
structure. Supernatant was collected 24-hours post-infection and titred as a measure of viral 
replication (Fig 3). The stem-loop within the untranslated region of the genome, SL47, was the only 
A)
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Figure 3.14: Translation is not impeded by disruption of CHIKV 5′ RNA structure. 
Translation phenotype in the context of replication-deficient sub-genomic CHIKV replicon system 
(CHIKV_Rep(GDD>GAA)) in (A) C2C12, (B) Huh7 and (C) C6/36 cells at 6 h post-transfection 
for mammalian cell lines and 8 h post-transfection for C6/36 cells (n=3)8. Replicons with wild-
type RNA structure (black) are compared to replicons bearing mutations predicted to destabilise 
the heteroduplex stem of RNA structures (white). A schematic of the structured region (dashed 
box) is displayed for reference. Data shown is the mean of three independent biological replicates, 
with the error bar representing the standard deviation of the mean. 
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3.3  Discussion 
Using reverse-genetic analysis in virus and replicon systems, this study demonstrates that the 
structured region of the CHIKV genome, comprising the 5′ UTR and adjacent nsP1-coding region 
(Fig 3.2), enhances CHIKV genome replication in human and Ae. albopictus cell lines. Novel RNA 
structural elements, within the positive-strand genomic copy of the CHIKV genome, were 
demonstrated to function by host-independent and dependent mechanisms (i.e. in either human- or 
mosquito-derived host cells or in both) during efficient replication of the virus genome. More 
specifically, RNA structures within the nsP1-encoding region are required for efficient CHIKV 
genome replication in a host-dependent manner, while SL47 in the 5′ UTR acts during genome 
replication in both human and mosquito host cells.  
 
While the synonymous mutations incorporated into the structured region (Fig 3.2) were designed 
to disrupt base-pairing in each stem, the effect of substitution in the primary nucleotide sequence 
cannot be discounted. Mutations alter dinucleotide frequencies, codon usage and potential binding 
motifs. Increased frequency of the dinucleotides CpG and UpA in viral genomes has been 
demonstrated to inhibit replication of several single-stranded RNA viruses including influenza A 
virus (398) and the picornavirus, echovirus 7 (399). The impact of dinucleotide frequency is of 
particular interest in multi-host pathogens such as arboviruses, which infect highly divergent host 
organisms. In silico analysis across the Flaviviridae demonstrated that flaviviruses infecting 
vertebrate hosts exhibit underrepresentation of CpG and UpA, while insect-only viruses suppress 
UpA alone (400). The mutations incorporated by site-directed mutagenesis were designed to 
maintain CpG and UpA frequencies where possible (Fig 3.16). Thus, it is unlikely that the 
replication phenotypes observed were due to changes in dinucleotide frequency. Similarly, codon 
usage was taken into consideration during design of structural mutants (Fig 3.17). Substitution of 
codons with vastly different transfer RNA (tRNA) frequencies can impact translational efficiency 
(401). Extensive codon deoptimisation attenuated CHIKV in primate and mosquito cells, 
indicating that codon usage is a critical determinant in productive CHIKV infection (402). 
Although further study was necessary to formally disregard altered codon usage as responsible for 
the replication phenotypes observed in this study (Chapter 4), the absence of translation 
phenotypes for the stem-loop mutants in mammalian and mosquito cells strongly suggests that 
changes to codon usage had no significant impact (Fig 3.14). Finally, the primary RNA sequence 
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may contain binding motifs for trans-activating factors. The relative importance of primary 
nucleotide sequence and structure in CHIKV replication was explored in Chapter 4, via 
compensatory mutations in the stem which restored base-pairing and extensive mutagenesis of 
single-stranded terminal loops and bulges. Compensatory mutants also provide insight into the 
potential impact of dinucleotide frequency and codon usage bias on replication; if the phenotypes 
observed in this study result from either of these factors, phenotypic compensation would not occur 
in mutants which retain the original substitutions. An alternative approach to mutagenesis design 
utilizing codon shuffle algorithms could have been taken to ensure equivalent dinucleotide 
composition and codon usage frequencies in the disrupted mutants. While extremely useful for 
disrupting structures and binding motifs without impacting other sequence features, codon shuffle 
methods do not allow for restoration of structures in the same manner as the approach taken here.  
 
Synonymous mutations were designed using the structural map of the 5′ of the positive-sense 
CHIKV genome but consideration must be given to the impact on structures in the corresponding 
region of the negative strand. The 3′ secondary structure of the negative strand intermediate differs 
greatly from that of the positive-sense genome due to determinants of structural stability such as 
stacking energy which vary by RNA context (403). UNAfold modelling predicts that the 
corresponding structure of the region of interest in the negative strand is very different to that of 
the positive strand (Fig 3.15). Several of the original mutations would not disrupt pairing in the 
negative strand intermediate. For example, the G>A mutations made in SL102mut which produce 
C:A pairs in the positive strand would represent G:U pairs in the corresponding negative strand. 
Given the replication defect exhibited by SL102mut, while the negative strand element could still 
form in the context of these mutations, it is clear that SL102 in the positive strand is responsible 
for enhancement of genome replication. Phylogenetic analysis demonstrates strong sequence and 
structure conservation in this region of the genome but does not distinguish between conservation 
of sequence elements in the positive or negative strands of the CHIKV genome. However, the 
frequency of G:U co-variation, which would produce disruptive C:A pairs in the negative strand, 
suggests structural conservation in the positive rather than the negative strand of the genomic 
RNA. Further consideration of the impact of mutations on negative strand secondary structure is 
given in Chapter 4. 
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Mutation of stem-loop 47 (SL47) in the 5′ UTR of the CHIKV genome reduced production of 
infectious virus, viral genome replication and replication of a sub-genomic replicon in human- and 
Ae. albopictus-derived cell lines. The dual-host replication phenotype exhibited by SL47mut may 
be explained by a host-independent mechanism of replication enhancement, utilising host factors 
present in both of the disparate cellular environments. Host-independent enhancers of arboviral 
genome replication have been demonstrated, for example, increasing the fidelity of the CHIKV 
nsP4 RdRp by a single mutation C483Y negatively impacts viral replication in mosquitoes and 
mice indiscriminately (404). Alternatively, SL47 may enhance replication in each host via a 
distinct pathway as has been demonstrated for sHP in the DENV 3′ UTR. The sequence of sHP is 
necessary for efficient replication of the DENV genome in mosquito cell lines, whereas the 
structure of the stem-loop alone is necessary to achieve this enhancement in human cells, 
indicating different mechanisms by which sHP impacts replication in each host (294). While 
clearly demonstrating a function for SL47 in CHIKV genome replication, this phenotypic study 
does not delve into the mechanism behind enhancement of replication. Further studies provide 
mechanistic insight by identifying the structure and sequence requirements for SL47-mediated 
enhancement of CHIKV genome replication in each host (Chapter 4). 
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Figure 3.16: Changes in CpG and UpA dinucleotide frequency in disrupted structure 
mutants. Net change in CpG and UpA dinucleotide frequencies in each of the stem-loop mutants, 
expressed as the number of each dinucleotide pair introduced (positive) or removed (negative) by 
the mutations displayed in Fig 3.4A. 
 
 
 
Figure 3.17: Changes in codon efficiency in disrupted structure mutants. Net change in codon 
efficiency for each stem-loop mutant in human- and D. melanogaster-derived cells. Changes to 
codon efficiency are displayed as a relative percentage increase (positive) or decrease (negative) 
in codon efficiency in each organism upon mutation. Each mutant contains a minimum of two 
substitutions relative to wild-type and thus each percentage is an average of the change induced 
by all substitutions per mutant. Standard deviation for each average was equal to or less than 10%. 
Codon efficiency is measured as codon frequency in the genome of each organism, as drawn from 
the codon frequency tool from Genscript (405). SL47 is in the untranslated region, thus codon 
usage is null.  
Stem-loop mutant CpG UpA
SL47mut 0 0
SL85mut 1 1
SL102mut -2 2
SL165mut 0 0
SL194mut 1 -2
SL246mut 0 2
Percentage change in codon 
efficiency
Human D. melanogaster
SL47mut - -
SL85mut -2 5
SL102mut -13 -2
SL165mut -8 1
SL194mut 16 -4
SL246mut -15 -3
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SL47 represents a previously unreported RNA replication element which is highly conserved 
across CHIKV genotypes and closely related viruses such as O′nyong nyong virus and Mayaro 
virus, although variation is observed in the single-stranded terminal loop sequence (Fig 3.18). 
Within more divergent members of the Semliki Forest Complex, including Ross river virus (RRV) 
and SFV, covariant and semi-covariant substitutions (the latter involving non-canonical G:U 
interactions) are observed within the base-paired stem, maintaining broadly homologous structures 
(Fig 6.1). It has been detailed in previous studies that the length of 5′ UTR region varies widely 
across the alphavirus genus (353) and more divergent alphaviruses such as VEEV, SINV and Eilat  
virus, lack the sequence domain within the 5′ UTR responsible for SL47 formation. Previous 
studies have demonstrated that the 5′ UTR sequences of SFV and SINV are involved in controlling 
template specificity for initiation of negative-strand synthesis (357). Since SL47 is not conserved 
across the alphavirus genus but is required for efficient CHIKV genome replication, it can be 
speculated that SL47 plays a role in CHIKV replicase template specificity. 
 
Disruption of SL85, SL102, SL165 and SL194 in the nsP1-encoding region of the CHIKV genome 
reduced viral replication, viral genome replication and replication of a sub-genomic replicon in 
mammalian- but not Ae. albopictus-derived cell lines. These results suggest host-specific 
mechanisms of action for stem-loops in nsp1 during enhancement of CHIKV genome replication 
in mammalian cells. Immediately downstream of the AUG start codon, SHAPE-constrained 
thermodynamic analysis demonstrated that the RNA structure of CHIKV differs from that 
previously observed for other alphaviruses (13). For instance, in SINV this region forms a single, 
long RNA element – deletion of which does not inhibit virus RNA replication (350). In this study, 
the homologous region of the CHIKV genome was demonstrated to contain two distinct RNA 
replication elements (SL85 and SL102), both of which are involved in efficient genome replication 
in human-derived cells but not those from Ae. albopictus. Interestingly, while the in silico 
thermodynamically predicted structure, SHAPE mapping and reverse genetic analysis were in 
close agreement for SL102, this was not the case for SL85 (Fig 3.2).  Phenotypic analysis 
demonstrated that SL85 plays a role in CHIKV genome replication in human-derived cells. 
However, SHAPE mapping of SL85 was inconsistent with the predicted structure, suggesting that 
this region of the genome may be structurally dynamic and able to form alternative interactions. 
One such potential interaction is a pseudoknot between complementary sequence motifs in the 
 133 
apical region of SL85 and an adjacent upstream region of the genome overlapping the AUG start 
codon, which would destabilise base-pairing within the stem of SL85. Further work was needed 
to determine whether SL85 forms as predicted by SHAPE-constrained thermodynamic analysis or 
as may be expected from SHAPE reactivity (Chapter 5). Compensatory mutations which reformed 
the stem of SL85 as it would be predicted to form by constrained thermodynamic prediction, shed 
light on the formation of the stem-loop in vivo (Chapter 4). Further to this, investigation of the 
spatio-temporal dynamics of SL85 formation may reveal at which stage of the viral lifecycle SL85 
exerts its effects and the location of its formation within the cell i.e in replicative complexes or in 
the cytosol. 
 
Downstream of SL85 and SL102 lies the alphaviral 51 nt conserved sequence element (CSE), 
comprised of SL165 and SL194 in CHIKV. The primary nucleotide sequence and structure of the 
nsP1 51 nt CSE has previously been shown to be highly conserved between divergent alphaviruses 
(Fig 3.1) (13). Although studies investigating the 51 nt CSE have not been previously published 
for CHIKV, published studies in VEEV and SINV have demonstrated that this element enhances 
virus replication in both mosquito- and mammalian-derived cells, via initiation of negative strand 
replication (357,375). It should be noted that several studies have provided conflicting reports of 
the importance of the 51 nt CSE in mammalian cells, with individual or dual disruption being 
tolerated during some studies (350,358). By comparison, this study demonstrates that the 51 nt 
CSE of CHIKV acts in a host-dependent manner – enhancing replication in human cells, while 
having no significant effect on viral replication in Ae. albopictus-derived cells. Given the high 
level of conservation of the 51 nt CSE, it has been hypothesised that it functions through a 
conserved mechanism across divergent members of the Alphavirus genus. However, differences 
demonstrated in this study between the host specificity of the CSE in CHIKV and those in 
previously published studies in VEEV and SINV, suggest that the function or mechanism of action 
may be more divergent than previously recognised. 
 
Within this study SL246 was the only RNA replication element, other than SL47, which was 
essential for efficient CHIKV genome replication in mosquito-derived cells. However, unlike 
SL47, it was not required for efficient replication in human cells. Furthermore, SL246 is much 
more highly conserved across divergent alphaviruses than SL47, with in silico UNAfold analysis 
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indicating that homologous structures are capable of forming within divergent viruses such as 
SINV, VEEV and Eilat (Fig 3.19). The conservation of this novel RNA replication element within 
the alphavirus genus suggests that SL246 functions within the positive-sense genomic RNA 
molecule during efficient genome replication in several alphaviruses.  
 
Each of the stem-loop mutants SL47mut-SL246mut exhibited a replication defect during this study, 
but the relative reduction in CHIKV titre varied between mutants. A ten-fold greater reduction in 
CHIKV titre was observed for SL85mut, SL165mut and SL194mut compared to SL47mut and 
SL102mut in Huh7 cells, and a thousand-fold greater reduction for SL47mut compared to 
SL246mut in C6/36 cells (Figs 3.5 & 3.6). This variation in magnitude of replication defect could 
be the result of individual, non-redundant mechanisms of action for each stem-loop, for example 
stem-loop-specific trans-activating factors or scaffold proteins. Alternatively, stem-loops 
displaying similar replication phenotypes may be involved in a cooperative interaction. Another 
possibility is that the stem-loops form part of a larger region of secondary or tertiary structure 
which is disrupted to differing degrees in each stem-loop mutant. For example, disruption of 
SL165 in the centre of a larger structure may cause a greater degree of disruption than SL47mut at 
the 5′ terminus. Pairwise and combinatorial mutagenesis of the stem-loops may provide insight 
into interactions and redundancy between the stem-loops and the possibility of a larger structure. 
This work was begun in Chapter 5.  
 
In addition to differing effect sizes between stem-loop mutants, luciferase assays produced a 
smaller effect size than that seen in viral one-step growth assays. There are several possible reasons 
for this, which can be broadly divided into biases of the two systems and true biological effects. 
Firstly, the sub-genomic replicon CHIKV_Rep does not contain the structural protein-coding ORF 
sequence. There may be RNA structures within this region of the genome which interact with the 
stem-loops directly or through recruitment of binding factors. Secondly, the products of 
CHIKV_Rep replication cannot egress and enter untransfected cells whereas CHIKV_IC can 
complete multiple rounds of reinfection. On average, CHIKV can complete three rounds of 
infection in 24 hours. Thus, it is likely that any difference in replication between the wild-type and 
mutant RNA would be amplified in viral assays compared to replicon assays. Thirdly, the 
reduction in initial RNA synthesis may disrupt the regulation of downstream events, amplifying 
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the initial effect by altering the progression of infection e.g by changing the ratio of non-structural 
proteins and genomic copies during early infection, prolonging the pre-26S RNA phase of 
infection. Finally, the stem-loops may play a direct role in other aspects of the viral lifecycle such 
as genome packaging, stability and transition between genomic and sub-genomic RNA synthesis 
and translation. This would result in a far greater effect on viral replication than the initial reduction 
in viral RNA synthesis.  
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Figure 3.19: Homologues of SL246 across the Alphavirus genus. 28°C in silico predicted 
UNAfold thermodynamic predictions for CHIKV SL246 homologous structures from the ECSA, 
WA and Asian CHIKV genotypes, closely related alphaviruses (ONNV and MAYV), other 
members of the complex (BFV, SFV and RRV) and from more distantly related members of the 
genus (SINV, VEEV and Eilat virus). There is conservation of an elongated stem in this region, 
which is most conserved in structure and sequence between the Old World viruses most closely 
related to CHIKV.  
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Supplementary Figure 3:
28°C in silico predicted UNAFOLD thermodynamic predictions for CHIKV SL246 homologous structures from t
ECSA, WA and Asian CHIKV genotypes, closely related alphaviruses (ONNV and MAYV), other members of the
complex (BFV, SFV and RRV) and from more distantly related members of the genus (SINV, VEEV and Eilat virus).
 137 
As an arbovirus, CHIKV must maintain fitness in both vertebrate and invertebrate host-cell 
environments. A compelling hypothesis for modulation of CHIKV replication in such different 
environments was a temperature-dependent switch between alternate structures. Given that 
mosquitoes are ectothermic insects native to tropical climes, where diurnal temperature range is 0-
40°C, temperature-sensitivity may be considered a major disadvantage for any arbovirus. It may 
be expected that structural variability with temperature would be disadvantageous and viral 
genomes would evolve to maintain stable structures across as great a temperature range as possible. 
However, mosquito innate immune responses vary greatly with temperature in a complex manner. 
For example, in anopheline mosquitoes, melanisation and defensin expression are highest at lower 
temperatures (18°C) while nitric oxide synthase expression peaks at higher temperatures (30°C) 
(406). In the case of ZIKV infection of Ae. aegypti, a reduction in temperature from 28°C to 20°C 
limits ZIKV replication via cold-induced changes to the midgut environment such as vitellogenin 
expression upregulation, altered ROS metabolism and other aspects of innate immunity such as 
Toll signalling pathway components (407). Thus, temperature-responsive elements may be 
beneficial in evading host innate immunity. In addition, the transmissible temperature for CHIKV 
is much narrower than the diurnal temperature range. CHIKV is transmissible between 16°C and 
32°C in Ae. albopictus with an optimum temperature of 26°C, and between 18°C and 35°C in Ae. 
aegypti with an optimum temperature of 29°C. Above and below this range, transmission drops to 
zero (408). Therefore, temperature-dependent limits on the stability of the virus exist in 
mosquitoes. While it may not be surprising that CHIKV maintains a stable genomic RNA structure 
in the 5′ region between 28°C and 37°C, investigation of temperature-dependence as a mechanism 
of adaptation to disparate hosts was warranted. 
 
 In order to investigate whether the different permissive temperature conditions of mosquito and 
human cells influenced the thermodynamic stability and resulting folding structure of the CHIKV 
genome, SHAPE mapping of full-length CHIKV genomic transcripts was carried out by A. Tuplin 
(University of Leeds) at mosquito and human host-cell permissive temperatures (28 and 37°C 
respectively). SHAPE reactivity profiles were strikingly similar within the predicted stem–loop 
structures, indicating that different ambient growth temperatures are not likely to result in 
alternative folding structures for essential replication elements in this region of the CHIKV 
genome (396). This suggests that host specificity of RNA replication elements identified and 
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analysed in this study is more likely due to interaction with host-specific trans-activating factors, 
than from different invertebrate and vertebrate host-cell temperatures stabilising alternative RNA 
structure conformations. Furthermore, Huh7 cells infected with mutant virus at 28°C displayed 
similar replication deficiencies to those observed at 37°C, confirming that the temperature 
difference cannot account for the host-specific phenotypes observed for stem-loop mutants in nsp1. 
While each stem-loop mutant in nsp1 replicated to a higher titre at 28°C than at 37°C, there 
remained a significant decrease in viral replication relative to virus of wild-type RNA structure. 
Interestingly, SL85mut replicated to a considerably higher titre at 28°C than at 37°C, around 1.5 
logs higher, though viral titre was still significantly decreased compared to WT. This is in line 
with SHAPE reactivity data which suggests the potential for dynamic interactions around SL85; 
lower temperatures may preferentially stabilise an alternate conformation of the region, stabilise a 
tertiary interaction or increase the stability of the stem-loop conformation, allowing it to form at 
the appropriate stage of replication. Further study is necessary to determine the range of structures 
possible in this region and the dynamics of folding.  
 
Surprisingly, translation of the viral genome was not significantly impacted by disruption of any 
of the stem-loops studied. Extensive 5′ RNA secondary structure has been demonstrated to reduce 
the efficiency of translation in cellular mRNAs (384). Conversely, specific RNA secondary 
structures have been demonstrated to regulate viral mRNA translation in several viruses (409–
411). In this study, disruption of the stem-loops did not significantly affect translation either 
positively or negatively, suggesting that this region does not contain structures which impede the 
helicase activity associated with elongation or viral RNA elements which up-regulate translation 
of the viral genome. However, SHAPE-constrained thermodynamic analysis of the structure in 
this region (Fig 3.2) reveals base-pairing of the AUG start codon with a second in-frame potential 
start codon AUG. These codons are separated by SL85 and SL102 in a manner which brings them 
into close proximity. The mutations introduced into SL85 and SL102 (Fig 3.4A) maintain base-
pairing of each AUG start codon, meaning that the lack of translation phenotype observed for 
SL85mut and SL102mut (Fig 3.13) does not preclude the possibility of a structure modulating 
translation in this region, for example through a mechanism alternatively blocking or stabilising 
AUG:AUG base pairing.  
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Following the demonstration that each of the nsP1-encoding region stem–loops function as RNA 
replication elements required for efficient genome replication, further studies were conducted to 
determine whether the phenotypes observed are due to changes to the primary nucleotide sequence 
of the duplex stem or the disruption of base-pairing. In addition, the importance of the primary 
nucleotide sequence within single stranded bulge or terminal-loop regions for replication was 
investigated, for example as recognition signals for host/viral trans-activating factors (Chapter 4). 
The potential contribution of, as yet uncharacterised, RNA-RNA interactions within the negative-
strand RNA intermediate remain to be investigated. 
 
3.3.1 Conclusion 
This study indicates the existence of RNA stem-loops within the positive-strand genomic copy of 
the CHIKV genome, which function by host-dependent and independent mechanisms (i.e. in either 
human- or mosquito-derived host cells or in both) during efficient replication of the virus genome. 
Further studies will identify the sequence and structural requirements responsible for enhancement 
of CHIKV replication by these six stem-loops (Chapter 4) and the potential tertiary interactions 
within this region (Chapter 5). 
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Chapter 4. Sequence and structure requirements for CHIKV 
genome replication 
4. 1  Introduction 
The previous chapter demonstrated that stem-loop 47 (SL47) within the 5′ UTR of the CHIKV 
genome enhanced viral genome replication in human- and Ae. albopictus-derived cells. In contrast, 
stem-loops within the adjacent nsP1-encoding region (SL85, SL102, SL165, SL194 and SL246) 
enhanced CHIKV genome replication in a host-specific manner (Figs 3.5 & 3.6). The mechanism 
behind the replication phenotypes was unknown, as were the relative importance of primary 
nucleotide sequence versus folding structure for the functionality of each RNA element. 
 
Stem-loops consist of a heteroduplex stem with a single-stranded terminal loop. Unpaired bulges 
along the stem may also form part of the structure. Stem-loops impact RNA virus replication via 
sequence and/or structure-dependent mechanisms in virus families as diverse as Retroviridae 
(311), Picornaviridae (312), Flaviviridae (313), Bunyaviriridae (314), and Orthomyxoviridae 
(315). Following the discovery in the previous chapter that synonymous substitutions in the 5′ 
region of the CHIKV genome inhibit virus genome replication, it was necessary to distinguish 
between nucleotide sequence- and structure-dependent effects of mutations in each stem. The 
original disruptive mutations (Fig 3.4A) were designed in such a manner that synonymous 
compensatory mutations could be made to restore base-pairing in the stem without returning to the 
wild-type RNA sequence - allowing the effects of RNA sequence and structure in the stem to be 
distinguished.  
Aside from the importance of RNA sequence and base-pairing in the stem regions, single-stranded 
terminal loop and bulge sequences have also been shown to function in recognition of viral 
genomes by trans-activating factors. For example, co-crystallisation of the HIV-1 trans-activation 
response element (TAR) stem-loop bound to the viral trans-activator of transcription (Tat) protein 
indicated that the terminal loop directs the interaction (412). In addition, the single-stranded bulge 
region of TAR has been shown by mutational analysis to contribute to Tat binding (413). In such 
instances, heteroduplex stems may present recognition sequences for preferential binding with 
interacting protein or RNA partners. In the case of HIV-1 TAR, disruption of base-pairing would 
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decrease the availability of terminal loop sequences for binding and thus impair replication 
indirectly. The relative importance of primary nucleotide sequence and structure in single-stranded 
terminal loops and bulges for CHIKV stem-loop functionality can be determined by reverse 
genetic analysis. 
Passaging phenotypic virus mutants can be used as a tool to investigate the importance of mutated 
elements and the interactions by which they function. For example, U57>C57 mutants in a non-
coding stem-loop in the DENV genome reverted directly to wild-type sequence within 10 passages 
in 10 of the 18 lineages passaged, indicating the importance of the region during replication of the 
virus (414). Indirect reversion, forming compensatory mutations which restore optimal base-
pairing without reverting to wild-type sequence, can demonstrate the importance of structure over 
primary sequence in heteroduplex stems. This has occurred in studies of multiple RNA structural 
elements in  cucumber mosaic virus (415) and for the splice donor hairpin of HIV-1 (416). Escape 
mutants may also identify interactions with other factors which, for example, overcome inhibition 
of viral replication via pseudoreversion in interacting proteins. Pseudoreversion was demonstrated 
during passage of VEEV, whereby changes to stem-loop 3 (SL3) were suppressed by non-
synonymous mutations in nsP1, nsP2 and nsP4 (358). Similarly, recent passaging studies of the 
CHIKV 3′ UTR demonstrated that a 258 nt deletion was compensated for by non-synonymous 
mutation in nsp1 and synonymous mutation in the capsid gene (417). 
The aim of the work described in this chapter is to investigate the relative importance of 
RNA structure and primary sequence in the function of stem-loops within the 5′ region of 
the CHIKV genome. Escape mutants were generated by prolonged passaging in each host 
species to explore the potential genetic routes of reversion. 
 
 
  
 142 
4.2  Results 
4.2.1 Stem-loops in the 5′ region of the CHIKV genome enhance CHIKV replication 
in a structure-dependent manner 
In order to confirm that previously observed mutant phenotypes (Figs 3.5 & 3.6) were due to 
synonymous-site disruption of base-pairing within predicted stem–loops, rather than due to 
alteration of the primary nucleotide sequence, compensatory synonymous mutations were 
incorporated into CHIKV_IC and CHIKV_Rep (Fig 3.4B). Compensatory mutations were 
designed to restore base-pairing within the duplex-stems without reverting to the wild-type 
nucleotide sequence (Fig 4.1). 
 
The ability of the compensatory mutations to rescue wild-type levels of CHIKV replication was 
investigated in both Huh7 and C6/36 cells (Fig 4.2A-C). Within the nsP1-encoding region, 
restoration of SL85, SL102, SL165 and SL194 significantly rescued CHIKV replication compared 
to the stem-loop disrupted mutants in Huh7 cells (Fig 4.2A). SL85mut-Comp and SL102mut-Comp 
displayed significantly increased CHIKV replication relative to their disrupted counterparts 
(p≤0.0001 and p≤0.0005, respectively). Similarly, SL165mut-Comp and SL194mut-Comp 
displayed significantly increased CHIKV replication relative to their disrupted mutants (p≤0.0005 
and p≤0.0001, respectively). Likewise, compared to SL246mut, SL246 was restored to wild-type 
replication levels in C6/36 cells by compensatory mutations (p≤0.05) (Fig 4.2B). These results 
suggest that enhancement of replication by RNA stem-loops in nsp1 requires base-pairing in the 
stem regions, rather than the primary nucleotide sequence.  
Within the 5′ UTR, restoration of base-pairing in the duplex stem of SL47 restored wild-type levels 
of CHIKV replication compared to SL47mut (p≤0.005) in mosquito-derived C6/36 cells at the 
permissive temperature of 28°C (Fig 4.2C)i)). In contrast, compensatory mutations in SL47 did 
not rescue wild-type levels of replication in human-derived Huh7 cells at 37°C (Fig 4.2C)ii)). 
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Figure 4.1: Compensatory mutants restoring RNA secondary structure. Mutations predicted 
to destabilise the heteroduplex stem of CHIKV genomic RNA structures (red) and compensatory 
mutations predicted to restore base-pairing (blue). All mutations in the nsP1-encoding region are 
synonymous. Compensatory mutations (blue) are labelled on the outside of the stem, while the 
sequence in the corresponding SL-mut (red) is displayed as part of the stem; for example, in SL165, 
U172A denotes an A>U mutation relative to SL165mut at nt 172 while A190C on the other side of 
the stem denotes an A>C mutation at nt 190 relative to SL165mut. In SL194, G199A denotes an 
A>G mutation relative to SL194mut which restores base-pairing in combination with the C211 
mutation of SL194mut (Fig 3.4A). Mutations to SL47 were introduced by H. Khalid (University 
of Leeds). 
  Fig 1.
SL47mut-Comp SL102mut-Comp SL165mut-Comp SL194mut-Comp SL246mut-CompSL85mut-Comp
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Lower temperatures increase thermodynamic stability, thus making formation of a stable RNA 
structure more favourable. In order to determine whether the formation of a functional stem-loop 
in SL47mut-Comp was dependent on the lower temperatures at which C6/36 cells are maintained, 
Huh7 cells were infected at 28°C. Full rescue was observed when Huh7 cells were maintained at 
28°C for the duration of the assay (p≤0.005) (Fig 4.2C)iii)). Temperature-dependent rescue of 
wild-type phenotype in SL47mut-Comp is consistent with in silico UNAfold-predicted free 
energies of folding at 37°C and 28°C. At 37°C, SL47mutComp is predicted to be less 
thermodynamically stable than the wild-type (wild-type DG=−2.9 kcal/mol and SL47mut-Comp 
DG=−2.3 kcal/mol). At 28°C, restoration of base-pairing in the stem of SL47mut-Comp is 
predicted, despite remaining relatively less stable compared to the wild-type sequence (wild-type 
DG=−4.35 kcal/mol and SL47mutComp DG=−3.75 kcal/mol). The ability of SL47mut-Comp to 
replicate to wild-type levels in Huh7 and C6/36 cells at 28°C suggests a structure-dependent 
mechanism for SL47 in both host species. Together, these results demonstrate that base-pairing in 
the stem of each stem-loop, rather than the primary sequence within the stem, is integral to 
enhancement of CHIKV replication. 
4.2.2 Stem-loops in the 5′ region enhance viral genome replication in a structure-
dependent manner 
The ability of compensatory mutations to rescue wild-type levels of genome replication 
specifically, rather than virus infection in general, was confirmed using the sub-genomic replicon 
system in both Huh7 and C6/36 cells (Fig 4.3A-C). For each stem-loop within nsp1, restoration of 
base-pairing by compensatory synonymous-site substitutions restored wild-type levels of CHIKV 
genome replication in the relevant host cell line (Fig 4.3A & B). There were no significant 
differences between compensatory mutants and wild-type sub-genomic replicon replication. 
Similarly, the temperature-dependence of SL47mut-Comp was observed at the level of genome 
replication; compensation of wild-type phenotype was observed during assays at 28°C but not at 
37°C (Fig 4.3C). These results confirm that structure-dependent enhancement of CHIKV 
replication by stem-loops in the 5′ region occurs specifically at the level of genome replication. 
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Figure 4.2: SL47-SL246 enhance viral replication in a structure-dependent manner. 
Replication phenotype of WT CHIKV (n=3) (black) compared to virus containing mutations 
(hatched bars) predicted to destabilise (m) or restore (c) the heteroduplex stem of genomic RNA 
structures following infection of Huh7 and C6/36 cells for 24 hours at MOI=1. Results are shown 
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only for cell lines in which destabilisation of stems exerts an effect on replication: (A) Huh7, (B) 
C6/36 cells and (C) both cell types. Replication phenotypes for SL47mut (m) and SL47mut-Comp 
(c) shown in both cell types, alongside data from Huh7 cells at 28°C. A schematic representation 
of the 5′ structure of the CHIKV genome is shown for reference (top right). * represents statistical 
significance for each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), 
≤0.01 (**), ≤0.001 (***). Data shown is the mean of three independent biological replicates, with 
the error bar representing the standard deviation of the mean. 
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Figure 4.3: SL47-SL246 enhance genome replication in a structure-dependent manner. 
Replication phenotype of sub-genomic CHIKV replicons (n=3) in (A) Huh7 and (B) C6/36 
cells, at 6 and 24 hours post-transfection respectively. Replicons with WT RNA structure 
(black) are compared to replicons bearing mutations (grey) predicted to destabilise (m) or 
restore (c) the heteroduplex stem of individual genomic RNA structures. (C) Replication 
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phenotypes for SL47mut (m) and SL47mut-Comp (c) shown in both cell types, alongside data 
from Huh7 cells at 28°C. A schematic representation of the 5′ structure of the CHIKV genome 
is shown for reference (top right). * represents statistical significance for each mutant 
compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), ≤0.001 (***). 
Data shown is the mean of three independent biological replicates, with the error bar 
representing the standard deviation of the mean. 
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4.2.3 Enhancement of viral genome replication requires the terminal loop sequence 
of SL194 
Several of the RNA replication elements mapped by SHAPE-constrained modelling were 
predicted to contain unpaired terminal-loop and bulge regions (Fig 3.4A). In order to investigate 
the role of these single-stranded regions within the nsP1 stem–loops, substitutions were introduced 
(Fig 4.4).  Replication phenotypes, compared to wild-type, were measured in the sub-genomic 
replicon system in both Huh7 and C6/36 cells (Fig 4.5). Levels of CHIKV genome replication for 
mutants with substitutions in the single-stranded regions of SL102, SL165 and SL246 were 
indistinguishable from wild-type in Huh7 and C6/36 cells - suggesting that the stem–loop 
structures themselves, rather than the primary sequence of unpaired motifs is important for 
efficient CHIKV genome replication. Increasing the number of unpaired nucleotides in the 
terminal-loop of SL165, by substitutions predicted to disrupt base-pairing in the apex of the duplex 
stem (SL165mut-Loop-IV), resulted in a small, consistent but non-significant (p=0.09) reduction 
in replication of the sub-genomic replicon (Fig 4.5). However, disruption of base-pairing in the 
duplex stem could not be excluded as a contributing factor. The only substitution in a single-
stranded region of the replication elements which significantly inhibited genome replication was 
a synonymous C>U substitution within the terminal loop of SL194 (SL194mut-Loop). This 
substitution reproduced a UUUU sequence motif that is conserved at this locus in divergent 
alphaviruses (including SINV, SFV and VEEV). This substitution significantly inhibited 
replication in Huh7 cells by ∼1 log compared to wild-type (p≤0.05), indicating that the primary 
terminal loop sequence of SL194, in addition to the requirement for an intact duplex stem, is 
important for its function as an RNA replication element during CHIKV genome replication. 
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Figure 4.4: Mutations in single-stranded regions of SL102-SL246. Substitutions (red) in single-
stranded regions of CHIKV genomic RNA structures. Black box indicates several distinct loop 
mutants in SL165. Mutations are synonymous in SL165 and SL194. Mutations are more extensive 
and non-synonymous in SL102 and SL246, where mutations were introduced by H. Khalid 
(University of Leeds). Mutations are labelled on the outside of the stem, while the wild-type 
sequence is displayed as part of the stem; for example, in SL165mut-Loop-I, U175A denotes an 
A>U mutation at nt 175 while G178U on the other side of the loop denotes a G>U mutation at nt 
178.   
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Figure 4.5: The terminal loop sequence of SL194 enhances viral genome replication in Huh7 
cells. Replication phenotype of sub-genomic CHIKV replicons (n=3) with wild-type RNA 
structure (black) compared to replicons bearing mutations (grey) in terminal loop and single-
stranded bulge regions of RNA structures in (A) Huh7 and (B) C6/36 cells, at 6 and 24 hours post-
transfection respectively. A schematic representation of the 5′ structure of the CHIKV genome is 
shown for reference (top right). * represents statistical significance for each mutant compared to 
wild-type under a two-tailed Student's t-test: p≤0.05 (*). Data shown is the mean of three 
independent biological replicates, with the error bar representing the standard deviation of the 
mean. 
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4.2.4 Enhancement of CHIKV replication requires the terminal loop sequence of 
SL194 and the terminal loop size of SL165 
The mutants SL194mut-Loop and SL165mut-Loop-IV, which exhibited a consistent reduction in 
CHIKV genome replication compared to WT, were assayed for their effect on virus replication in 
Huh7 cells (Fig 4.6). Virus replication was significantly inhibited for SL165mut-Loop-IV 
compared to wild-type (p≤0.0001), although this was not observed at the level of genome 
replication (Fig 4.5). SL165mut-Loop-IV contains two substitutions which increase the size of the 
terminal loop, decreasing the number of base-pairs in the stem and thus reducing its stability (Fig 
4.4). These factors complicate the conclusions which can be drawn about the terminal loop of 
SL165. Significant inhibition of CHIKV replication was observed for SL194mut-Loop compared 
to wild-type (p≤0.005), recapitulating the phenotype seen during assays of genome replication. 
Interestingly, disruption of base-pairing in the stem (SL194mut) reduced viral replication to a 
greater degree than alterations to the primary sequence of the terminal loop (SL194mut-Loop) 
(p≤0.01). This suggests that the intact duplex stem of SL194 is significantly more important to 
viral replication than the terminal loop sequence, UUCU. 
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Figure 4.6: The terminal loop sequences of SL165 and SL194 enhance viral replication in 
Huh7 cells. Replication phenotype of WT CHIKV (black) compared to viruses containing 
mutations (hatched bars) in terminal loop and single-stranded bulge regions of genomic RNA 
structures following infection of Huh7 cells for 24 hours. * represents statistical significance for 
each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), 
≤0.001 (***), ≤0.0001 (****). Data shown is the mean of three independent biological replicates, 
with the error bar representing the standard deviation of the mean. 
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4.2.5 Passaging stem-loop mutants in mammalian cells leads to phenotypic reversion 
within 10 passages 
Passaging, by multiple rounds of harvest/re-infection, can reveal selection pressures acting on 
specific regions of the viral genome. Selection of escape mutants may result in restoration of wild-
type phenotype through direct or indirect reversion of a mutated sequence, to restore wild-type 
sequence or stem-loop structure respectively. Alternatively, selection pressure can act to restore 
functional RNA/RNA or RNA/protein interactions, through pseudo-revertant mutations in a long-
range RNA interacting sequence or virally expressed protein trans-activating partner. Escape 
mutants provide information about the mechanisms involved in viral replication, whether they act 
to conserve wild-type sequence, structure or interactions via direct, compensatory or pseudo-
reversion respectively. In order to explore the potential routes of reversion, and thus gain 
mechanistic insight, mutant viruses were passaged repeatedly in cell lines representing appropriate 
host species, assayed for phenotypic reversion and sequenced by Sanger sequencing to determine 
the basis of reversion (Figs 4.7 & 4.8).  
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Figure 4.7: Workflow during repeated infection experiments to produce passaged virus. i) 
P0 virus was generated by electroporation of BHK-21 cells with in vitro transcribed CHIKV_IC 
RNA, titred by plaque assay and one-step growth assay carried out in the appropriate cell line to 
confirm replication phenotype at the outset of passaging. The first passage was carried out at 
MOI=1; ~2x106 cells were infected with P0 virus (WT and mutants) over 48 hours in 10ml. ii) 9ml 
of passage supernatant was stored and the remaining 1ml used to infect ~2x106 cells. This process 
was repeated to generate several passages, as denoted by dashed lines. iii) At intervals, passage 
supernatant was titred to probe for potential phenotypic reversion. Passaging was continued until 
no significant difference was observed between passaged WT and mutants, as denoted by a dotted 
line. 
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Figure 4.8: Workflow during passage experiments to analyse passaged virus phenotype and 
genotype. i) Passage supernatant (Pn virus) was generated as described in Fig 4.7 (dotted line) and 
titred by plaque assay. Potential phenotypic escape was determined by comparison of viral titre in 
200µl of passaged WT and mutant virus. Where a significant difference in viral titre remained, 
passaging was resumed (dotted line). Where no significant difference in viral titre was observed, 
phenotypic escape was confirmed by one-step growth assay. ii) If no significant replication 
phenotype was observed, the basis of phenotypic escape was determined, otherwise passaging was 
resumed. iii)  ~2x106 cells of the relevant cell line were infected with Pn virus over 48 hours. 
Infected cells were harvested in Trizol, intracellular viral RNA extracted and reverse transcribed. 
The region of interest was amplified  and sequenced in duplicate. Sequencing the region of interest 
revealed direct revertants (wild-type sequence in the region of interest), compensatory revertants 
(substitutions or additional mutations in the region of interest) and potential pseudorevertants 
(original mutant sequence in region of interest). iv) For direct and compensatory revertants, the 
accumulation of mutations was examined by sequencing of previous passages. Compensatory 
revertants, mutations were cloned into CHIKV_IC to confirm that these mutations were the basis 
of phenotypic reversion. Where no sequence reversion was observed in the region of interest, the 
non-structural ORF-1 was sequenced to detect mutations outside the region of interest.  
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Stem-loop mutant viruses were generated by electroporation of in vitro transcribed RNA into 
BHK-21 cells, as described in 2.4.1, to produce virus (P0) for serial passage experiments. Stem-
loop mutants were passaged and assayed alongside wild-type virus in order to discount host 
adaptation as the cause of genotypic changes. As expected, each of the mutants SL47mut, SL85mut, 
SL102mut, SL165mut and SL194mut exhibited significantly reduced replication at P0 compared to 
wild-type virus during a one-step growth assay in Huh7 cells (p≤0.01)(Fig 4.9A). Huh7 cells were 
then infected with P0 virus at MOI=1 for 48 hours, before 1/10th of the supernatant was transferred 
to a new flask of uninfected cells. Passaging continued for a total of 10 rounds in Huh7 cells. 
Several passages were titred between P0 and P10 to sample for potential phenotypic reversion. 
However, as significant reversion to wild-type phenotype was not observed, passaging was 
continued blind until P10. Analysis at P10 indicated that mutant viruses SL47mut, SL85mut, 
SL102mut, SL165mut or SL194mut were replicating to wild-type levels, suggesting phenotypic 
reversion. In order to confirm the presence of escape mutants, a one-step growth assay was carried 
out with P10 virus (Fig 4.9B). No significant difference in viral titre was observed for any of the 
stem-loop mutants compared to wild-type, demonstrating that phenotypic reversion had occurred. 
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Figure 4.9: Mammalian cell passaging leads to phenotypic reversion within ten passages. 
Results of passaging stem-loop mutants i) SL47mut and SL194mut and ii) SL85mut, SL102mut and 
SL165mut in mammalian cells. Replication phenotype of WT CHIKV (black bar) compared to 
virus bearing mutations predicted to destabilise the heteroduplex stem RNA structures (grey bars) 
following MOI=1 infection of Huh7 cells over 24 hours with (A) P0 and (B) P10 virus. A 
schematic representation of the 5′ structure of the CHIKV genome is shown for reference (top 
right). * represents statistical significance for each mutant compared to wild-type under a two-
tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), ≤0.001 (***), ≤0.0001 (****). Data shown is the 
mean of three independent biological replicates, with the error bar representing the standard 
deviation of the mean. 
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4.2.6 Escape mutants exhibit direct and indirect reversion in the 5′ region in 
mammalian cells 
In order to determine the genotypic basis of reversion, RNA was extracted from Huh7 cells 
infected with P10 SL47mut, SL85mut, SL102mut, SL165mut and SL194mut viruses. The first 1 kb 
of each P10 viral genome was reverse transcribed, amplified by PCR and sequenced by Sanger 
sequencing. Direct reversion to wild-type sequence was observed for SL47mut-SL165mut at P10 
(Fig 4.10). SL194mut contained the two synonymous substitutions in the duplex stem at P10, 
alongside an additional compensatory mutation predicted to restore base-pairing.   
 
 
4.2.6.1 SL47 mutant reversion 
The sequential genetic basis of reversion for each mutant was then mapped by sequencing earlier 
passages and modelling corresponding thermodynamically-predicted structures using UNAfold 
software. SL47mut retained four substitutions until P5 (Fig 4.11A). Two revertant mutations 
occurred during P6 (C56G57>G56C57), although these did not affect the RNA structure of the region, 
which remained single-stranded (Fig 4.11B). This suggests that there is selection pressure to 
restore the sequence, independent of the structure. A further revertant mutation during P7 
(C60>G60) resulted in the formation of a short stem-loop (Fig 4.11C), followed by a final reversion 
(C61>G61) during P9 which restored the wild-type sequence and therefore the structure in full by 
re-forming the base-pair at the base of the stem (Fig 4.11D). 
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Figure 4.10: Development of reversion in Huh7 cells over 10 passages (P1-P10) for each stem-
loop. Ticks represent direct or compensatory reversion to wild-type sequence or structure 
respectively. Crosses represent no or incomplete reversion. Number of mutations reverted to the 
wild-type sequence from P0 is expressed as a fraction (eg 2/4 mutations reverted at P6). ‘Comp’ 
represents a compensatory mutation which reforms a base-pair but does not restore wild-type 
sequence. Yellow dashed lines denote sampling for phenotypic reversion in passage supernatant, 
yellow filled boxes denote phenotypic reversion during one-step growth assay. 
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Figure 4.11: Development of reversion in SL47 from passage 0 to passage 10 (P0-P10) in 
Huh7 cells. i) The passage sequences of P0 and P5-P10 are aligned below the WT sequence. The 
mutations of SL47mut (red boxes) are shown in P0. Passage sequences are grouped (dotted red 
lines) according to the sequence changes occurring over the course of the experiment (groups 
A: (P0 – P5)
P0
P5
P6
P7
P8
P9
P10
WT: SL47
A
B
C
D
B: (P6) C: (P7 – P8) D: (P9 – P10)
WT
Fig 9.
i) ii) iii)
iv) v) vi)
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containing the same sequence are labelled A:D). ii) The wild-type structure of SL47 is displayed, 
with the sites targeted for mutation in P0 highlighted (green circles). iii-vi) The region equivalent 
to SL47 is denoted by a grey dotted line in the P0 predicted structure. Mutated nucleotides are 
displayed for passage sequences (red circles). Each panel A:D displays the UNAfold-predicted 
structure in the region for the passage sequence shown in the alignment. The order of sequential 
passages is denoted by a grey arrow. 
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4.2.6.2 SL85 mutant reversion 
SL85mut retained both substitutions until P5 (Fig 4.12). The presence of both mutations resulted 
in an elongated stem preceding SL102 (Fig 4.13A). During P6, direct reversion occurred to restore 
wild-type sequence and thus structure of SL85 (Fig 4.13B). 
 
 
 
Figure 4.12: Development of reversion in SL85 from passage 0 to passage 10 (P0-P10) in 
Huh7 cells. The passage sequences of P0 and P5-P10 are aligned below the WT sequence. The 
mutations of SL85mut (red boxes) are shown in P0. Passage sequences are grouped (dotted red 
lines) according to the sequence changes occurring over the course of the experiment (groups 
containing the same sequence are labelled A and B).  
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Figure 4.13: Incremental restoration of SL85 structure during passaging. i) The wild-type 
structure of SL85 is displayed, with the sites targeted for mutation in P0 highlighted (green circles). 
ii-iii) The region equivalent to SL85 is denoted by a grey dotted line in the P0 predicted structure. 
Mutated nucleotides are displayed for passage sequences (red circles). Each panel A:B displays 
the UNAfold-predicted structure in the region for the passage sequence shown in the alignment.  
 
B: (P6 – P10)
A: (P0 – P5)
WT: SL85
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4.2.6.3 SL102 mutant reversion 
SL102mut retained three G>A stem mutations until P5 (Fig 4.14). The combination of these 
mutations resulted in the disruption of SL85, the elongation of SL102, more prominent and 
frequent bulges in the stem and increase in the size of the terminal loop from 4 to 7nt (Fig 4.15A). 
During P6, the G130>A130 substitution of SL102mut detectably reverted to the wild-type A (Fig 
4.14). This reversion drastically altered the structure of SL102, producing an expanded bulge 
which contained the sequence of the original terminal loop in a single-stranded configuration (Fig 
4.15B), whereas it had been base-paired in SL102mut (Fig 4.15A). During P7, the final two G>A 
mutations were reverted to the wild-type sequence (Fig 4.14). Direct reversion restored the wild-
type structure for both SL102 and the preceding stem-loop SL85. 
 
 
 
Figure 4.14:  Development of reversion in SL102 from passage 0 to passage 10 (P0-P10) in 
Huh7 cells. The passage sequences of P0 and P5-P10 are aligned below the WT sequence. The 
mutations of SL102mut (red boxes) are shown in P0. Passage sequences are grouped (dotted red 
lines) according to the sequence changes occurring over the course of the experiment (groups 
containing the same sequence are labelled A:C).  
A
B
C
P0
P5
P6
P7
P8
P9
P10
WT
Fig 12.
 167 
 
 
Figure 4.15:  Incremental restoration of SL102 structure during passaging. i) The wild-type 
structure of SL102 is displayed, with the sites targeted for mutation in P0 highlighted (green 
circles). ii-iv) The region equivalent to SL102 is denoted by a grey dotted line in the P0 predicted 
structure. Mutated nucleotides are displayed for passage sequences (red circles). Each panel A:C 
displays the UNAfold-predicted structure in the region for the passage sequence shown in the 
alignment. The order of sequential passages is denoted by a grey arrow. 
WT: SL102
B: (P6)
A: (P0 – P5)
C: (P7 – 10)
Fig 13.
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4.2.6.4 SL165 mutant reversion 
SL165mut retained both original substitutions (C172>A172 and U190>A190) until P4 (Fig 4.16). These 
mutations are sufficient to disrupt the structure of the stem-loop (Fig 4.17A). Indirect reversion 
occurred during P5, whereby an A190>C190 mutation restored base-pairing in the base of the duplex 
stem via a G165:C190 pair (Fig 4.17B). This synonymous compensatory mutation produced a more 
stable base-pair than the wild-type non-Watson Crick base-pair G:U at this site, allowing 
restoration of base-pairing within the stem, despite the continued presence of a C172>A172 mutation 
at the apex. The presence of the C172>A172 mutation increased the size of the terminal loop of 
SL165 by two nucleotides compared to wild-type SL165. Direct reversion occurred during P6 for 
both the C172>A172 mutation at the apex of the stem and the compensatory A190>C190 mutation at 
the base (Fig 4.16). Direct reversion at the base of the stem restored the weaker G:U base-pair seen 
in wild-type SL165 (Fig 4.17C). 
 
 
Figure 4.16:  Development of reversion in SL165 from passage 0 to passage 10 (P0-P10) in 
Huh7 cells. The passage sequences of P0 and P5-P10 are aligned below the WT sequence. The 
mutations of SL165mut (red boxes) are shown in P0. Passage sequences are grouped (dotted red 
lines) according to the sequence changes occurring over the course of the experiment (groups 
containing the same sequence are labelled A:C).  
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Figure 4.17:  Incremental restoration of SL165 structure during passaging. i) The wild-type 
structure of SL165 is displayed, with the sites targeted for mutation in P0 highlighted (green 
circles). ii-iv) The region equivalent to SL165 is denoted by a grey dotted line in the P0 predicted 
structure. All mutated (non- wild-type) nucleotides are displayed for passage sequences (red 
circles). Compensatory mutations which do not restore wild-type sequence but reform base-pairing 
in the stem associated with wild-type structure are boxed in black across the base-pair. Each panel 
A:C displays the UNAfold-predicted structure in the region for the passage sequence shown in the 
alignment. The order of sequential passages is denoted by a grey arrow. 
A: (P0 – P4)WT: SL165
C: (P6 – P10)B: P5
Fig 15.
i) ii)
iii) iv)
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4.2.6.5 SL194 mutant reversion 
SL194mut contained two substitutions, U211>C211 and A214>C214 (Fig 4.18). These mutations are 
sufficient to disrupt the structure of the stem-loop (Fig 4.19A). Direct reversion of the U211>C211 
mutation was detectable in P1 (Fig 4.18), which partially reformed the duplex stem, allowing 
presentation of the wild-type terminal loop and A bulge (Fig 4.19B). However, this mutant still 
contained the A214>C214 mutation at the base of the stem, which resulted in a U196/C214 bulge. 
During P3, a compensatory mutation altered the A199:U211 base-pair to a G199:U211 base-pair via 
synonymous A199>G199 substitution (Fig 4.18). This substitution retained base-pairing in the stem 
(Fig 4.19C). Interestingly, during P4, the original U211>C211 substitution present in SL194mut was 
restored (Fig 4.18). This U211>C211 return to the SL194mut sequence produced a co-variant G:C 
bond, more stable than the original A:U bond present in wild-type SL194 (Fig 4.19D). The 
compensatory A199>G199 mutation, in combination with the original substitutions present in 
SL194mut, was detectable as the predominant sequence in the population in all passages thereafter 
(Fig 4.18). In order to demonstrate that the compensatory A199>G199 mutation alone was sufficient 
to cause phenotypic reversion, the compensatory mutation was incorporated into SL194mut to form 
SL194mut(A199G) (Fig 4.20A). A one-step growth assay was carried out with SL194mut(A199G) 
virus in Huh7 and C6/36 cells (Fig 4.20B & C). There was no significant difference between WT 
and SL194mut(A199G) CHIKV replication, indicating that the A199>G199 mutation in P10 
SL194mut was responsible for restoration of wild-type CHIKV replication. Surprisingly, the 
compensatory mutation detected at P4 did not result in phenotypic reversion during sampling of 
P5 passage supernatant (Fig 4.10). Phenotypic reversion was detected during sampling of P10 
supernatant and subsequent one-step growth assay. In light of the phenotypes observed for 
SL194mut(A199G), it is likely that A199>G199 did not become fixed in the population until after P5 
and thus a small but significant replication phenotype remained. 
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Figure 4.18:  Development of reversion in SL194 from passage 0 to passage 10 (P0-P10) in 
Huh7 cells. The passage sequences of P0-P5 and P10 are aligned below the WT sequence. The 
mutations of SL194mut (red boxes) are shown in P0. Passage sequences are grouped (dotted red 
lines) according to the sequence changes occurring over the course of the experiment (groups 
containing the same sequence are labelled A:D).  
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Figure 4.19: Incremental restoration of SL194 structure during passaging. i) The wild-type 
structure of SL194 is displayed, with the sites targeted for mutation in P0 highlighted (green 
circles). ii-v) The region equivalent to SL194 is denoted by a grey dotted line in the P0 predicted 
structure. All mutated (non- wild-type) nucleotides are displayed for passage sequences (red 
circles). Compensatory mutations which do not restore wild-type sequence but reform base-pairing 
in the stem associated with wild-type structure are boxed in black across the base-pair. Each panel 
A:D displays the UNAfold-predicted structure in the region for the passage sequence shown in the 
alignment. The order of sequential passages is denoted by a grey arrow. 
A: (P0)WT: SL194
B: (P1 – P2) C: (P3) D: (P4 – P10)
Fig 17.
i) ii)
iii) iv) v)
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Figure 4.20: Phenotypic analysis of SL194mut(A199>G199). (A) Schematic of A199>G199 
compensatory mutation (blue) incorporated into SL194mut (mutations in red) to produce 
SL194mut(A199>G199). Replication phenotype of WT virus (black bar) compared to 
SL194mut(A199>G199) (grey bar) following one-step growth assay in (B) Huh7 and C) C6/36 cells 
over 24 hours. Data shown is the mean of three independent biological replicates, with the error 
bar representing the standard deviation of the mean. 
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4.2.7 Passaging stem-loop mutants in Ae. albopictus cells leads to phenotypic reversion 
within 3 passages 
In order to explore the potential routes of reversion in mosquito cells, mutant viruses were passaged 
repeatedly in C6/36 cells and assayed for phenotypic reversion, as previously carried out in 
mammalian cells (Figs 4.7 & 4.8). As expected, both SL47mut and SL246mut exhibited 
significantly reduced replication compared to wild-type virus following a one-step growth assay 
in C6/36 cells with P0 virus (p≤0.01) (Fig 4.21A). C6/36 cells were then infected with P0 virus at 
MOI=1 for 48 hours, before 1/10th of the supernatant was transferred to a flask of uninfected cells. 
Passaging continued for a total of 3 passages in C6/36 cells. Each passage was titred between P0 
and P3 to sample for potential phenotypic reversion. Significantly inhibited replication phenotypes 
for both stem-loop mutants were observed 	at P1 and P2. At P3, there was no significant reduction 
in viral titre in the passage supernatant relative to wild-type for SL47mut or SL246mut, suggesting 
potential phenotypic reversion. In order to confirm this, one-step growth assays were carried out 
with P3 virus (Fig 4.21B). No significant difference in viral fitness was observed for either of the 
stem-loop mutants compared to wild-type, demonstrating that phenotypic reversion had occurred. 
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Figure 4.21: Mosquito cell passaging leads to phenotypic reversion within three passages. 
Replication phenotype of WT CHIKV (black bar) compared to virus bearing mutations predicted 
to destabilise the heteroduplex stem RNA structures (grey bars) following one-step growth assay 
of C6/36 cells over 24 hours using (A) P0 and (B) P3 virus. A schematic representation of the 5′ 
structure of the CHIKV genome is shown for reference (top right). * represents statistical 
significance for each mutant compared to wild-type under a two-tailed Student's t-test: p≤0.05 (*), 
≤0.01 (**), ≤0.001 (***), Data shown is the mean of three independent biological replicates, with 
the error bar representing the standard deviation of the mean. 
 
 
  
W
T
S L
4 7
m
u t
S L
2 4
6m
u t
1 0 3
1 0 4
1 0 5
1 0 6
1 0 7
1 0 8
P 3  M O I= 1
C
H
IK
V
 t
it
re
 (
P
F
U
/m
L
)
Fig 22.
A)
W
T
S L
4 7
m
u t
S L
2 4
6m
u t
1 0 3
1 0 4
1 0 5
1 0 6
1 0 7
1 0 8
1 0 9
P 0  M O I= 1
C
H
IK
V
 t
it
re
 (
P
F
U
/m
L
)
***
***
B)
SL47SL85
SL102
SL165
SL194
SL246
5´ 3´
Schematic representation of 5′ 300nt
 176 
4.2.8 Escape mutants accumulate necessary revertant mutations over 5 passages in 
Ae. albopictus cells 
In order to determine the genotypic basis of reversion in P3 SL47mut and SL246mut viruses, RNA 
was extracted from infected C6/36 cells. The first 1 kb of each P3 viral genome was reverse 
transcribed, amplified by PCR and sequenced by Sanger sequencing in duplicate. The SL47mut 
escape mutant exhibits direct reversion at P3 (Fig 4.22A). Interestingly, unlike in mammalian cells, 
SL47mut escape mutants in C6/36 cells occurred over a single 48-hour passage with no detectable 
genetic intermediate.  
 
Although SL246mut had phenotypically reverted to wild-type levels of CHIKV replication by P3 
(Fig 4.21E), each of the 4 synonymous substitutions in the duplex stem were still present and no 
compensatory mutations were observed in the stem-loop (Fig 4.22B). Further experiments were 
carried out using the P3 SL246mut escape mutant to explore the potential for pseudo-reversion 
within the non-structural protein-encoding ORF-1, which spans the first 6 kb of the CHIKV 
genome. In order to provide enough viral RNA for analysis of this length of the genome, the 
infection was extended from 48 to 96 hours, effectively 2 further passages. Unfortunately, while 
this successfully provided high quantities of viral RNA, it allowed direct reversion to occur during 
the growth period. The sequence of ORF-1 in viral RNA extracted from this infection, termed P5 
due to the length of the growth period, was identical to the wild-type sequence throughout. This 
included direct reversion of SL246 and presumably any potential pseudo-reversions in ORF-1. 
These results are summarised according to the passage at which direct genetic reversion was 
detectable for SL47mut and SL246mut (Fig 4.22C). 
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Figure 4.22: Development of reversion in SL47 and SL246 from passage 0 to passage 5 (P0-
P5) in C6/36 cells. The passage sequences P0-P5 of A) SL47mut and B) SL246mut are aligned 
below the WT sequence. The original mutations of SL47mut and SL246mut (red boxes) are shown 
in P0. Passage sequences are grouped (dotted red lines) according to the sequence changes 
occurring over the course of the experiment (groups containing the same sequence are labelled A 
and B). C) Development of reversion in C6/36 cells over 5 passages (P0-P5). Ticks represent direct 
reversion to wild-type sequence. Crosses represent no reversion. Yellow dashed lines denote 
sampling for phenotypic reversion in passage supernatant, yellow filled boxes denote phenotypic 
reversion during one-step growth assay. 
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4.3  Discussion 
The previous chapter demonstrated that stem-loop 47 (SL47) within the 5′ UTR of the CHIKV 
genome enhances replication of the viral genome in human- and Ae. albopictus-derived cells. In 
contrast, stem-loops within the adjacent nsP1-encoding region (SL85, SL102, SL165, SL194 and 
SL246) enhance CHIKV genome replication in a host-dependent manner (Figs 3.5 & 3.6). In this 
study, the relative importance of primary RNA sequence and secondary structure of each stem-
loop was investigated in the appropriate host(s), by reverse genetic analysis and serial passage, to 
investigate evolutionary routes of escape. 
 
4.3.1 Structure-led reverse genetic analysis 
The secondary structure of each duplex stem was found to be integral to enhancement of CHIKV 
genome replication (Figs 4.2 & 4.3). Compensatory mutations, designed to restore base-pairing in 
the stem without returning to the wild-type RNA sequence, were introduced into infectious virus 
and replicon constructs (Fig 4.1), allowing the effects of RNA sequence and structure in the stem 
to be distinguished. Rescue of wild-type levels of CHIKV genome replication by compensatory 
mutants demonstrated that the stem-loops enhance CHIKV genome replication in a structure-
dependent manner (Figs 4.2 & 4.3). However, mutations designed to disrupt RNA structure do so 
by altering primary RNA sequence. Primary nucleotide sequence has been demonstrated to affect 
the stacking energy of RNA and thus the stability of secondary structures with equivalent base-
pairing. Thermal denaturation studies of a stable RNA hairpin from the bacteriophage T4 
demonstrated that the orientation (C:G or G:C) of the closing base-pair determined the stability of 
the structure (403). Compensatory mutations in this study do not identically reproduce wild-type 
structure in the stem-loops, rather maintain the number of base-pairs. This disparity may account 
for the preference for direct reversion to wild-type sequence observed in escape mutants as 
opposed to compensatory mutation (Fig 4.10), as well as the relative reduction in CHIKV titre for 
compensatory mutants compared to WT (Fig 4.2). In addition, compensatory mutations in SL165 
and SL246 replaced Watson-Crick base-pairs with G:U base-pairs (Fig 4.23A&B). Non-Watson-
Crick G:U base-pairs result in less stable RNA secondary structures compared to G:C/A:U pairs. 
Therefore, SL165mut-Comp and SL246mut-Comp are not ideal comparisons for the wild-type 
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structures. However, maintaining synonymy within nsP1 placed limitations of the design of 
compensatory mutations. Despite the relative instability of G:U base pairs, the degree of 
compensation observed for SL165mut-Comp and SL246mut-Comp was not significantly different 
to that of the other compensatory mutants (Figure 4.2). Thus, although the strength of G:U pairing 
is lower, no significant effect of decreased stability was observed for compensatory mutants which 
utilised G:U. 
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Figure 4.23: Types of base-pair formed by mutation in the positive strand. UNAfold 
prediction of wild-type positive-strand RNA structure overlaid with (A) disruptive and (B) 
compensatory mutations denoted by coloured circles which depict the type of alteration made in 
the positive strand structure: red circles indicate that base-pairing is absent or disrupted, pink 
circles indicate a non-Watson-Crick base-pair formed by an introduced mutation, turquoise circles 
indicate a Watson-Crick base-pair formed by an introduced mutation. The structure is labelled 5′ 
to 3′. Base-pairing in the predicted wild-type structure is denoted by blue lines: one line for A:U 
pairs, two lines for G:C pairs and a line with a white circle for G:U pairs. 
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As discussed in Chapter 3, synonymous mutations alter codon usage and dinucleotide frequencies, 
thus the replication phenotypes observed may be the result of reduced translational efficiency or 
enhanced immune recognition of the genome - rather than disruption of RNA structure. 
Compensatory mutation typically increased the number of CpG and UpA dinucleotides (Fig 4.25). 
For example, SL85mut-Comp contained a greater number of CpG and UpA dinucleotides (+2 CpG 
and +3 UpA relative to WT) than SL85mut (+1 CpG and +1 UpA relative to WT). In spite of 
increased CpG and UpA dinucleotide frequencies, SL85mut-Comp rescued wild-type levels of 
CHIKV genome replication. This suggests that CpG and UpA frequencies are not responsible for 
the replication phenotype observed for SL85mut. Overall, changes to dinucleotide frequency did 
not correlate with replication phenotype. SL165mut and SL165mut-Comp contain the same 
frequency of CpG and UpA as wild-type SL165, but SL165mut exhibited a replication defect while 
SL165mut-Comp did not. SL102mut-Comp contains 5 more UpA dinucleotides than WT but this 
had no significant effect on replication.  
In addition to dinucleotide content, the role of codon efficiency must be considered. Codon 
efficiency is known to affect translation and stability of host and viral mRNA (418,419). 
Synonymous codons are not used at equal frequency, as demonstrated in Escherichia coli, 
Saccharomyces cerevisiae and vertebrate-derived muscle and liver tissue (420–422). Codon usage 
bias refers to the preference displayed by different organisms for particular synonymous codons. 
Substitution of codons with vastly different frequencies in the host genome can impact 
translational efficiency (401). Codon deoptimisation has been shown to impact CHIKV 
replication, attenuating the virus (402). Codon efficiency and dinucleotide usage in the 
compensatory mutants is similar to the disruptive mutants, thus the restoration of wild-type 
replication is likely due to reformation of the stem-loop structures.  
 
As discussed in Chapter 3, UNAfold modelling predicts that the corresponding structure of the 
region of interest in the negative strand differs greatly from that of the positive strand (Fig 3.15). 
A structure equivalent to SL194 is present, as well as less homologous versions of SL3, SL102 
and SL246. In contrast, homologues of SL47, SL85 and SL165 are not predicted to form in the 
negative strand. As compensatory mutations were designed based on a structural model of the 
positive sense genomic copy of the CHIKV genome, rescue of wild-type replication by this 
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approach suggests the importance of stem-loops in the positive strand, rather than unforeseen 
disruption of potential functional elements in the negative strand intermediate of the viral genome. 
For example, compensatory G:U pairing in SL246mut-Comp would represent C:A at the same 
position in the negative strand, which would not form a base-pair (Fig 4.1). Given that SL246mut-
Comp rescues wild-type levels of CHIKV genome replication, it is likely that SL246 in the positive 
strand is responsible for the enhancement of genome replication in Ae. albopictus, since the 
corresponding structure in the negative strand could not have reformed via these compensatory 
mutations. However, SL102mut-Comp and SL194mut-Comp reform Watson-Crick base-pairing in 
the negative strand (Fig 4.24). Therefore, despite the major differences between the positive- and 
negative-strand secondary structure in this region, compensatory effects due to restoration of 
negative strand structures for SL102 and SL194 cannot be ruled out based on the evidence 
presented here. Further SHAPE-constrained thermodynamic modelling could be carried out to 
determine the secondary structure of the negative strand 3′  terminus, which corresponds to the 5′ 
region of the positive strand.  
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Figure 4.25: Changes in CpG and UpA dinucleotide frequency in compensatory structure 
mutants. Net change in CpG and UpA dinucleotide frequencies in each of the stem-loop mutants 
alongside the corresponding compensatory mutant, expressed as the net number of dinucleotide 
pairs introduced (positive) or removed (negative) by the mutations displayed in previous chapters 
(Figs 3.4A & 4.1). 
 
  
Stem-loop mutant CpG UpA
SL47mut 0 0
SL47mut-Comp 0 0
SL85mut 1 1
SL85mut-Comp 2 3
SL102mut -2 2
SL102mut-Comp -3 5
SL165mut 0 0
SL165mut-Comp 0 0
SL194mut 1 -2
SL194mut-Comp 2 -3
SL246mut 0 2
SL246mut-Comp 0 1
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Figure 4.26: Changes in codon efficiency in compensatory structure mutants. Net change in 
codon efficiency for each stem-loop mutant and its corresponding compensatory mutant in human- 
and D. melanogaster-derived cells. Changes to codon efficiency are displayed as a relative 
percentage increase (positive) or decrease (negative) in codon efficiency in each organism upon 
mutation. Each mutant contains a minimum of two substitutions relative to WT and thus each 
percentage is an average of the change induced by all substitutions per mutant. Standard deviation 
for each average was equal to or less than 10%. Codon efficiency is measured as codon frequency 
in the genome of each organism, as drawn from the codon frequency tool from Genscript (405). 
SL47 is in the untranslated region, thus codon usage is null.  
  
Percentage change in codon 
efficiency
Human D. melanogaster
SL47mut - -
SL47mut-Comp - -
SL85mut -2 5
SL85mut-Comp -7 17
SL102mut -13 -2
SL102mut-Comp -7 5
SL165mut -8 1
SL165mut-Comp 4 8
SL194mut 16 -4
SL194mut-Comp 4 -2
SL246mut -15 -3
SL246mut-Comp -11 -7
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4.3.2  SL47 
SL47mut exhibits a larger phenotype than the stem-loop mutants in the nsP1-coding region. It is 
possible that SL47 represents a uniquely important stem-loop with a larger biological effect than 
the adjacent stem-loops. However, it must also be considered that SL47mut contains the greatest 
number of mutations. 25% of the nucleotides in SL47 were mutated in SL47mut, the highest 
percentage of any of the stem-loops. In part, this was due to the position of SL47 within the 5′ 
UTR which allowed for extensive disruption without altering the protein-coding sequence. 
Nonetheless, the larger effect size may be partially due to greater disruption. One argument against 
this is that SL47mut-Comp, which contains only 50% of the original SL47 sequence, was able to 
replicate to wild-type titres. Regardless, the higher number of mutations in SL47 likely played a 
large role in the temperature sensitivity of SL47mut-Comp. Only SL47mut-Comp demonstrated 
temperature-sensitivity during CHIKV replication, suggesting strict thermodynamic constraints on 
folding structure. SL47mut-Comp, although it contains four sequence substitutions relative to 
SL47mut and eight relative to wild-type SL47, maintains four C:G base-pairs in its stem. Given 
that the number of hydrogen bonds in the stem remains equivalent to wild-type, it is interesting 
that SL47mut-Comp exhibits such dramatic temperature sensitivity. De-stabilisation of the 
compensatory mutant at higher temperatures may be explained by changes in stacking energy and 
other constraints on RNA structure formation (403), as demonstrated by the predicted free energy 
of folding at 37°C relative to the wild-type structure (wild-type ΔG= −2.9 kcal/mol and 
SL47mutComp ΔG= −2.3 kcal/mol). The temperature-sensitivity of SL47mut-Comp demonstrates 
that the formation of SL47 is under strict sequence constraints, despite sequence-independent 
functionality (Figs 4.2C & 4.3C). The wild-type sequence of SL47 is therefore an evolutionarily 
stable element under strong purifying selection in mammalian cells; sequence variation causes a 
steep fitness decrease due to temperature-sensitivity of the structure. This sequence constraint may 
be an incidental by-product of thermodynamic stability constraints or may be functional as the 
preferred binding context of a trans-activating factor.  
 
Interestingly, during passage of SL47mut in Huh7 cells, partial sequence reversion was fixed in 
the population prior to any structure restoration, at P6 and P7 respectively (Fig 4.11). There is 
selection for G56C57 prior to structure reformation, which suggests a preference for this sequence 
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independent of stable stem-loop formation. However, it is possible that the P6 mutant containing 
G56C57 is capable of transiently forming the apical region of SL47. While most of the in silico 
predicted structures of P6 SL47mut in the context of the entire structured region do not favour the 
formation of the apical region without a stable base, analysis of the P6 SL47mut sequence in 
isolation predicts a structure containing three base pairs U50G51C52:G56C57A58 with a terminal loop 
A53-55 (Fig 4.27B). The UNAfold-predicted free energy of folding for this structure is very small 
(ΔG= -0.20kcal/mol), indicating that the structure is unstable at 37°C. Nevertheless, the potential 
ability of the P6 SL47mut mutant to transiently form the structure may represent a fitness increase 
relative to P0-P5 SL47mut, which is not predicted to form any stable secondary structure (ΔG≥ 
0kcal/mol). The potential formation of the apical region of SL47 in P6 SL47mut could be 
investigated via SHAPE mapping. Furthermore, the replication phenotypes of passage mutants P6 
and P7 during one-step growth assays of Huh7 cells could shed light on the level of rescue achieved 
during the process of reversion. In particular, the replication phenotype of P7 SL47mut merits 
further  exploration, given the temperature-sensitivity of SL47mut-Comp. P7 SL47mut forms ¾ of 
the hydrogen bonds present in SL47mut-Comp and maintains the wild-type orientation of these 
bonds. Comparison of the replication phenotypes of P7 SL47mut and SL47mut-Comp would 
determine the relative importance of number and orientation of bonds in the duplex stem.  
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Figure 4.27: The apex of SL47 reforms at P6. UNAfold-predicted structure of (A) SL47mut P6 
and (B) wild-type SL47. Nucleotide 1 in the prediction corresponds to nt 47 in the CHIKV genomic 
RNA. Sites of mutation in SL47mut (P0) are circled and coloured according to sequence: wild-
type (green) and mutant (red).  
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4.3.3 SL85 and SL102 
In Chapter 3, SHAPE-constrained thermodynamic analysis demonstrated that the RNA structure 
of CHIKV immediately downstream of the AUG start codon differs from that previously observed 
for the New World alphaviruses SINV and VEEV. SHAPE mapping of SINV and VEEV has 
demonstrated a single, long RNA element (13)– deletion of which does not inhibit SINV genome 
replication (350). In contrast, the homologous region of the CHIKV genome was demonstrated to 
contain two distinct RNA replication elements (SL85 and SL102 (Fig 3.2A), both of which are 
involved in efficient genome replication in human-derived cells but not those from Ae. albopictus 
(Fig 3.4). In the case of SL85, the in silico thermodynamically predicted structure, SHAPE 
mapping and reverse genetic analysis were not in close agreement (Fig 4.2). Raw SHAPE 
reactivity data for SL85 was not consistent with the structure predicted by combined 
thermodynamic and reverse genetic analysis, suggesting that this region of the genome may be 
structurally dynamic and able to form alternative interactions. Structure-led reverse genetic 
analysis, destabilising SL85 and then restoring base-pairing with compensatory substitutions, 
demonstrated that SL85 is essential for efficient CHIKV genome replication in human-derived 
cells and functions through a structure-dependent mechanism (Figs 4.2A & 4.3A). The ability of 
SL85mut-Comp to rescue wild-type CHIKV replication demonstrates that the structure forms 
during the CHIKV lifecyle in vivo. Further investigation of the spatio-temporal dynamics of SL85 
formation may reveal at which stage of the viral lifecycle SL85 exerts its effects and the location 
of its formation within the cell i.e. in membrane-bound replicative complexes. The potential for 
alternative structure formation in this region is investigated in Chapter 5. 
 
The substitutions made in SL85mut and SL102mut each result in a single, longer RNA element 
similar to that observed in SINV and VEEV (Figs 4.11 & 4.13; (13)). As demonstrated in Chapter 
3, SL85mut and SL102mut exhibit replication defects relative to the wild-type structure, indicating 
that this region functions differently in CHIKV than in VEEV and SINV. During passage of 
SL85mut and SL102mut in Huh7 cells, direct reversion to wild-type sequence was observed over 
6 and 7 passages respectively (Figs 4.12-15). No intermediate changes were observed for SL85mut. 
SL102mut exhibited an intermediate structure at P6, which is conformationally distinct to that of 
wild-type SL102 (Fig 4.15). The P6 intermediate structure restores the single-stranded 
conformation of nt 118-121 (U118U119U120G121) - which represents the terminal loop of wild-type 
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SL102. Interestingly, this region was heavily mutated during reverse genetic analysis of the 
terminal loop sequence of SL102 (Fig 4.4) and found to be dispensable to CHIKV genome 
replication (Figs 4.5 & 4.6). Thus, it is unlikely that the A130>G130 reversion detected in the 
population during P6 is due to selection for the unpaired terminal loop sequence UUUG, rather 
than the primary nucleotide sequence. One element of the P6 structure, which bears similarity to 
the wild-type structure is the apical region. While the lower portion of the P6 structure diverges 
greatly from both the wild-type and P0 structures, the apical region of P6 appears far closer to the 
wild-type structure (Fig 4.28); the terminal loop is smaller (7 nt, 5 nt and 4 nt in P0, P6 and wild-
type respectively) and the first bulge becomes smaller (4 nt, 2 nt and 2 nt in P0, P6 and wild-type 
respectively). Overall, P6 represents a truncated form of the apex of SL102. 
In light of the structure-dependent replication phenotypes observed for SL102, partial restoration 
of the apical structure may represent a sufficient increase in fitness to allow predomination of the 
P6 mutant. A comparison of the binding partners of P6 SL102mut and WT SL102 may allow the 
recognition of interacting protein partners, which recognise the apical structure. The replication 
phenotype of P6 SL102mut would also provide insight into the relative importance of an elongated 
SL102 as compared to a truncated stem of similar apical dimensions. 
4.3.4 SL165 and SL194 
SL165mut and SL194mut each selected compensatory mutations during passage in Huh7 cells. The 
compensatory mutations detected during passaging recapitulated substitutions made during the 
design of compensatory mutants, A190>C190 in SL165 and A199>G199 for in SL194 (Fig 4.1). 
SL165mut acquired a compensatory A190>C190 mutation during P5, which stabilised the base of the 
structure by formation of a G165:C190 pair (Fig 4.17B) in place of a wild-type G165:U190. During P6, 
direct reversion was observed, producing G165:U190 (Fig 4.17C). There appears to be selection for 
U190, either as a sequence component or due to preference for weaker bonding at the base of the 
structure. The preference for weaker bonding at this site could be investigated by phenotypic 
analysis of the single substitution U190>C190. In lieu of this, compensatory mutant analysis can 
provide information about the effect of the A190>C190 mutation, as this mutation is one of two 
present in the compensatory mutant, SL165mut-Comp (Fig 4.1). SL165mut-Comp demonstrated 
increased CHIKV genome replication relative to SL165mut (p≤0.05) with no significant difference  
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Figure 4.28: The apical structure of SL102, but not sequence, reforms at P6. UNAfold-
predicted structure of the apex of SL102 in (A) WT SL102. (B) SL102mut P0 and (C) SL102mut 
P6. Nucleotide 115 is labelled in each structure for comparison. Sites of mutation in each structure 
are circled and coloured according to sequence: wild-type (green) and mutant (red).  
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to wild-type SL165 (Fig 4.3). Thus, it can be concluded that the sequence U190 is not required to 
enhance CHIKV genome replication, since SL165mut-Comp contains C190 and can replicate to 
wild-type levels. The destabilised apex of P5 SL165mut, which contains the disruptive mutation 
C172>A172, may select for the stronger G165:C190 pair in P5 SL165mut. Reversion of the C172>A172 
mutation in P6 SL165mut would remove the selection pressure for increased hydrogen bonding in 
the base of the stem and allow selection for G165:U190 to prevail. In this way, it appears that the 
compensatory mutation exhibited by P5 SL165mut acts as an intermediate stage allowing direct 
reversion via incremental fitness increase. 
 
Uniquely, passage of SL194mut in Huh7 cells resulted in a fixed compensatory mutation, which 
predominated in the population by P4. During P1, one of the two substitutions in SL194mut directly 
reverted to the wild-type sequence (C211>U211), reforming the A199:U211 base-pair of SL194 (Fig 
4.19B). This single substitution was sufficient to reform the terminal loop, apical region of the 
stem and A210 bulge. The other mutation in SL194mut, A214>C214, remained throughout all 
passages, representing the only disruptive mutation detectable by P10 in any of the mutants 
passaged in mammalian cells. During P3, a compensatory mutation altered the A199:U211 base-pair 
to G199:U211 via synonymous substitution (Fig 4.19C). G199 represents a substitution made during 
the design of SL194mut-Comp. Fixation of G199 during P3 is interesting, as it replaces the wild-
type A:U base-pair with a G:U base-pair thus forming a structure with a less negative free energy 
of folding (P2 ΔG= -8.00kcal/mol and P3 ΔG= -7.10kcal/mol). Non-Watson-Crick G:U base-
pairing has been shown to alter helical geometry in certain RNA structures (423). It is possible 
that the U196/C214 bulge alters the steric context of the stem-loop in such a manner that a G:U base-
pair is favourable but the free energy data does not support this. Codon usage frequencies are also 
unable to explain selection of G199, since the usage of AGG and AGA codons is equivalent in 
humans, at 20% total arginine tRNAs per codon. Another possibility is that the U196/C214 bulge 
and the A199:U211 base-pair in combination form a sequence- or structure- recognition signal that 
is unfavourable to CHIKV replication. This could explain selection for G:U, which would alter the 
sequence context of the region as well as the structure around the base-pair. A final substitution 
occurred during P4, which was present in all passages thereafter (Fig 4.19D). This substitution 
reversed that made during P1, reverting to the SL194mut sequence at nt 211 (U211>C211). The 
substitution made during P4 produces a G199:C211 pair. In a similar manner to the sequential 
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changes in SL165mut, it can be hypothesised that a greater number of hydrogen bonds in one region 
of the stem offsets the ongoing destabilisation in another region. Although a single substitution 
would be sufficient to produce P4 SL194mut from its P0 counterpart, the route of reversion 
observed was less direct.  
Passage sequences presented in this study represent the predominant sequence in the region of 
interest at each passage, as determined in duplicate following RT-PCR amplification and Sanger 
sequencing. Due to the limitations of Sanger sequencing for analysis of quasispecies, variation 
present within each passage is not presented or quantified here. Sampling of passage supernatant 
did not suggest full phenotypic reversion for P5 SL194mut relative to WT, but the compensatory 
G199 mutation was detected during P4. Each passage sequence P4-P10 contained the compensatory 
mutation G199 and the original mutations of SL194mut, indicating that these mutations were present 
in the population. When this set of mutations was incorporated into CHIKV_IC via site-directed 
mutagenesis and used to infect cells of human and Ae. albopictus origin, wild-type titres of CHIKV 
were recovered (Fig 4.20). This demonstrates that the compensatory substitution G199 is sufficient 
to rescue SL194mut replication in human-derived cells, and that the structure of the apical region 
is responsible for SL194-mediated enhancement as opposed to the base of the stem.  
4.3.5 Passaging in Ae. albopictus 
Passaging in mammalian cells led to direct genetic reversion in the majority of stem-loop mutants 
through the accumulation of revertant mutations, incrementally reforming the wild-type structure. 
In one case, a compensatory revertant predominated. In contrast, passaging of SL47mut and 
SL246mut in mosquito cells led to direct genetic reversion without detectable intermediate 
mutations (Fig 4.22A & B). During passaging of SL47mut, direct genetic reversion of four 
mutations was detected during a single 48-hour passage, P3 (Fig 4.22A), which corresponded to 
phenotypic reversion during one-step growth assay in C6/36 cells with P3 virus (Fig 4.22B). 
Interestingly, the phenotypic reversion observed at P3 for SL246mut (Fig 4.22B) did not 
correspond to direct or compensatory reversion in SL246 when intracellular viral RNA was 
extracted from infected cells (Fig 4.22B).  
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Previous passage studies with RNA structural mutants of SINV and VEEV have demonstrated the 
development of compensatory ‘pseudorevertant’ mutations in non-structural proteins nsP1-4, 
which restore interactions with RNA (350,358). In order to investigate the genetic basis of 
phenotypic reversion in P3 SL246mut virus, the non-structural protein-encoding ORF-1 was 
sequenced in 1 kb overlapping fragments. A contiguous sequence of ORF-1 from P3 SL246mut 
did not reveal pseudorevertant mutations in ORF-1. Phenotypic reversion in P3 may be due to 
pseudoreversion of a structural protein encoded by ORF-2, restoring an interaction between a 
structural protein and RNA stem-loops, or by an unrelated beneficial mutation whereby increased 
infectivity or egress compensate for decreased genome replication. During the 2005-6 epidemic in 
La Réunion, mutation in structural proteins resulted in increased CHIKV replication in Ae. 
albopictus; virus extracted from infected mosquitoes contained the A226V mutation in E1 and 
replicated to higher titres in Ae. albopictus than previously documented (45). However, the ORF-
1 sequence exhibited direct genetic reversion within SL246 (Fig 4.22C). Larger quantities of P3 
viral RNA for analysis were generated by extension of the infection period from 48 to 96 hours, 
prior to extraction from infected cells, which may have allowed the development of direct 
reversion. The ORF-1 sequence was termed P5 due to the elongated period of infection. The 
presence of direct genetic reversion within SL246 of P5 SL246mut limits the conclusions that can 
be drawn about pseudoreversion in P3, as further mutation clearly occurred during P5. 
Pseudorevertant mutations in ORF-1 may have directly reverted over the course of P5 and thus not 
have been detected during sequencing. The speed of reversion in Ae. albopictus-derived cells 
presents a technical challenge to the accurate genotyping of phenotypic revertants in mosquito 
host-cells.  
In contrast to the high genetic stability seen in mammalian cells, phenotypic reversion in mosquito 
cells for SL47mut and SL246mut occurred at P3 (Figs 4.21 & 4.22C) and genetic reversion at P3 
and P5, respectively. Higher rates of CHIKV reversion have been observed in mosquito cell lines 
compared to mammalian-derived cells during passaging studies of nsP3 (197). During a study by 
Gao and colleagues, revertant mutations in nsP3 were detectable in C6/36 and U4.4 Ae. albopictus 
cells within 24 hours post-transfection with a CHIKV replicon, becoming fixed in the population 
by 72 hours post-transfection. Over the same time course, no reversion was detected in murine 
C2C12 cells. It is clear that rapid reversion is possible in Ae. albopictus-derived cells, highlighting 
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the need for dual-host studies of vaccine candidates for alphaviruses. Rapid reversion in mosquito 
cells may be the result of increased variation within the genetic pool or a greater number of 
replication cycles per passage. Mosquito-specific interactions, either protein:RNA or 
protein:protein interactions, could decrease the fidelity of the replicase during replication. An 
increase in error rate would increase variation within the quasispecies, widening the pool of genetic 
variants under selection. In this way, revertants would arise at a faster rate. Similarly, differing 
sites of replication within mosquito cells may favour rapid reversion by increasing genetic 
variability. In mammalian cells, replication complexes form at the plasma membrane and are 
internalised shortly after transcription of the negative strand. This may represent a checkpoint for 
successful replication which ensures cytopathic vacuoles contain only active replication 
complexes. In mosquito cells, spherules form directly on the membranes of cytopathic vacuoles. 
Thus, adjacent replication complexes may interact differently in mosquito cells, potentially 
increasing the likelihood of recombination between viral genomes or functional interactions 
between neighbouring spherules.  
Alternatively, rapid reversion may be the result of generally increased replication rates and reduced 
cell death in mosquito cells. Mammalian cells typically undergo lysis or apoptosis as a result of 
infection within 48 hours. In contrast, mosquito cells do not undergo apoptosis as a result of 
CHIKV infection, remaining productively infected over long periods. Therefore, mosquito cells 
continuously replicate the virus over each passage with little cell death, enabling many more 
rounds of replication in an average population of cells over a given period. In addition, the 
establishment of productive CHIKV infection takes longer in mosquito cells but eventually 
produces a much greater quantity of infectious virus, possibly by the establishment of a greater 
number of replication complexes. The reasons for these differences are not well understood but 
could contribute to more rapid reversion. 
4.3.6 Passaging approach 
Previous studies of passaging in arboviruses have investigated single-host passaging compared to 
alternating passaging, as a method of analysing the evolutionary dynamics imposed by natural 
cycling between human and mosquito hosts. During these studies, single-host passaging often 
resulted in the accumulation of host-specific mutations and reduced replication in the bypassed 
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host (392,394). Multi-host passaging between primate and mosquito cell lines has been shown to 
limit rates of CHIKV evolution relative to single-host passaging; beneficial mutations were 
selected during alternating passaging of a 3′ UTR deletion mutant, which provided fitness 
increases in both host species (417). In this study, single-host passaging of stem-loop mutants 
demonstrated phenotypic reversion within a maximum of ten passages. The potential for, and 
relative speed of, reversion during alternating passaging could be investigated in future work. 
 
The predominant viral genome sequence in each passage was determined by Sanger sequencing 
of amplified cDNA. RNA viruses exist as a ‘quasispecies’ during infection; a population of non-
identical viral genome sequences exists in dynamic equilibrium where viable mutants arise at a 
high rate and are strongly selected against by competition with an optimal wild-type sequence 
(424). In light of such variation within the pool of viral RNAs following infection and particularly 
during passage of mutants, analysis of a single predominant sequence by Sanger sequencing 
provides limited information. This approach could be expanded by sequencing of multiple full-
length cDNA clones. Alternatively, next-generation sequencing can provide a greater depth of 
sequence information within heterogeneous populations, by sequencing a vast number of viral 
genomes utilising a sequencing-by-synthesis approach such as pyrophosphate release (425). 
Whilst there is more genetic variation within the pool of viral RNAs than can be observed by 
sequencing the predominant genome, the chronological development of escape mutants was clear. 
4.3.7 Single-stranded regions 
In contrast to the other structures in the nsP1-encoding region, the function of SL194 as an RNA 
replication element during CHIKV genome replication is dependent on both the structure of the stem–
loop and the primary sequence of the single-stranded terminal loop. A single synonymous C>U 
substitution within this unpaired region significantly inhibited both sub-genomic replicon and 
infectious virus replication (Figs 4.5A & 4.6). As this single substitution reproduced a UUUU terminal 
loop sequence conserved within the CSE elements of other divergent alphaviruses (including VEEV, 
SINV and SFV), it was predicted that it would not affect CHIKV replication - the fact that replication 
was inhibited suggests that the terminal loop of SL194 represents a CHIKV-specific signal motif. The 
single A210 bulge in SL194 and the A186 bulge in SL165 cannot be synonymously mutated. Each of 
these unpaired adenosines is positioned at the centre of a His codon (CAU), shares the same local steric 
context (G:C pair above, A:U pair below) and both exhibit very high reactivity to NMIA during 
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SHAPE mapping, indicating that they are consistently unpaired. Further study could determine the 
importance of the unpaired bulges, for example by targeting with locking nucleic acids (LNAs). A 
current study by O. Prosser (University of Leeds) has demonstrated the efficacy of an LNA targeting 
SL165 in reducing CHIKV replication. The LNA is designed to disrupt base-pairing of the stem but 
also blocks access to the A186 bulge. Alternatively, non-synonymous mutations could be designed, as 
non-synonymous mutation may exhibit no phenotypic consequence for CHIKV replication, as was the 
case for SL102mut-Loop and SL246mut-Loop.  
 
While the sequence or size of the terminal loop of SL165 did not significantly affect genome replication 
directly, virus replication as a whole was inhibited by increasing the size of the unpaired terminal-loop 
by four nucleotides (Figs 4.4-6). The primary nucleotide sequence and structure of the nsP1 CSE, has 
previously been shown to be highly conserved between divergent alphaviruses (13). Reverse genetic 
evidence presented here suggests that the size of the terminal loop, rather than its primary sequence, 
may contribute to functionality of this RNA replication element during the viral lifecycle. 
Interestingly, although extensive non-synonymous mutations in single-stranded regions of SL102 
and SL246 had no significant impact on CHIKV genome or virus replication, these regions were 
not subject to genetic drift during CHIKV passaging. Likewise, SL165 did not accumulate 
mutations in the terminal loop of SL165mut over 10 passages. Therefore, the single-stranded 
regions appear to be conserved during experimental passage, which parallels the conservation of 
this region observed during epidemics (395). Preference for the wild-type sequence in single-
stranded regions may be a result of codon usage bias or selection for thermodynamic stability of 
the structure, rather than restoring functionality of the sequence as a cis-acting element. 
4.3.8 Conclusion  
Enhancement of CHIKV replication by the 5′ region of the genome is structure-dependent, as well 
as dependent on the terminal loop sequence of SL194. Passaging of stem-loop mutant viruses 
selected revertant mutations, which restored wild-type RNA sequence and, in one case, a 
compensatory revertant, which restored base-pairing of the stem - but not primary sequence. 
Further study will be necessary to determine potential interactions between stem-loops in the 
structured region (Chapter 5) and between stem-loops and trans-acting host or viral factors. 
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Chapter 5. Dynamic interactions between structures within the 
5′ region of the CHIKV genome  
5.1  Introduction 
In previous chapters, the impact of disrupting individual stem-loops structures within the 5′ 300 nt 
of the CHIKV genome was investigated (Chapters 3 & 4). Stem-loop 47 (SL47) within the 5′ UTR 
of the CHIKV genome enhanced viral genome replication in human and Ae. albopictus derived 
cells, while stem-loops within the adjacent nsP1-encoding region (SL85, SL102, SL165, SL194 
and SL246) enhanced replication in a host-specific manner (Figs 3.5 & 3.6). In addition to 
individual functionality, RNA stem-loop replication elements may act synergistically. Synergy can 
result from direct RNA:RNA interactions, for example between stem-loops F and G in the 
poliovirus genome. In addition to their individual functions, these two elements are required in 
close proximity to bind the p36 factor, which does not bind to either stem-loop alone (426). 
Alternatively, synergy can result from simultaneous protein:RNA interactions. For example, the 
cis-acting constitutive and RNA transport elements, CTE and RTE, in the HIV-1 genome 
synergistically increase expression of otherwise poorly expressed genes via increased binding 
affinity of the Nuclear RNA Export Factor 1 (NXF1) protein in the presence of both structures 
(427). Besides additive or synergistic interactions, RNA structures may exhibit functional 
redundancy, whereby the disruption of one structure is tolerated in the presence of an intact 
proximal structure. Pairwise disruption of RNA elements has been shown to elicit a different 
impact on virus replication compared to individual disruption in VEEV and DENV in a host-
specific manner (376). Individual removal of stem-loops SL-I and SL-II in the 3′ UTR of DENV 
was tolerated in human cell lines, but removal of both structures significantly reduced genome 
replication (393). 
 
Despite the fact that SL85, SL102, SL165 and SL194 were dispensable to CHIKV replication in 
mosquito cell lines, these stem-loops were conserved during single-host passaging in C6/36 cells. 
Similarly, SL246 was conserved during passaging in Huh7 cells. Genetic drift was not detected in 
any of the stem-loops in the 5′ 300 nt during single-host passaging, suggesting a selective 
advantage. Both functional redundancy and synergistic interactions may be revealed by pairwise 
or cumulative disruption of RNA structures. 
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RNA secondary structure dictates the tertiary structure of an RNA molecule. Regions of complex 
secondary structure can direct long-range RNA:RNA interactions (428), act as a recognition motif 
for trans-activating factors (429) and determine global folding of RNA (430). Several types of 
RNA tertiary structure have been described, the simplest being the hairpin-type pseudoknot (295). 
A hairpin-type pseudoknot is formed when the single-stranded terminal loop of a hairpin or stem-
loop base-pairs with a complementary single-stranded region elsewhere in the RNA (Fig 5.1). 
Tertiary RNA structures, including pseudoknots and transient kissing interactions, are essential 
during translation and genome replication of several viruses. For example, HCV employs a 5′ 
internal ribosome entry site (IRES) composed of a four-way junction necessary to direct cap-
independent translation (431). Meanwhile, SL2 in the 3′ UTR of HCV and a cruciform structure 
within the coding sequence of non-structural protein 5B (NS5B) form a kissing-loop interaction 
essential for genome replication (341).  
Tertiary structures are highly stable compared to their secondary structure counterparts (432). 
However, the stability of a tertiary structure may be altered by protein binding, providing an 
elegant mechanism of differential gene expression (433). Dynamic shifts in tertiary RNA structure 
have been demonstrated to facilitate the switch from translation to replication of viral RNA in 
picornaviruses at the appropriate stage of the viral lifecycle (434). Similar phenomena have been 
observed in coronaviruses, for example, thermodynamic studies and in silico simulations have 
demonstrated the formation of two mutually exclusive RNA structures in the 3′ UTR of mouse 
hepatitis virus (MHV) (435). A conformational switch between the double-hairpin structure and a 
marginally stable cis-acting pseudoknot occurs only when the hairpins cannot form, initiating a 
switch from production of the negative-sense replication intermediate to positive-sense sub-
genomic RNA. Differential formation of RNA structure occurs in different local conditions. For 
example, the tRNA-like structure (TLS) of turnip yellow mosaic virus (TYMV) is aminoacylated 
upon entry of the viral genome into cells, promoting translation via eukaryotic translation 
elongation factor 1 α (eEF1A) binding in conjunction with an upstream pseudoknot (436,437). As 
infection progresses, pseudoknot-dependent binding of the viral RdRp to the TLS initiates 
negative-strand synthesis (438). Increasing levels of RdRp outcompete eEF1A for binding of the 
TLS, signalling progression of the viral lifecycle, and genomic RNA is sequestered into spherules, 
further reducing the local concentration of eEF1A (439). 
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Figure 5.1: The structure of a hairpin-type pseudoknot (adapted from (440)). (A) The terminal 
loop of a hairpin base-pairs (dotted line) with a proximal single-stranded region, resulting in (B) a 
H-type pseudoknot with base-pairing within two stems separated by two intervening loops. Colour 
gradient (red to blue) represents the 5′ to 3′ polarity of the RNA molecule.  
  
A) B)
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As previously noted, while reverse genetic studies support the predicted structure of SL85 and the 
fact that it functions in a structure-dependent mechanism (Figs 4.2 & 4.3), in vitro SHAPE 
reactivity data suggested that this region is also able to undergo alternative interactions (Fig 3.2). 
These observations may be explained by the dynamic formation of a pseudoknot competing with 
SL85. Pseudoknots and similar RNA tertiary motifs have been demonstrated to direct various 
forms of alternative translation including frameshifting (441), readthrough (442) and ribosomal 
shunting (443). The presence of RNA secondary or tertiary structures around an AUG start codon 
has been demonstrated to impact the rate of initiation from alternative (AUG and non-AUG) start 
sites, particularly by ribosomal shunting across the base of secondary structures (411). For 
example, plant pararetroviruses including cauliflower mosaic virus (CaMV) exhibit ribosomal 
shunting across an extended hairpin, resulting in translation from an alternative start codon which 
is essential for infectivity (444). The region of secondary structure containing SL85 and SL102 
lies between two in-frame AUG start codons, both of which have been demonstrated to function 
in human cells (unpublished data, discussed in 5.2.4). Thus, we hypothesis that formation of 
dynamic higher order RNA-RNA interactions in this region could influence initiation of translation 
from alternative start codons, or represent a mechanism by which CHIKV switches from ORF-1 
translation to genome replication. 
The aim of the work described in this chapter was to identify potential tertiary interactions 
of the 5′ region of the CHIKV genome, including the possibility of stem-loop:stem-loop 
interactions and alternative pseudoknot interactions involving SL85. 
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5.2  Results 
5.2.1 Stem-loops in the 5′ region are essential for CHIKV genome replication in 
mammalian and mosquito hosts 
In order to investigate the potential for direct or indirect synergistic interactions between stem-
loops in the 5′ region of the CHIKV genome, each stem-loop was disrupted cumulatively to 
produce a fully destabilised 5′ mutant, termed CombmutA (Fig 5.2). Infectious virus could not be 
recovered following electroporation of Huh7 and C6/36 cells with in vitro transcribed CombmutA 
CHIKV_IC RNA (Fig 5.3A). Similarly, infectious virus could not be recovered when this RNA 
was transfected by liposome delivery into Huh7 or C6/36 cells, demonstrating that the abolition of 
viral replication is independent of the RNA transfection method (Fig 5.3B). 
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Figure 5.2: Combined mutant A. Each stem-loop mutant (labelled in bold) was incorporated into 
CHIKV_IC in combination to produce the CombmutA. Synonymous mutations (red) were 
designed to destabilise base-pairing of the heteroduplex stem. 
SL47mut SL85mut SL102mut SL165mut SL194mut SL246mut
Fig 1.
A) CombmutA
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Figure 5.3: Combined disruption of SL47-SL246 abolished CHIKV replication. CHIKV titres 
following (A) electroporation and (B) transfection of (i) Huh7 and (ii) C6/36 cells with WT and 
CombmutA CHIKV_IC in vitro transcribed RNA over 24 hours (n=3). Data shown is the mean of 
three independent biological replicates, with the error bar representing the standard deviation of 
the mean. 
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Figure 5.4: Combined disruption of SL47-SL246 abolished viral genome replication. (A) 
Replication phenotype of sub-genomic replicons (n=3) in (i) Huh7 and (ii) C6/36 cells over 24 
hours post-transfection. CHIKV_Rep replicon with wild-type RNA structure (black) compared to 
CombmutA CHIKV_Rep replicon (light grey), alongside WT CHIKV_Rep(GDD>GAA) (dark 
grey) as a non-replicating control. * represents statistical significance for each mutant compared 
to wild-type under a two-tailed Student's t-test: p≤0.0001 (****). Data shown is the mean of three 
independent biological replicates, with the error bar representing the standard deviation of the 
mean. 
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5.2.2 Combinations of stem-loops are essential for CHIKV replication in mammalian 
and mosquito hosts 
Combined destabilisation of all stem-loops within the 5′ 300 nt of the CHIKV genome prevented 
virus and genome replication, demonstrating that base-pairing in this region was essential for 
CHIKV replication in both mammalian and mosquito hosts. In contrast, complete abolition of 
CHIKV replication was not seen following disruption of any one single stem-loop in either host 
(Figs 3.5 & 3.6). These data suggest that a combinatorial effect had occurred for CombmutA via 
direct or indirect interactions between stem-loops. Alternatively, the stem-loops may have distinct 
functions and an additive effect may have occurred.   
 
In order to explore the interactions between stem-loops and determine the minimum set of stem-
loops which prevented replication in each host, two further mutants were designed (Fig 5.5). Each 
mutant contained only those mutations which had been shown to impact CHIKV replication in 
either mammalian-, CombmutB, or mosquito-, CombmutC, derived cells. Infectious virus could 
not be recovered following electroporation of BHK-21 cells with in vitro transcribed CombmutB 
CHIKV_IC RNA (Fig 5.6A). In order to formally demonstrate that CombmutB was incapable of 
virus replication due to a lack of genome replication, as CombmutA was, the CombmutB mutations 
were cloned into the sub-genomic replicon CHIKV_Rep and transfected into Huh7 and C6/36 
cells. Genome replication for CombmutB was indistinguishable from the non-replicating GAA 
control, indicating that CombmutB was non-functional at the level of genome replication, as had 
been demonstrated for CombmutA (Fig 5.6B, p>0.05). The inability of CombmutB to replicate in 
C6/36 cells was of particular interest, since individually disrupting stem-loops SL85, SL102, 
SL165 or SL194 had previously been demonstrated to have no impact on CHIKV replication in 
mosquito cells (Figs 3.5 & 3.6). Thus, it was predicted that CombmutB would be comparable in its 
replication to SL47mut, since an intact SL246 was present. Unexpectedly, CombmutB was 
completely incapable of producing infectious virus in C6/36 cells. Mutation of each of the stem-
loops SL85, SL102, SL165 and SL194 only contributed to inhibition of CHIKV replication in 
mosquito cells in the combination with other mutated structures, indicating functional redundancy 
between two or more of the stem-loops. 
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In contrast to CombmutB, infectious virus was recovered following electroporation of BHK-21 
cells with in vitro transcribed CombmutC CHIKV_IC RNA, although virus replication was 
significantly reduced compared to WT (p≤0.05) (Fig 5.6A). The ability of CombmutC to replicate 
in Huh7 and C6/36 cells was investigated in one-step growth assays (Fig 5.6C). Infections were 
carried out alongside the mutants SL47mut and SL246mut, (i.e. the two stem-loops destabilised in 
the combined mutant CombmutC). Both SL47mut and SL246mut recapitulated the phenotypes 
previously observed in both Huh7 and C6/36 cells (Figs 3.5 & 3.6). CHIKV replication was 
significantly reduced in the combined mutant CombmutC compared to WT in Huh7 and C6/36 
cells (p≤0.001). Interestingly, the reduction in CHIKV replication for CombmutC exceeded the 
expected additive phenotype of SL47mut and SL246mut in both cell lines, suggesting synergistic 
interaction between the stem-loops. In particular, since SL246mut was previously demonstrated 
not to impact CHIKV replication in mammalian cells, SL47mut should be directly comparable to 
CombmutC (Fig 5.6B)i)). This is not the case – CHIKV replication was significantly reduced in 
CombmutC compared to SL47mut in Huh7 cells (p≤0.0001). These data suggested an interaction 
between SL47 and SL246 in mammalian cells. In mosquito cells, the synergistic effect was much 
more modest, exceeding the expected additive phenotype by less than 0.5 logs. 
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Figure 5.5: Combined mutants B and C. (A) CombmutB contains synonymous substitutions in 
all stem-loops shown to affect CHIKV replication in mammalian cell lines. (B) CombmutC 
contains synonymous substitutions in both stem-loops shown to affect CHIKV replication in 
mosquito cell lines. Mutated stem-loops labelled in red. Each stem-loop mutant (labelled in bold) 
was incorporated into CHIKV_IC in combination. 
SL47mut SL85mut SL102mut SL165mut SL194mut SL246
SL47mut SL85 SL102 SL165 SL194 SL246mut
Fig 4.
A) CombmutB
B) CombmutC
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Figure 5.6: Combined mutations abolished or severely reduced CHIKV replication similarly 
in both host species. (A) CHIKV titres following electroporation of BHK-21 cells with WT, 
CombmutB and CombmutC in vitro transcribed CHIKV_IC RNA over 24 hours. (B) Replication 
phenotype of sub-genomic replicons in (i) Huh7 and (ii) C6/36 cells over 24 hours post-
transfection. CHIKV_Rep replicon with wild-type RNA structure (black) compared to CombmutB 
(light grey), alongside WT CHIKV_Rep(GDD>GAA) (dark grey) as a non-replicating control. (C) 
CHIKV titres following infection of (i) Huh7 cells with WT, SL47mut and CombmutC virus and 
(ii) C6/36 cells with WT, SL47mut, SL246mut and CombmutC virus over 24 hours. n=3 for all 
experiments. . * represents statistical significance for each mutant compared to wild-type under a 
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two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), ≤0.001 (***), ≤0.0001 (****). Data shown is 
the mean of three independent biological replicates, with the error bar representing the standard 
deviation of the mean. 
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5.2.3 Potential pseudoknot formation 
In Chapter 3, SHAPE-constrained thermodynamic analysis demonstrated that the RNA structure 
of the CHIKV genome immediately downstream of the AUG start codon contained two distinct 
RNA replication elements (SL85 and SL102 (Fig 3.2A)), both of which are involved in efficient 
genome replication in human-derived cells but not those from Ae. albopictus (Fig 3.4). However, 
SHAPE reactivity data for SL85 was not consistent with the structure predicted by SHAPE-
constrained thermodynamic modeling, suggesting that this region of the genome may be 
structurally dynamic and able to form alternative interactions (Figs 5.7B & 5.8A). Structure-led 
reverse genetic analysis, de-stabilising SL85 and then restoring base-pairing with compensatory 
substitutions, demonstrated that SL85 is essential for efficient CHIKV genome replication in 
human-derived cells and functions through a structure-dependent mechanism (Figs 4.2A & 4.3A) 
(Fig 5.7A). The ability of SL85mut-Comp to rescue wild-type CHIKV replication demonstrates 
that the structure forms during the CHIKV lifecycle in vivo. Given the lack of agreement between 
the combined structural model/reverse genetic data and SHAPE reactivity data for SL85, the 
potential for alternative structure formation was explored. It was predicted that a pseudoknot may 
form in competition with the SL85 stem-loop and this was investigated by structural prediction 
and reverse genetic analysis. 
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Figure 5.7: Disagreement between phenotypic studies and SHAPE reactivity for SL85. (A) 
Combined model of SL85 secondary structure, with base-pairing labelled in blue, including (i) the 
wild-type structure, (ii) SL85mut with disruption of two base-pairs in the stem (yellow) and (iii) 
SL85mut-Comp which restores of those base-pairs by compensatory mutations on the opposite side 
of the stem (green). The substitution of the wild-type G:C pair with a compensatory A:U pair 
distinguishes between structure- and sequence-based effects. WT and SL85mut-Comp have 
comparable phenotypes. Therefore, phenotypic data suggests that the stem-loop shown in the 
figure is likely to form. (B) Binary representation of SHAPE mapping data from A. Tuplin 
(University of Leeds) with unpaired nucleotides predicted in the stem (red circles) and paired 
nucleotides ( circles) in the terminal loop. SHAPE mapping suggests that the stem-loop shown in 
the figure is highly dynamic or does not form.  
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Regions of the terminal loop predicted by thermodynamic modelling and reverse genetic analysis 
to be single-stranded but suggested by SHAPE mapping to be base-paired were analysed for 
sequence complementarity with proximal single-stranded regions. Two potential alternative 
RNA/RNA interactions were predicted, termed Pseudoknot-1 (Pk1) and Pseudoknot-2 (Pk2). 
Base-pairing of the terminal loop sequence of SL85 was hypothesised to involve upstream (Pk1) 
or downstream (Pk2) regions (Fig 5.8B). The potential pseudoknots Pk1 and Pk2 were investigated 
by reverse genetic analysis in a similar manner to that utilised during investigation of individual 
stem-loops. Unfortunately, the upstream single-stranded region, predicted to base-pair in Pk1, 
contained the AUG start codon of ORF-1, complicating reverse genetic analysis due to the 
presence of the start codon and surrounding Kozak context.  
Synonymous mutations were designed to disrupt Pk1 from the upstream sequence (Pk1smut) and 
terminal loop (Pk1Lmut) regions and incorporated into CHIKV_IC (Fig 5.9A). A compensatory 
set of mutations was also designed to restore base-pairing within Pk1 (Pk1-Comp). One-step 
growth assays were carried out for WT CHIKV and Pk1 mutant virus in Huh7 and C6/36 cells 
over 24 hours. In order to assess the potential formation of Pk1 during CHIKV replication, the 
number of infectious virions released during infection was determined by plaque assay (Fig 5.9B-
C). CHIKV replication was significantly reduced for Pk1smut compared to WT (p≤0.01) in Huh7 
cells, whereas no significant difference in viral titre was observed in C6/36 cells (Fig 5.9B)i) & 
C)i)). Pk1Lmut virus replicated to wild-type titres in both Huh7 and C6/36 cells (Fig 5.9B)ii) & 
C)ii)). Subsequently, Huh7 cells were infected with Pk1-Comp virus to determine whether the 
replication phenotype of Pk1smut in these cells could be rescued by restoring base-pairing across 
the predicted pseudoknot. Replication of Pk1-Comp was significantly reduced relative to WT 
(p≤0.0001), representing an even greater replication phenotype than Pk1smut alone. Taken 
together, these data suggested that Pk1 did not form in the CHIKV genome and that phenotypes 
observed for the upstream region mutants may have been due to disturbance of the Kozak 
sequence. 
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Figure 5.8: Potential pseudoknot formation. (A) SHAPE-constrained UNAfold-predicted 
structure of SL85 and SL102. 37°C SHAPE reactivities for individual nucleotides are overlaid 
onto a 37°C thermodynamically derived model of RNA folding, generated using SHAPE-directed 
constraints. The AUG start codon of nsP1 is denoted by a grey arrow. SHAPE reactivities are 
shown as a heat map: white SHAPE reactivities between 0–0.3 and increasing intensities from 
light pink to dark red indicate increasing SHAPE reactivities, as denoted by the key. High 
reactivity (red) denotes unpaired nucleotides whereas low reactivity (white) denotes base-paired 
nucleotides. (B) Schematic representation of two potential pseudoknots involving SL85: (i) 
pseudoknot-1 (Pk1) forming over the downstream AUG start codon of nsP1 (grey arrow) and (ii) 
pseudoknot-2 (Pk2) forming with an upstream sequence within SL102. Dotted lines represent 
potential base-pairing in each putative pseudoknot.  
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Figure 5.9: Phenotypic analysis of the putative pseudoknot, Pk1. (A) Mutations (red) predicted 
to destabilise the putative pseudoknot Pk1 from the i) upstream (Pk1Smut) or ii) loop (Pk1Lmut) 
regions. iii) A compensatory set of mutations predicted to restore base-pairing of the pseudoknot: 
Pk1-Comp. The AUG start codon of nsP1 is denoted by a grey arrow; all mutations are 
synonymous. Dotted lines represent potential base-pairing in Pk1; black lines represent base-
pairing, red lines represent disrupted pairing, grey lines represent a non-Watson-Crick base-pair 
produced by mutation. (B-C) CHIKV titres following MOI=1 infection with virus of wild-type 
RNA structure (black bar) and mutants (hatched bars) over 24 hours (n=3). (B) Infections were 
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carried out in Huh7 cells with i) Pk1Smut, ii) Pk1Lmut and iii) Pk1-Comp virus and (C) C6/36 cells 
with i) Pk1Smut and ii) Pk1Lmut virus. A schematic of the structured region (dashed box) is 
displayed for reference, with the loop region (green) and upstream sequence (purple) denoted. * 
represents statistical significance for each mutant compared to wild-type under a two-tailed 
Student's t-test: p≤0.05 (*), ≤0.01 (**), ≤0.001 (***), ≤0.0001 (****). Data shown is the mean of 
three independent biological replicates, with the error bar representing the standard deviation of 
the mean. 
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Synonymous mutations were then designed to disrupt Pk2 from the downstream sequence 
(Pk2smut) and terminal loop regions. Unfortunately, the range of synonymous mutations which 
could be incorporated into the terminal loop of SL85 were limited. Only two nucleotides predicted 
to base-pair in Pk2 could be synonymously mutated. Pk1Lmut, although originally designed to 
disrupt Pk1, was predicted to disrupt base-pairing in Pk2 (Fig 5.10A)ii)) and had displayed no 
replication phenotype (Fig 5.9B)i) & C)i)). Huh7 and C6/36 cells were infected with either 
WTCHIKV or Pk2smut virus at MOI=1 for 24 hours. CHIKV replication was significantly reduced 
for Pk2smut compared to WT (p≤0.01) in Huh7 cells, whereas no significant difference in viral 
titre was observed in C6/36 cells (Fig 5.10B & C). These data suggest a function for the upstream 
single-stranded region during the viral lifecycle but do not demonstrate the formation of Pk2.  
 
5.2.4 Alternative AUG start codon  
Several studies undertaken by members of the group (O. Antoniak, E. Levitt and T. Nguyen) have 
demonstrated that the Met24 AUG codon in nsP1 functions as an alternative start site, producing a 
smaller, N-terminally truncated form of nsP1 (Fig 5.11). Western blot analysis and mutagenesis 
studies have determined the presence and importance of this truncated protein product 
respectively. Interestingly, Met1>Ala mutation of the authentic 5′ AUG start codon abolishes virus 
replication completely, indicating that the truncated form of nsP1 is not sufficient for CHIKV 
replication. However, Met24>Ala mutation significantly reduces CHIKV replication suggesting 
that the truncated nsP1 plays an important but non-essential role in the viral lifecycle. 
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Figure 5.10: Phenotypic analysis of the putative pseudoknot, Pk2 
(A) Mutations (red) predicted to destabilise the putative pseudoknot Pk2 from (i) the downstream 
(Pk2Smut) region and (ii) the terminal loop region (Pk1Lmut). The AUG start codon of nsP1 is 
denoted by a grey arrow; all mutations are synonymous. Dotted lines represent potential base-
pairing in Pk2; black lines represent base-pairing, red lines represent disrupted pairing, grey lines 
represent a non-Watson-Crick base-pair produced by mutation. (B-C) CHIKV titres following 
MOI=1 infection with virus of wild-type RNA structure (black bar) and Pk2Smut (hatched bars) 
over 24 hours in (B) Huh7 and (C) C6/36 cells (n=3). A schematic of the structured region (dashed 
box) is displayed for reference, with the loop region (green) and downstream sequence (blue) 
denoted. . * represents statistical significance for each mutant compared to wild-type under a two-
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tailed Student's t-test: ns (non-significant), p≤0.01 (**). Data shown is the mean of three 
independent biological replicates, with the error bar representing the standard deviation of the 
mean. 
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Figure 5.11: Alternative initiation of nsP1 translation 
Schematic representation of CHIKV non-structural protein 1, showing wild-type nsP1 relative to 
the N-terminal truncated mutant (△N-nsP1). The N-terminus (N) and C-terminus (C) are labelled, 
along with each start codon AUG1 (Methionine1) and AUG2 (Methionine24). The N-terminal 
sequence is denoted in darker green in wild-type nsP1. A schematic of the structured region 
(dashed box) is displayed for reference, with AUG1 (M1) codon (purple) and downstream AUG2 
(M24) codon (orange) denoted. 
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SL85 and SL102 lie between the two in-frame AUG codons, looping out to allow base-pairing 
between the start codons (Fig 5.11). In order to analyse the mechanism by which AUG2 functions 
as a start codon, a stop codon (UAG) was introduced into the terminal loop of SL85 (Fig 5.12A). 
The resulting mutant, AUG1STOP, retains the AUG1 sequence but presumably cannot express full 
length nsP1 due to termination after 4 aa. This mutant can be compared to AUG1mut, which lacks 
the AUG1 sequence altogether. Comparison of these mutants allows the mechanism of AUG2 
initiation to be determined as AUG1-dependent or independent, Secondarily, the stop codon 
disrupts base-pairing of the predicted pseudoknot Pk2 in a manner that allows for restoration of 
base-pairing by compensatory mutation. Thus, the AUG1STOP mutant can be compared to the 
AUG1STOP-Pk2-Comp mutant to assess the role of the putative pseudoknot Pk2 during viral 
replication. While the introduction of a stop codon limits the conclusions that can be drawn about 
the formation of Pk2, an interesting replication phenotype was observed. AUG1STOP and 
AUG1STOP-Pk2-Comp replicate to wild-type titres in C6/36 cells, in spite of the introduced stop 
codon (p≥0.05) (Fig 5.12B)ii)). The introduction of a stop codon presumably prevents production 
of full-length nsP1, which therefore appears to be dispensable to CHIKV replication in mosquito 
cells. However, AUG1mut, which lacks the authentic start codon AUG1, is incapable of virus 
replication in C6/36 cells. This was previously assumed to be due to dependence on full-length 
nsP1 for CHIKV replication in mosquito cells. In light of the ability of AUG1STOP to replicate in 
the absence of full-length nsP1, it appears that the sequence of AUG1 is essential for viral 
replication in mosquito cells but not the functionality of AUG1 as a start codon in producing full-
length nsP1.  
Unlike in C6/36 cells, the introduction of a stop codon significantly reduced CHIKV replication 
in Huh7 cells, as may be expected (Fig 5.12B)i)). AUG1STOP and AUG1STOP-Pk2-Comp 
exhibited significantly reduced virus replication relative to WT in Huh7 cells (p≤0.01). AUG1mut 
displayed a complete lack of infectious virus release, as was observed in C6/36 cells. These data 
suggested that the sequence and function of AUG1 are necessary for CHIKV replication in 
mammalian cells. Interestingly, AUG1STOP-Pk2-Comp did not rescue AUG1STOP replication, 
indicating that restoring base-pairing in Pk2 had no effect on virus replication in the context of the 
stop codon.  
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Figure 5.12: Introduction of a stop codon between the authentic and alternative start sites is 
tolerated in mosquitoes. (A) Schematic representation of (i) AUG1STOP, (ii) AUG1STOP-Pk2-
Comp and (iii) AUG1mut displaying mutations (red). AUG1STOP and AUG1STOP-Pk2-Comp 
contain a stop codon (red box) within SL85 between the two in-frame AUG start codons, AUG1 
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and AUG2 (grey arrows). Dotted lines represent potential base-pairing in Pk2; black lines 
represent base-pairing, red lines represent disrupted pairing. AUG1mut contains a non-
synonymous (Met>Ala) mutation which replaces the first AUG start codon with a GCG (yellow 
arrow). (B) Description of each mutant. (C) CHIKV titres following MOI=1 infection with virus 
of wild-type RNA sequence (black bar) and mutants (hatched bars) over 24 hours in (i) Huh7 and 
(ii) C6/36 cells (n=3). * represents statistical significance for each mutant compared to wild-type 
under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**). Data shown is the mean of three 
independent biological replicates, with the error bar representing the standard deviation of the 
mean. 
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5.2.5 Alternative UUG start codon 
In addition to reverse genetic studies demonstrating the importance of the authentic and alternative 
start sites AUG1 and AUG2, selection pressure acting on this region was revealed during passaging 
of CHIKV in mammalian cells. Serial passaging of WT CHIKV and mutants in Huh7 cells 
revealed a preference for UUG at the alternative Met24 start site. A single point mutation was 
present in the P10 sequence of all constructs passaged in mammalian cells, including WT and each 
of the mutants SL47mut, SL85mut, SL102mut, SL165mut and SL194mut, indicating a mammalian-
specific cell culture adaptation (Fig 5.13A). This non-synonymous A146>U146 substitution has 
several effects. Firstly, primary RNA sequence is altered. Secondly, RNA structure is altered 
through the replacement of an A146:U79 base-pair with a U146/U79 bulge (Fig 5.13B). Thirdly, the 
nsP1 protein sequence is altered by Met24>Leu24 substitution, potentially affecting the protein 
structure. Finally, AUG>UUG alters the alternative start codon AUG2, likely reducing expression 
of the N-terminally truncated form of nsP1.  
 
UUG encodes leucine but is also known to function as an alternative start codon, albeit less 
efficiently than AUG (445). The selection of the point mutant AUG>UUG in 7 separate passage 
series, including twice in the wild-type virus, suggests that less efficient expression of the truncated 
form is desirable in mammalian cells. The AUG>UUG mutation was fixed in each stem-loop 
mutant at a different passage (Fig 5.14). SL194mut and WT virus fixed the UUG substitution 
extremely quickly, within 1-2 passages, whereas SL85mut acquired the substitution much later, at 
P9. 
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Fig 5.13: The alternative AUG start codon is invariably substituted with UUG during 
mammalian cell passage. (A) Presence of the AUG>UUG mutation (red box) for each stem-loop 
mutant at passage 10 (P10) in Huh7 cells. The P10 sequence for each passaged mutant is aligned 
below the WT P0 sequence containing AUG. (B) Schematic representation of UNAfold-predicted 
structures for (i) WT (P0) sequence containing base-paired AUG:AUG and (ii) P10 sequence 
containing UUG. The AUG1 start codon of nsP1 is denoted by a grey arrow and the A146>U146 
mutation is circled in red.  
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Figure 5.14: Acquisition of AUG>UUG point mutation during passage. Acquisition of 
AUG>UUG point mutation in Huh7 cells for each stem-loop over 10 passages (P1-P10) for wild-
type (WT) and stem-loop (SL) mutants. Ticks represent A146>U146 mutation (UUG) detectable at 
that passage, crosses represent WT (AUG) sequence at that passage. WT and WT(2) represent 
independent passages of WT virus, since SL47mut and SL194mut were passaged alongside WT(1) 
prior to passage of SL85-SL165 alongside WT(2), providing two WT passages.  
 
  
Stem-
loop
P0 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
WT(1) û û ü ü ü ü ü ü ü ü ü
WT(2) û û û û û ü ü ü ü ü ü
SL47 û û û û û û ü ü ü ü ü
SL85 û û û û û û û û û ü ü
SL102 û û û û û û û ü ü ü ü
SL165 û û û û û û ü ü ü ü ü
SL194 û ü ü ü ü ü ü ü ü ü ü
Fig 20.
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The strong selection pressure for the AUG>UUG substitution suggests that there may be a fitness 
benefit associated with UUG in mammalian cell culture. In order to examine the effect of this 
substitution, one-step growth assays were carried out for P0 and P10 virus derived from the WT 
in Huh7 and C6/36 cells (Fig 5.15A). While the P10 virus containing UUG exhibited an increased 
titre compared to P0 virus in Huh7 cells, this effect was not statistically significant. However, the 
same virus stock exhibited an ~3 log reduction in CHIKV titre in C6/36 cells compared to its P0 
counterpart (p≤0.005). It may be expected that other mammalian-specific mutations had 
accumulated in the structural proteins of Huh7-passaged CHIKV over 10 passages, explaining the 
reduction in viral replication in mosquito cells by a reduction in infectivity or packaging efficiency. 
In order to determine whether the AUG>UUG substitution was responsible for decreasing CHIKV 
replication in mosquito cells, the A146>U146 mutation was incorporated into the CHIKV_IC 
construct to produce UUGmut. Huh7 and C6/36 cells were infected with UUGmut and WT virus 
at MOI=1 (Fig 5.13B). UUGmut significantly decreased CHIKV replication in C6/36 cells 
(p≤0.0001) while producing a small but non-significant increase in CHIKV titre in Huh7 cells. 
The detriment to CHIKV replication in Ae. albopictus cells explains the preference for AUG at the 
second start site in wild-type isolates. The replacement of the alternative start site with a less 
efficient codon may suggest a preference for altered regulation in mammalian cells, 
downregulating but not eliminating the truncation product. The selection of the codon UUG in 
multiple independent isolates, rather than the other viable leucine start codon CUG, indicates an 
advantage in mammalian cells which may be due to improved stability or flexibility of the local 
RNA structure, formation of alternative RNA structures including long-distance interactions or 
interaction with mammalian-specific binding factors. It cannot be ruled out that the selection of 
UUG is due to a tissue culture-specific benefit. Further analysis of AUG:AUG base-pairing is 
required to determine the effect of this interaction on translation and replication. 
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Figure 5.15: Substitution of AUG>UUG at the alternative start site is not tolerated in 
mosquitoes. (A) Replication phenotype of P0 WT CHIKV (black) compared to P10 WT-derived 
CHIKV containing the UUG mutation (grey) following infection of i) Huh7 and ii) C6/36 cells 
over 24 hours (n=3). (B) Replication phenotype of WT virus (black) compared to UUGmut virus 
(grey), synthesised by site-directed mutagenesis, following infection of (i) Huh7 and (ii) C6/36 
cells over 24 hours (n=3). * represents statistical significance for each mutant compared to wild-
type under a two-tailed Student's t-test: p≤0.05 (*), ≤0.01 (**), ≤0.001 (***), ≤0.0001 (****). Data 
shown is the mean of three independent biological replicates, with the error bar representing the 
standard deviation of the mean.  
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5.3  Discussion 
5.3.1 Secondary structures in the 5′ of the CHIKV genome are essential to genome 
replication 
Combined destabilisation of SL47, SL85, SL102, SL165, SL194 and SL246 abolished CHIKV 
genome replication in human- and Ae. albopictus-derived cells, demonstrating that RNA structures 
within the 5′ 300 nt of the CHIKV genome are essential for CHIKV replication in both host species 
(Figs 5.3 & 5.4). A total of 17 mutations in the 5′ 300 nt were sufficient to prevent production of 
infectious virus (Fig 5.2). A similar result was observed by Michel and colleagues upon extensive 
silent mutation of the 5′ 300 nt of VEEV, whereby 95 mutations prevented production of infectious 
virus in BHK-21 cells. Interestingly, the same study found that 97 synonymous mutations 
predicted to disrupt the secondary structure in the 5′ 300 nt of SINV did not completely abolish 
virus replication, although viral titre was reduced by ~3-4 logs in both BHK-21 and C710 cells 
(376). In contrast, an earlier study in SINV had demonstrated that 44 synonymous mutations in 
the same region resulted in barely detectable viral titres following infection of BHK-21 cells and 
no infectious virus recovery from mosquito cells (357). Overall, it can be concluded that the 
structured region in the 5′ 300 nt of alphavirus genomes plays a critical role in viral replication and 
is essential in CHIKV. 
 
Clearly, the identity and location of substitutions during mutagenesis plays a major role in 
replication phenotype when disrupting alphavirus RNA structures. Far fewer mutations were 
necessary in CHIKV than in VEEV and SINV to abolish viral replication. Furthermore, 44 
mutations resulted in abolition of SINV replication in one study, whereas 97 mutations were not 
sufficient in a later study. This may complicate the interpretation of previous findings and explain 
disagreement between phenotypic studies of the 51 nt CSE (352,376). In future studies, 
consideration of RNA sequence and structure, codon usage and dinucleotide frequency during 
design of targeted mutations may reduce variability between studies. It is important to note that 
four of the mutations present in the CHIKV CombmutA were in SL47, which has no homologue 
in VEEV or SINV. Therefore, the disruption of secondary structure in this region of CHIKV is not 
as directly comparable as between VEEV and SINV.  
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As discussed in Chapter 3, the replication-competent sub-genomic replicon CHIKV_Rep cannot 
distinguish between early stages of genome replication, such as translation of the ORF-1 non-
structural polyprotein and initiation of transcription by the RdRp. The lack of genome replication 
for CombmutA (Fig 5.4) and CombmutB (Fig 5.6B) observed during assays of CHIKV_Rep could 
be the result of impaired translation. The translation phenotype of CombmutA could be determined 
using the CHIKV_Rep(GDD>GAA) construct, which undergoes initial translation to express the 
reporter in ORF-1 but expresses non-catalytic RdRp, preventing subsequent transcription events 
(Fig 3.13). Although individual stem-loop disruptions were shown not to impact translation (Fig 
3.14), CombmutA and CombmutB contain more extensive changes to RNA structure and sequence. 
Further study is necessary to formally discount translational inhibition as the cause of impaired 
CHIKV replication for these mutants. Alternative methods of distinguishing the effects of 
translation and replication of the viral genome include trans-replicase studies. Translation and 
replication are uncoupled in such assays by the expression of the non-structural proteins in trans 
from an alternative promoter. The mutated genome acts as a template and expresses a reporter in 
place of viral proteins. In this way, the ability of the mutant sequence to act as a template for 
replication can be assayed in isolation. This approach has been successfully employed in the study 
of CHIKV in both human and mosquito cells (446). The impact of RNA stem-loops on CHIKV 
translation could also be further assessed by Western blot analysis of nsP expression or through 
polysome profiling to quantify the association of ribosomes with viral RNA. 
Synonymous mutations alter codon usage and dinucleotide frequency, as discussed in Chapter 3. 
Thus, the replication phenotypes observed for the combined mutants may be the result of reduced 
codon efficiency or enhanced immune recognition of the genome rather than disruption of RNA 
structure. However, there was no net increase in CpG frequency in any of the combined mutants 
and the net increase in UpA frequency did not exceed one pair (Fig 5.16). Therefore, dinucleotide 
frequency is not a likely explanation for the abolition in viral replication observed for CombmutA 
and CombmutB. Similarly, codon usage cannot account for abolition of replication as changes to 
codon usage did not reduce net codon efficiency more than 15% for any of the combined mutants 
(Fig 5.17). 
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Figure 5.16: Changes in CpG and UpA dinucleotide frequency in combined mutants. Net 
change in CpG and UpA dinucleotide frequencies in each of the combined mutants, expressed as 
the net number of dinucleotide pairs introduced by the mutations displayed (Figs 5.2 & 5.5). 
 
 
 
 
Figure 5.17: Changes in codon efficiency in combined mutants. Net change in codon efficiency 
for each of the combined mutants in human- and D. melanogaster-derived cells. Changes to codon 
efficiency are displayed as a relative percentage decrease in codon efficiency in each organism 
upon mutation. Each percentage is an average of the change induced by all substitutions per 
mutant. Standard deviation for each average was equal to or less than 10%. Codon efficiency is 
measured as codon frequency in the genome of each organism, as drawn from the codon frequency 
tool from Genscript (405). SL47 is in the untranslated region, thus codon usage is null.  
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5.3.2 Secondary structures exhibit synergy and functional redundancy 
CombmutA contained disruptive mutations in each stem-loop in the region of interest: SL47, SL85, 
SL102, SL165, SL194 and SL246 (Fig 5.2). CombmutB and CombmutC contained mutations in 
only those stem-loops which enhanced replication in either human- or Ae. albopictus-derived cells 
respectively (Fig 5.5). These mutants served two purposes during the study. Firstly, in cell lines 
where the stem-loops had exhibited functionality, individual and combined mutant phenotypes 
were compared to reveal interactions between stem-loops.  In the case of no functional interactions 
between stem-loops, an additive effect would be expected, representing the sum of the individual 
replication phenotypes. In the case of functional interactions between stem-loops, a synergistic 
effect would be expected, whereby the combined mutant replication phenotype exceeds the sum 
of individual phenotypes. Secondly, in cell lines where the individual stem-loop mutants exhibited 
no replication phenotype, functional redundancy could be determined by the presence of a 
replication phenotype for the combined mutant.  
 
Genome replication was not detectable following transfection of Huh7 and C6/36 cells with in 
vitro transcribed CombmutA CHIKV_Rep RNA (Fig 5.4). The abolition of genome replication for 
CombmutA in Huh7 cells suggested that essential synergistic interactions occur between stem-
loops, since replication was not abolished in assays of any individual stem-loop mutant (Chapter 
3). The predicted additive phenotype for CombmutAmay be expected to be relatively large due to 
the number of structures disrupted. However, genome replication for CombmutA was measured 
24-hours post-transfection, when the additive phenotype was predicted to be no more than a ~1.5 
log decrease in genome replication relative to WT (Fig 3.9A-F). In light of the ~3-4 log decrease 
in genome replication to below detectable levels, synergistic interaction between the stem-loops 
in Huh7 cells was concluded. As might be expected, CombmutB was similarly incapable of 
genome replication, indicating that SL246 was not sufficient to restore genome replication (Fig 
5.6B). This was not surprising, given the lack of phenotype for SL246 in mammalian cells when 
individually disrupted (Fig 3.9F). The synergistic interaction occurring within the 5′ 300 nt of the 
genome in mammalian cells involves two or more of the stem-loops which had exhibited 
individual phenotypes: SL47, SL85, SL102, SL165 and SL194.  
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In addition to synergy between stem-loops in mammalian cells, the abolition of genome replication 
in C6/36 cells for CombmutA suggested synergistic interactions in the mosquito host. Since 
CombmutA cannot form SL47 or SL246, each of which exhibited an individual replication 
phenotype in C6/36 cells, it was hypothesised that the essential synergistic interaction may occur 
between these stem-loops (Fig 3.12A & F). Interestingly, CombmutB was also incapable of 
genome replication in C6/36 cells, demonstrating that the reintroduction of SL246 was not 
sufficient to restore genome replication (Fig 5.6B). Given that SL47 is the only stem-loop 
disrupted in CombmutB which had demonstrated an individual phenotype, the replication 
phenotype of CombmutB in C6/36 cells should be equal to that of SL47mut (Fig 3.12). This was 
not the case – SL47mut exhibits a ~1 log decrease in genome replication while CombmutB exhibits 
a ~2.5 log decrease in replication to below detectable levels. These data suggest that SL85, SL102, 
SL165 and SL194, or some combination of these stem-loops, play an essential role in CHIKV 
genome replication in C6/36 cells. Since no phenotype was previously detected during individual 
disruption of these stem-loops, functional redundancy was concluded to exist between one or more 
of these structures in mosquito cells. Host-specific functional redundancy has been demonstrated 
in DENV, as a means of mitigating the effect of host-switching (393).  
In contrast to CombmutB, CombmutC infectious virus was detectable following infection of Huh7 
and C6/36 cells (Fig 5.6C). The ability of CombmutC to replicate in C6/36 cells precludes the 
hypothesis that a synergistic interaction between SL47 and SL246 is essential for viral replication 
in the mosquito host. A small but significant synergistic interaction did occur, whereby the 
phenotype exceeds the additive phenotype by ~0.5 logs, but this was not essential to CHIKV 
replication. An even greater synergistic effect was observed between SL47 and SL246 in Huh7 
cells. Since SL246mut displayed no replication phenotype in Huh7 cells during previous assays, 
the replication phenotype of CombmutC should be equal to that of SL47mut. This was not the case 
– SL47mut exhibited a ~1 log decrease in viral titre relative to WT in Huh7 cells while CombmutC 
exhibited a ~2.5 log decrease. Therefore, a synergistic interaction between SL47 and SL246 in 
Huh7 cells was concluded to occur. In a similar pattern to SL85-194 in mosquito cells, host-
specific functional redundancy occurred for SL246 in mammalian cells. The results from 
CombmutC assays highlight the benefits of pairwise disruptions in revealing functional 
redundancy and synergy of stem-loops in CHIKV replication. Further pairwise and multiple 
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disruptions should be designed to dissect the minimum set of stem-loops required to prevent or 
restore CHIKV replication e.g. reintroduction of SL47 may restore replication in CombmutB and 
pairwise disruption of SL85/102 and SL165/194 in CombmutC may abolish replication. A mutant 
restoring SL47 in CombmutB would enable investigation of functional redundancy in SL85-194.  
As discussed earlier, the genetic stability of attenuation is a critical factor in the consideration of 
vaccine candidates. CombmutC is attenuated in both human and mosquito cell lines but not 
incapable of replication in either, making it a possible component in an attenuated vaccine strain. 
Single- and multi-host passaging will be necessary to determine the stability of the combined 
mutations. Passaging may also reveal potential routes of reversion, whether in the proximal stem-
loops SL85-194 or in interacting proteins which may be attenuated in turn during vaccine 
development.  
 
5.3.3 Alternative conformations of SL85 
In Chapter 3, SL85 was demonstrated to be essential for efficient CHIKV genome replication in 
human-derived cells (Fig 3.5). In Chapter 4, structure-led reverse genetic analysis, destabilising 
SL85 and then restoring base-pairing with compensatory substitutions, demonstrated that SL85 
functions through a structure-dependent mechanism (Figs 4.2A & 4.3A). However, SHAPE 
reactivity data for SL85 suggests that this region of the genome may be structurally dynamic and 
able to form alternative interactions (Figs 5.7 & 5.8A). 
 
The formation of alternative RNA structures is well established in several positive-sense RNA 
viruses, as a means of temporal and spatial control of viral replication (343,447). Conformational 
switching between alternative structures may involve local rearrangement or modulation of long-
range RNA:RNA interactions. Local conformational changes are exemplified by riboswitches, 
such as the tertiary L-box motif of Bacillus subtilis lysC mRNA which undergoes local structural 
rearrangement in the presence of lysine (448). Two possible local alternative conformations around 
SL85 were investigated during this study, pseudoknot-1 (Pk1) and pseudoknot-2 (Pk2) (Fig 5.8). 
Pk1 was predicted to form between the terminal loop of SL85 and the upstream start codon AUG1. 
Therefore, mutations were designed in close proximity to the start codon which disrupted and 
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restored base-pairing in the pseudoknot. The sequence surrounding a start codon is known to 
impact the efficiency of translation (449). While the formation of a tertiary structure involving 
AUG1 may be selected to regulate translation, base-pairing of the Kozak sequence presented two 
major difficulties for reverse genetic analysis. Firstly, of the three mutants assayed, only those with 
a mutated Kozak sequence exhibited a reduction in viral titre, suggesting reduced translational 
efficiency (Fig 5.9). The translation phenotypes of Pk1Smut and Pk1-Comp could be determined 
using the CHIKV_Rep(GDD>GAA) construct or a trans-replicase system in order to confirm 
reduced translation. Secondly, the C76>G76 mutation present in both Pk1Smut and Pk1-Comp 
disrupts a C:G base-pair between AUG1 and AUG2 (Fig 5.9). The potential for competing base-
pairing between AUG1:AUG2 and AUG1:SL85 further complicated reverse genetic analysis of 
the region, as mutations designed to disrupt one interaction inevitably affected the other.  
Reverse genetic analysis indicated that Pk1 is unlikely to form. Pk1-Comp did not rescue viral 
replication relative to Pk1Smut and in fact exhibited a more severe phenotype. Restoring base-
pairing in Pk1 did not rescue replication, suggesting that the phenotype observed for Pk1Smut was 
not due to the disruption of the pseudoknot Pk1. Additionally, Pk1Lmut replicated to wild-type 
titres, suggesting that the mutated nucleotides were not involved in base-pairing as proposed in 
Pk1. However, only two of the seven predicted base-pairs in Pk1 were fully disrupted by the 
mutations made in Pk1Lmut, since C91>U91 produces a G79:U91 non-Watson-Crick pair. Therefore, 
Pk1Lmut may still form the pseudoknot Pk1. Due to the restrictions imposed by synonymous 
mutation, the range of alternative mutations was extremely limited. Non-synonymous mutants 
could be designed followed by in vitro SHAPE mapping to probe for disruption and restoration of 
tertiary structure. Biochemical determination of RNA structure would be particularly useful as it 
allows more extensive mutation of the loop region as well as mutation of the start codon and Kozak 
sequence. Interestingly, Pk1Smut replicated to wild-type titres in C6/36 cells, suggesting less 
stringent restrictions on Kozak sequence in mosquito cells.  
Pk2 was predicted to form between the terminal loop of SL85 and a downstream sequence in 
SL102 (Fig 5.10), therefore the Kozak sequence and disruption of AUG:AUG pairing was not an 
issue during design of synonymous mutants. However, the range of potential silent mutations in 
the terminal loop region was limited. Only two nucleotides predicted to base-pair in Pk2 could be 
synonymously mutated: G88 and C91. C91>U91 was the only synonymous mutation that could be 
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made at nt 91 and this had been made in Pk1Lmut. Additionally, C91:G79 in Pk1 corresponds to 
C91:G139 in Pk2, meaning that in both cases, C>U at this position produced a G:U non-Watson-
Crick base-pair as opposed to full disruption. It was not possible to design a synonymous structural 
mutant of the terminal loop which disrupted Pk2 but not Pk1. In fact, all synonymous mutants 
predicted to disrupt base-pairing of the terminal loop of SL85 disrupted Pk1 to a greater degree 
than Pk2. Thus, the wild-type level of replication displayed by Pk1Lmut also demonstrated that 
Pk2 is unlikely to form. However, two silent mutations in Pk2Smut were sufficient to reduce viral 
replication by ~2 logs in Huh7 cells, indicating a function for this region of SL102 during viral 
replication. AUG1STOP represents a non-synonymous mutant of the terminal loop which disrupts 
Pk2 base-pairing but not that of Pk1 (Fig 5.12A)i)). The compensatory mutant AUG1STOP-Pk2-
Comp contains the mutations of both AUG1STOP and Pk2Smut, designed to restore base-pairing 
in Pk2 (Fig 5.12A)ii)). Although the mutants are non-synonymous, a comparison of AUG1STOP 
and AUG1STOP-Pk2-Comp indicated that restoring base-pairing in Pk2 did not rescue wild-type 
levels of replication. Interestingly, no additive effect was observed for AUG1STOP-Pk2-Comp; 
the replication defect was equal to that of either of the component mutants Pk2Smut and 
AUG1STOP. As described for Pk1, SHAPE mapping of Pk2 may provide structural data without 
the restrictions imposed by phenotypic analysis. Equally, trans-replicase studies could reveal the 
importance of each putative pseudoknot in the template.  
Alternative structures may form involving SL85 aside from Pk1 and Pk2. As discussed above, 
conformational switching between alternative structures may involve the formation of long-range 
RNA:RNA interactions. One example is SL9266 of HCV, which takes part in multiple, mutually 
exclusive long-range interactions with structures in the 5′ and 3′ non-coding regions (430). 
Sequences and structures from the 3′ UTR could be screened for likely interactions with the 
terminal loop of SL85, experimentally or in silico. Circularisation of alphaviral genomes is thought 
to occur by indirect PABP binding, as occurs with cellular mRNA. However, it is possible that 
direct interactions occur between the 5′ and 3′ termini of the CHIKV genome resulting in 
circularisation in vivo. This may be determined by in vivo SHAPE mapping. Alternatively, in vitro 
SHAPE mapping on a 5′ fragment of the CHIKV genome lacking the 3′ terminus may demonstrate 
altered reactivity in SL85. SHAPE studies of the CHIKV 5′ terminus to date have been carried out 
by NMIA treatment of full-length genomic RNA and probed only in the region of interest (13,396). 
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5.3.4 Alternative start codons 
CHIKV replication required the AUG1 start codon in both Huh7 cells and C6/36 cells (Figs 5.12 
& 5.18). This suggested a requirement for full length nsP1 during the viral lifecycle. However, the 
introduction of a stop codon between AUG1 and AUG2 was tolerated during CHIKV replication 
in C6/36 cells. Presumably, introduction of a stop codon prevents generation of full-length nsP1, 
producing a short polypeptide and the truncated form of nsP1 (Fig 5.19). The ability of 
AUG1STOP to replicate to wild-type titres in C6/36 cells may be explained by rapid reversion, 
which could be investigated in the manner described in Chapter 4 for passage mutants. In this case, 
rapid reversion must have occurred independently within 24 hours in AUG1STOP and 
AUG1STOP-Pk2-Comp. A second hypothesis to explain the tolerance for a stop codon between 
AUG1 and AUG2 in C6/36 cells was that the sequence of AUG1 and not functionality as a start 
codon is necessary for viral replication. AUG1 or base-pairing of AUG1:AUG2 may represent a 
binding motif for a trans-activating factor. Insertion of a stop codon immediately following AUG1 
may provide further insight, by preventing translation elongation. Alternatively, the 4 aa peptide 
which would be translated from AUG1 prior to termination in AUG1STOP may be sufficient to 
enact a function of the N-terminus of nsP1 essential to replication. This could be determined by 
supplementing AUG1mut with the 4 aa peptide in trans to determine rescue of viral replication.  
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Figure 5.18: Different requirements for alternative translation initiation in nsp1 in 
mosquitoes and humans. Mutations tolerated in (A) Huh7 and (B) C6/36 cells. Each mutant is 
capable of wild-type levels of replication in the given cell line. Start codons are denoted by a grey 
arrow and labelled according to position and type of start codon: AUG codons AUG1 and AUG2, 
and an alternative UUG codon. AUG>UUG mutation is denoted by a red circle. The introduced 
stop codon is denoted by a red box and labelled STOP. 
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Figure 5.19: Truncation products resulting from introduction of a stop codon between the 
authentic and alternative start sites of nsP1. Schematic representation of CHIKV non-structural 
protein 1, showing wild-type nsP1 relative to the N-terminal truncated mutant (△N-nsP1) and 
AUG1STOP. The N-terminus (N) and C-terminus (C) are labelled, along with each start codon 
AUG1 (Methionine1) and AUG2 (Methionine24). The N-terminal sequence is denoted in darker 
green in wild-type nsP1. The stop codon introduced into AUG1STOP is labelled STOP. 
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A final hypothesis explaining tolerance of the stop codon was drawn from the work of Hemmings-
Mieszczak and colleagues who demonstrated that initiation, elongation and termination of a short 
peptide was required for translation of a downstream open reading frame in cauliflower mosaic 
virus (CaMV) (450). “Toeprinting” of ribosomal initiation and elongation inhibition was used to 
demonstrate that AUG recognition and peptide release of a short upstream open reading frame was 
necessary for ribosomal shunting across a stable secondary structure and initiation at a downstream 
alternative start site. The upstream open reading frame was found to drive ribosomal shunting 
efficiently at only 3 aa in length.  In order to explore this possibility in CHIKV replication, the 
sequence between AUG1 and the stop codon could be replaced with a random 9 nt (3 aa) sequence, 
as the sequence of the peptide was shown not to impact the process in the context of CaMV. 
Alternatively, deep sequencing methods for analysis of ribosomal distribution and accumulation 
on vRNA such as ribosome profiling (Riboseq) could be carried out to determine the relative usage 
of the alternative start site in human and mosquito cells.  
Interestingly, efficient CHIKV replication requires an AUG codon at the second start site in C6/36 
cells, while UUG is preferred at this site in Huh7 cells (Fig 5.15). The UUG codon was selected 
in multiple independent passages in Huh7 cells (Fig 5.14), whereas AUG was present at this site 
in every sequence recovered from C6/36 cells. AUG>UUG mutation represents Met>Leu at the 
amino acid level, thus the lack of tolerance for UUG in C6/36 cells may be due to non-synonymous 
mutation of nsP1 rather than reduced alternative translation efficiency. Investigation could be 
carried out by western blot to determine the presence of △N-nsP1 in C6/36 cells infected with 
UUGmut, alongside phenotypic analysis of a range of non-synonymous mutations at Met24. This 
study is currently being undertaken by K. Loveday (University of Leeds).  
Aside from alteration of protein sequence, UUG weakened the strength of the second start site 
(445) and reduced the number of hydrogen bonds present between AUG1:AUG2 (Fig 5.18A). A 
weaker context for translation initiation may downregulate production of △N-nsP1, preventing 
accumulation of the truncated product in the cell. The cellular location and function of △N-nsP1 
is unknown at present, although the truncated nsP1 may be cytosolic if altered tertiary structure 
prevents anchoring of the replicase polyprotein to the plasma membrane. The preference for UUG 
may represent mammalian cell-specific culture adaptation which would not represent a selective 
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advantage during in vivo infection of a human host. It must be noted, however, that CUG (451) 
and GUG (452) have been demonstrated to act as effective alternative start codons in a range of 
viruses. UUG was selected specifically, perhaps because it represents the weakest translational 
context. 
5.3.5 Conclusion 
The secondary structure of the 5′ 300 nt of the CHIKV genome is essential for viral genome 
replication in human and mosquito hosts. Synergistic and functionally redundant interactions occur 
between stem-loops. There is also the possibility that SL85 exists in a dynamic tertiary interaction. 
Two proximal sites were investigated for potential pseudoknot formation with no conclusive result, 
suggesting that SL85 may be involved in long-range RNA:RNA interactions. The requirements 
for function of an alternative start codon vary between mosquito and human cells.  
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Chapter 6. Final Discussion  
 
CHIKV is a major public health threat, re-emerging in recent years to establish local transmission 
on five continents (453). There are no currently available vaccines or direct-acting anti-viral 
therapeutics. A greater understanding of the CHIKV replication cycle is essential, as much of what 
is known about the replication cycle is assumed from related but divergent alphaviruses such as 
SINV and VEEV. Two regions of 5′ structure have been studied in SFV, SINV and VEEV in the 
context of viral genome replication. The 5′ CSE, conserved as SL3 in CHIKV, forms part of the 
core promoter for negative and positive strand synthesis in mammalian and mosquito cells. The 
importance of the 51 nt CSE during SINV and VEEV replication in mosquitoes has been 
repeatedly demonstrated, but there are conflicting reports of functionality in mammalian cells 
(13,350). This study represents the first investigation of functional elements within the 5′ UTR and 
nsP1-coding region in CHIKV.  
 
Chapter 3 set out to determine the phenotypic importance of each stem-loop SL47-SL246 in human 
and mosquito cells at multiple stages of the CHIKV replication cycle. None of the individual stem-
loops examined were essential for replication in either host. Rather, each stem-loop enhanced viral 
genome replication. Disruption of the stem-loops had no impact on translation of the viral genome, 
acting instead at the level of RNA synthesis. The results of the sub-genomic replicon assays in 
Chapter 3 demonstrate that the stem-loops impact early replication events, subsequent to initial 
translation of the genome and prior to the translation of the sub-genomic 26S RNA. Synthesis of 
positive- and negative-sense genomic RNA and sub-genomic RNA occurs during this phase of the 
viral replication cycle, as well as potential innate immune restriction. The phenotypes observed 
may be due to direct disruption of RNA synthesis mechanisms such as RNA-binding protein 
association or RNA:RNA interactions. Pull-down assays could be carried out to compare binding 
of wild-type and stem-loop mutant RNAs. The differential association of RNA-binding proteins, 
either cellular or viral in origin, with the stem-loop mutants could provide further insight into the 
mechanisms by which they function.  
 
Alternatively, disruption of RNA stem-loops may render viral RNA vulnerable to recognition by 
innate immune mechanisms such as RIG-I or Mda5 binding. Similar pull-down studies may reveal 
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an association of innate immune factors with mutant RNAs, suggesting a role in evasion of host 
immunity. Knock-down or knock-out studies of known interactors, followed by measurement of 
cytokines and chemokines released during infection with mutant RNAs, could determine the extent 
and nature of immune modulation by the structures.  
 
In order to determine which stage of RNA synthesis is affected by disruption of the stem-loops, 
further study could focus on RNA synthesis in CombA-electroporated cells. CombA -
electroporation does not result in or sub-genomic RNA synthesis or production of infectious virus, 
as demonstrated during sub-genomic replicon and virus studies. However, CombA transfection 
may still result in negative-strand intermediate production. The qRT-PCR method of detecting 
positive- and negative-sense genomic RNA used in Chapter 3 could detect production of genomic 
RNA and differentiate between stages of RNA synthesis which depend on the stem-loops. 
 
SL47, a novel stem-loop in the 5′ UTR which is highly conserved among the Old World 
alphaviruses, enhanced genome replication in human- and Ae. albopictus-derived cells (Fig 6.1). 
SL47 has no homologue in SINV or VEEV and these viruses lack the necessary region of the UTR 
entirely. This study is the first to examine the presence and function of SL47 in any alphavirus. 
Given the severe reduction in CHIKV replication in the absence of SL47, similar studies in ONNV 
and RRV may reveal novel targets for prevention of replication in other Old World alphaviruses.  
 
 
Figure 6.1: SL47 UNAfold predicted structures in several Old World alphaviruses. UNAfold 
predicted structure of SL47 for CHIKV ECSA/Asian/WA strains, O’nyong’nyong virus (ONNV), 
Mayaro virus (MAYV), Ross River virus (RRV) and Semliki Forest virus (SFV). 
 
CHIKV SL47
ECSA/ASIAN WA ONNV SL47 MAYV SL47 RRV SL47 SFV SL47
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In contrast to SL47, SL85-SL246 enhanced genome replication in a host-dependent manner. SL85 
and SL102 were mapped as distinct stem-loops in CHIKV, as opposed to the single elongated 
stem-loop mapped in SINV and VEEV (13). During Chapter 3, SL85 and SL102 were 
demonstrated to individually enhance CHIKV replication in mammalian cells. Deletion of the 
elongated stem-loop in SINV had no impact on viral replication in either host, except in the context 
of combined deletion of the 51 nt CSE (357). This suggests that the structural divergence between 
the SINV and CHIKV stem-loops represents functional divergence.  
 
SL165 and SL194, representing the 51 nt CSE of CHIKV, individually enhanced CHIKV 
replication in mammalian cells but were dispensable in mosquito cells. This is in direct contrast to 
studies of the 51 nt CSE in SINV and VEEV which have consistently demonstrated the importance 
of the stem-loops for replication in mosquito cells (350,375). In addition, studies of the 51 nt CSE 
in VEEV have demonstrated that individual disruption of stem-loops in the 51 nt CSE is well 
tolerated in mammalian cells (376). Thus, the structural conservation of the 51 nt CSE in CHIKV 
may not mirror functional conservation. Alternatively, there may be functional redundancy 
between SL165 and SL194 in CHIKV replication in mosquito cells. Pairwise deletion of the stem-
loops may severely inhibit CHIKV replication in mosquitoes, producing a similar phenotype to 
that seen in other alphaviruses. 
 
A stem-loop downstream of the 51 nt CSE, SL246, was investigated for the first time during this 
study. SL246 was demonstrated to enhance replication in mosquito cells and was dispensable to 
replication in mammalian cells, representing the first mosquito-specific replication enhancer in 
alphaviruses, although the effect size is small. Phylogenetic analysis and in silico thermodynamic 
folding predictions suggest that SL246 homologues are present in a range of alphaviruses including 
the insect-specific EILV. Further investigation is required to determine whether SL246 has 
conserved functions within the Alphavirus genus. Interestingly, the host-specific phenotypes of 
stem-loops in nsp1 were not temperature-dependent. Mammalian cells cultured at 28°C exhibited 
the same phenotypes as at 37°C, with the partial exception of SL85. Therefore, the basis of host-
dependent functionality is likely due to differences in protein milieu. Comparative pull-downs in 
mosquito and human cells for wild-type and structural mutants may determine differential binding 
to the 5′ structures. 
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This study was limited to the European CHIKV vector, Ae. albopictus. As previously described, 
Ae. aegypti is a significant vector across the world, including North and South America. The 
functionality of the stem-loops investigated in this study remains to be seen in Ae. aegypti and 
could be determined by similar studies in Ae. aegypti-derived A20 cells. Both A20 and C6/36 cells 
have defective RNAi pathways. Alternative immunocompetent cell lines such as Aag2 and U4.4 
could be optimised. Furthermore, infection and passaging studies would benefit from the use of in 
vivo mosquito models. Infection within an individual mosquito is far more complicated than can 
be measured using cell culture systems, in particular the bottlenecks of quasispecies diversity 
which occur between the midgut and haemocoel. Similarly, mouse models, 3D vascularised 
epidermal cultures or primary human muscle cell lines may provide further insight into the 
dependence of CHIKV on stem-loops during replication in mammalian tissues. 
 
The sequence and structure requirements for stem-loop functionality were explored in Chapter 4 
via phenotypic studies and passaging of mutants to examine potential routes of reversion. Each of 
the stem-loop mutants investigated could be rescued by compensatory mutations which restored 
base-pairing in the stem, indicating that the sequence of the stems was not essential for 
functionality. Furthermore, extensive mutations in the single-stranded bulges and terminal loop of 
SL102 and SL246 had no impact on CHIKV replication. Mutations in the terminal loop of SL194 
produced a 10-fold decrease in viral genome replication, while terminal loop mutations of SL165 
and SL194 reduced virus replication 100-fold. This is in agreement with the 100-fold decrease in 
SINV replication upon similar mutations in the 51 nt CSE (375).  
 
Passaging of the stem-loop mutants resulted in direct reversion to the wild-type sequence, with a 
single exception in which a compensatory mutation became fixed. In contrast, studies in SINV and 
VEEV often produced pseudorevertants in interacting proteins such as nsP2 and nsP3. These 
studies passaged extensively mutated constructs (>40 mutations) or deletion mutants which 
prevented direct reversion. Extensive mutation (17 mutations) of CHIKV during Chapter 5 
abolished replication, precluding this form of study. However, CombmutC displayed a low level 
of replication which may be sufficient to establish passaging studies. Pull-downs carried out by 
M. Müller (University of Leeds) demonstrated strong co-precipitation of nsP3 with a fragment 
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comprising the 5′ 300 nt of the CHIKV genome. Therefore, passaging of CombmutC could be 
carried out and any revertant viruses sequenced to probe for pseudoreversion, particularly in nsP3. 
A common theme during passaging was the incremental restoration of the stem-loops beginning 
with the apical region. Sequences capable of reforming the apical loop and stem of SL47, SL102 
and SL194 were detected during early passages before full structure reformation. This suggests 
that partial structure restoration is preferable to sequence restoration at the base of the stem. 
Interestingly, stem-loops which had proven dispensable to replication in mosquito cells were 
conserved during passaging in C6/36 cells and conversely for SL246 in mammalian cells.   
 
Although a single sequence for each mutant virus was presented for the passages 0-10 in Chapter 
4, it is important to note that each passage contained a quasispecies. Each round of replication 
produces a staggering number of genomic variants of differing frequencies. The sequences 
presented in Chapter 4 are composites, determined by the most common nucleotide at each 
position, as measured by Sanger sequencing of a sample of the quasispecies population. The 
consensus sequence produced from this data is an average of the population and does not represent 
a single genomic sequence. More information about the makeup of the quasispecies could be 
gained using next-generation sequencing (NGS) methods. NGS methods exhibit higher sensitivity 
to detect low-frequency variants and higher numbers of reads, resulting in greater sequencing 
depth and more information about the prevalence of certain mutations within the quasispecies. 
NGS methods could also reveal the comparative complexity of quasispecies in mammalian and 
mosquito cells, which may account for the differences in relative reversion rates. 
 
The potential for synergistic interactions and functional redundancy between the stem-loops was 
explored in Chapter 5. Synonymous site mutations which disrupted the stem-loops SL47, SL85, 
SL102, SL165 and SL194 in combination abolished viral genome replication in human and Ae. 
albopictus cells. This was particularly interesting given that SL85-SL194 had no individual impact 
on replication in mosquito cells. Therefore, it is likely that these stem-loops are functionally 
redundant in mosquito cells but not in mammalian cells. Host-specific redundancy has been 
observed in another arbovirus, DENV. Two stem-loops in the 3′ UTR of DENV, SL-I and SL-II, 
each impact viral replication in mosquito cells but are functionally redundant in the human host 
(393). Similarly, SL47 and SL246 exhibit synergistic interactions during infection of mammalian 
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cells while SL246 has no individual impact on replication in the same cells. Multiple and pairwise 
mutations will be necessary to untangle the minimum set of structures required for CHIKV 
replication in both hosts. The effect of extensive synonymous site mutation in the 3′ 500nt of 
alphaviral genomes is particularly contentious. One study in SINV introduced 43 synonymous 
mutations into the 5′ 300 nt which abolished replication in mosquito cells but had no impact on 
viral replication in mammalian cells (350). A second study in SINV mutated the homologues of 
SL85-SL194 and found a 50-fold decrease in viral replication in mammalian cells and a 5-fold 
decrease in negative strand synthesis in vitro (357). Similar mutations in VEEV abolished 
replication in both hosts (376). Thus, the conclusions made during this study are limited to CHIKV.  
 
Chapter 5 also explored the potential for tertiary structure formation around SL85. Two proximal 
sequences with complementarity to the terminal loop of SL85 were probed for pseudoknot 
formation by reverse genetic analysis. Neither the upstream or downstream sequences could be 
rescued by double mutation, suggesting that the putative pseudoknots do not form. The analysis 
was complicated by the presence of the AUG1 initiation site within the upstream sequence and 
limitations of synonymous mutation within the terminal loop of SL85. SHAPE analysis of more 
extensively mutated pairings would more conclusively determine the potential for pseudoknot 
formation. Alternatively, long-range interactions may occur with the terminal loop of SL85, which 
could be investigated by SHAPE on fragments of the genome and pairs of fragments such as the 
5′ and 3′ termini. In addition, trans replicase assays could determine the ability of the pseudoknot 
mutants to act as templates when the Kozak context is mutated.  
 
Finally, single-host passaging revealed host-specific preferences around the alternative start site 
AUG2. UUG was selected at the second start site in all mammalian-passaged strains, which was 
poorly tolerated by mosquito cells. Conversely, mosquito cells tolerated the insertion of a stop 
codon between AUG1 and AUG2, which was not tolerated in mammalian cells. Therefore, the 
requirements for alternative translation differ between human and mosquito cells. Further work is 
needed to elucidate the different mechanisms of alternative translation. Studies of the shunting 
mechanism in cauliflower mosaic virus utilised initiation and elongation inhibitors in combination 
with ribosomal toeprinting to demonstrate the requirement for initiation at the first start site in 
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promoting translation from the second (450). A similar approach in CHIKV may determine 
whether shunting occurs across SL85 and SL102 during translation in mosquito cells.  
 
Further work is needed to determine the mechanisms by which stem-loops in the 5′ region of 
CHIKV enhance replication. In particular, interacting partners such as nsP2 and nsP3 which have 
been identified in preliminary studies could be serially truncated to identify specific RNA binding 
sites. Conversely, the ability of non-structural proteins to bind to disrupted stem-loop mutants 
during EMSA could identify the sequence and structure requirements for interaction. Further study 
of the structure of the CHIKV genome would also provide insight into the mechanism of CHIKV 
replication, particularly exploration of tertiary structure by NMR or hydroxyl radical footprinting, 
investigation of dynamic changes over the course of the viral replication cycle and isolation of 
genomic RNA from different intracellular locations. The secondary structure map of the CHIKV 
5′ 300nt provides a foundation for a deeper understanding of the mechanisms by which CHIKV 
utilises RNA structure to direct genomic replication. 
 
In addition to broadening knowledge of CHIKV and alphaviral replication, the stem-loops 
characterised within this work represent targets for attenuation during vaccine design. RNA stem-
loops within the CHIKV genome could be mutated, alongside independent targets such as 
envelope proteins, to produce a heavily attenuated live CHIKV vaccine. The data presented in 
Chapter 5 indicates that combinations of stem-loop mutants would be most effective in attenuating 
the virus and maintaining genetically stable mutations. Alternatively, the stem-loops may represent 
targets for drug design as has been achieved for HIV-1 RNA secondary structures with the drug 
NSC (323). Drug targeting may provide a specific therapeutic for CHIKV-induced disease which 
would greatly reduce the suffering associated with infection.  
 
6.1  Conclusion 
The secondary structure of the 5′ 300 nt of the CHIKV genome is essential for genome replication 
in human- and Ae. albopictus-derived cells. The novel stem-loop SL47 in the 5′ UTR functions in 
a host-independent manner while individual stem-loops in nsp1 function in a host-dependent 
manner. Base-pairing within the stems represents the greatest determinant of replication 
enhancement, with a high tolerance for sequence substitution. Further research is necessary to 
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determine the mechanisms of action and tertiary interactions of the stem-loops during CHIKV 
replication. 
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Appendix 
 
Primer name Primer sequence 
Sequencing Primers 
CHIKV_0_FWD ATGGCTGCGTGAGACACAC 
CHIKV_5_REV CTACGTGTGTCTCACGCAG  
CHIKV_729_REV   TTGCCTCGTCTACCTTCCG  
CHIKV_1585_REV  GCTTCGCGAGTCAGTTCT   
CHIKV_2401_REV GACTGGTCTGTTGCATCCA  
CHIKV_3123_REV GAGGATAGGGACCAAGCTCT 
CHIKV_3945_REV GTGTCACCAGCAACACTGAG 
CHIKV_4817_REV TGCGTCTGCATCATCCAC   
CHIKV_5590_REV CGCTGTCTGTCAAGTCATCC 
CHIKV_6389_REV TCCTAATAGGGCTGGCAGC  
CHIKV_7196_REV CCTGTCACAGTATCGTGCAG 
CHIKV_7946_REV CTTGCTCACGAATACGACGG 
CHIKV_8432_FWD TGCTGGTGCCCACACTAT   
CHIKV_8599_REV CGCTGGTTGTTTCTGTCAG  
CHIKV_9194_FWD TTAAGGCCAAGAAGGGCGG  
CHIKV_9995_FWD CCCCTGACGAGCATCACAAA 
CHIKV_10805_FWD GACTCCCCGTCGTGTAGAT  
CHIKV_11560_FWD AAGGGAATAAGGGCGACAC  
ORF2 Sequencing Primers 
CHIKV_7471_FWD CGTCATAACTTTGTACGGCGG 
CHIKV_8206_FWD GGCAGACCGATCTTCGACAA 
CHIKV_9084_FWD GTCACAACAGTCCGGCAAC 
CHIKV_9920_FWD GACTCTTACCATGCTGCTGT 
CHIKV_10765_FWD GGCTGCCAAATAGCAACAA 
Passaging Sequencing Primers 
CHIKV 1-20_FWD ATGGCTGCGTGAGACACACG 
CHIKV 1018_REV CCGTGTCGGTAGTCTTGCAC 
CHIKV 989_REV CCGTCTGCGTGGTGGGTTAC 
Walking Sequencing Primers 
CHIKV_301_FWD CAGGAAGTACCACTGCGTCTGCCCG 
CHIKV_1209_FWD CCATGAAAAATTATCTGCTTCCCGTGGTCGCCCAAGCC 
CHIKV_1284_REV CCATGTCTTTCCGGCACTCCTTTGCCCACTTAC 
CHIKV_2103_FWD GCTGTAAGAAGGAAGAAGCCGCAGGACTGG 
CHIKV_2186_REV GCCCTTCATATGCGAATTCGTGGTAGGGCGG 
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CHIKV_3002_FWD GGAAACTTCAAAGCAACTATTAAGGAGTGGGAGG 
CHIKV_3082_REV GGTCATTTGGTGACTGCAGATGCCCGCC 
CHIKV_3930_FWD CGTTGAAACCACCATGTGTCACCAGCAACAC 
CHIKV_4003_REV CCTTCTGCCATTGTCAAAGTTGCTGAATAGG 
CHIKV_4830_FWD ACGCATCATCTCCCCCCAAAACTGTCCCG 
CHIKV_4892_REV CGCGTTCTGGAGTCATAGCGTAACGGC 
CHIKV_5467_FWD GCCGATCTCCTTCGGAGCATCAAGCG 
CHIKV_5518_REV GTCCCCAAATGTAATGGGGAACGTCTCGC 
CHIKV_6341_REV CCACGTTGAATACTGCTGAGTCCAAAGTGGG 
Combination Mutagenesis Primers 
SL84_FWD  ATGGATCCTGTATACGTGGACATCGACGCTGACAG 
SL84_REV CTGTCAGCGTCGATGTCCACGTATACAGGATCCAT 
SL102_FWD GCCTTTTTGAAAGCCCTACAACGTGCATACCCCATGTTTG 
SL102_REV CAAACATGGGGTATGCACGTTGTAGGGCTTTCAAAAAGGC 
SL165_FWD CAAGGCAGGTAACACCGAATGACCATGCAAATGCTAGAGC 
SL165_REV GCTCTAGCATTTGCATGGTCATTCGGTGTTACCTGCCTTG 
SL194_FWD GCGTTCTCGCACCTCGCTATAAAACTAATAG 
SL194_REV CTATTAGTTTTATAGCGAGGTGCGAGAACGC 
SL246_FWD AAATTGACCCGGACTCTACAATACTGGATATCGGGAGTGCCCCAG 
SL246_REV CTGGGGCACTCCCGATATCCAGTATTGTAGAGTCCGGGTCAATTT 
Compensatory Mutagenesis Primers 
SL84c_FWD  ATCATGGATCCGGTATACGTGGATATCGACGCTGAC 
SL84c_REV GTCAGCGTCGATATCCACGTATACCGGATCCATGAT 
SL102c_FWD CGTGGACATAGATGCTGATAGCGCTTTTTTGAAAGCCCTAC 
SL102c_REV GTAGGGCTTTCAAAAAAGCGCTATCAGCATCTATGTCCACG 
SL165c_FWD CAAGGCAGGTTACACCGAATGACCATGCCAATGCTAGAGC 
SL165c_REV GCTCTAGCATTGGCATGGTCATTCGGTGTAACCTGCCTTG 
SL194c_FWD CATGCTAATGCGAGGGCGTTCTCGCAC 
SL194c_REV GTGCGAGAACGCCCTCGCATTAGCATG 
SL246c_FWD1 AAATTGACCCGGACTCGACTATTCTGGATATCGGGAGTGCGCCAG 
SL246c_REV1 CTGGCGCACTCCCGATATCCAGAATAGTCGAGTCCGGGTCAATTT 
SL246c_FWD2 AGGATGATGTCCGACAGGAAGTACC 
SL246c_REV2 GGTACTTCCTGTCGGACATCATCCT 
Terminal Loop Mutagenesis Primers 
194i_terminal_loop_FWD CATGCTAATGCTAGAGCGTTTTCGCATCTAGCTATAAAAC 
194i_terminal_loop_REV GTTTTATAGCTAGATGCGAAAACGCTCTAGCATTAGCATG 
SL165i_terminal_loop_FWD GTGGAACCAAGGCAGGTCACTCCTAATGACCATGCTA 
SL165i_terminal_loop_REV TAGCATGGTCATTAGGAGTGACCTGCCTTGGTTCCAC 
SL165ii_terminal_loop_FWD GTGGAACCAAGGCAGGTCACGCCAAATGACCATGCTA 
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SL165ii_terminal_loop_REV TAGCATGGTCATTTGGCGTGACCTGCCTTGGTTCCAC 
SL165iii_terminalloopFWD GTGGAACCAAGGCAGGTCACCCCGAATGACCATGCTA 
SL165iii_terminal_loop_REV TAGCATGGTCATTCGGGGTGACCTGCCTTGGTTCCAC 
SL165iv_terminal_loop_FWD GGAACCAAGGCAGGTAACACCGAACGACCATGCTAATGCTA 
SL165iv_terminal_loop_REV TAGCATTAGCATGGTCGTTCGGTGTTACCTGCCTTGGTTCC 
Pseudoknot Mutagenesis Primers 
Pk1 L _mut_FWD TAACCCATCATGGATCCTGTCTATGTCGACATAGACGCTGACAGC 
Pk1 L _mut_REV AAGGCGCTGTCAGCGTCTATGTCGACATAGACAGGATCCATGATG 
Pk1S_mut_FWD CAAGAGATTAATAACCCAAGATGGATCCTGTGTACGTGGACATAG 
Pk1S_mut_REV GTCTATGTCCACGTACACAGGATCCATCTTGGGTTATTAATCTCT 
Pk1-Comp_FWD TTAATAACCCATGATGGATCCTGTATATGTCGACATAGACGCTGAC 
Pk1-Comp_REV GTCAGCGTCTATGTCGACATATACAGGATCCATCATGGGTTATT 
Pk2S_mut_FWD GGCCCTGCAACGTGCCTATCCCATGTTTGAGGTGG 
Pk2S_mut_REV CCACCTCAAACATGGGATAGGCACGTTGCAGGGCC 
AUG1STOP_FWD CCCATCATGGATCCTGTATAGGTGGACATAGACGCTG 
AUG1STOP_REV CAGCGTCTATGTCCACCTATACAGGATCCATGATGGG 
AUG1mut_FWD GCAAGAGATTAATAACCCATCGCGGATCCTGTGTACGTG 
AUG1mut_REV CACGTACACAGGATCCGCGATGGGTTATTAATCTCTTGC 
Passage mutant mutagenesis primers 
UUGmut_FWD GCCCTGCAACGTGCGTACCCCTTGTTTGAGGTGGAACC 
UUGmut_REV GGTTCCACCTCAAACAAGGGGTACGCACGTTGCAGGGC 
SL194mut(A199G)_FWD CCATGCTAATGCTAGGGCGTTCTCGCACCTCGCTATAAAAC 
SL194mut(A199G)_REV GTTTTATAGCGAGGTGCGAGAACGCCCTAGCATTAGCATGG 
 
Table 1: Oligonucleotide primers 
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SL47mutWT: SL47
SL85mut
WT: SL85
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WT: SL102
SL102mut
SL165mutWT: SL165
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Table 2: UNAfold predictions of stem-loop mutants in the positive strand relative to WT 
SL194mutWT: SL194
SL246mutWT: SL246
